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1.0 Abstract 
Chronic lymphocytic leukemia (CLL) and non-localised low grade or indolent 
lymphomas (LGL) are two of the common cancers that individuals are diagnosed with in 
the UK. Both of these chronic illnesses are considered slow growing and these 
individuals are often diagnosed when one is not exhibiting any symptoms from the 
cancer. For a high proportion of individuals who are diagnosed with these forms of 
cancer, they are subject to a form of care known as “watch and wait”. As conventional 
chemotherapy treatments do not cure the disease nor prolong survival, a policy of watch 
and wait is utilized until the patients become symptomatic from the disease. For those 
patients who have been given a diagnosis of CLL, the watch and wait approach will 
include periodic medical examinations and laboratory analysis to determine whether the 
disease is stable or beginning to progress. The goal is of course to maintain QOL by not 
administering unnecessary treatment rather than ‘least invasive treatment’. Such an 
approach is due to the fact that the research has not evidenced a medical benefit for early 
intervention. Since being given a diagnosis of cancer and being told that there would be 
no immediate intervention may be contrasting to how an individual would conceptualize 
cancer, the researchers questioned the impact that such a diagnosis and form of care can 
have on the individual’s well-being. Participants with a diagnosis of CLL or LGL were 
recruited to complete psychological questionnaires (uncertainty in illness, anxiety, 
depression posttraumatic stress). These questionnaires were administered 4 times over a 
12-month period to determine the impact of the diagnosis and what being placed on 
watch and wait has on their psychological well-being. Results indicated that a high 
proportion of participants were above clinical cut-off at time-1, but that there was also 
not much group or individual change over the 6-month time period. Results also 
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highlighted that posttraumatic stress at time-1 was the strongest predictor of 
psychological distress at 6-months, and a number of strong relationships between the 
psychological variables were also found at time-1, following the participants’ initial 
diagnosis. Although preliminary, the findings were not in keeping with initial hypotheses 
that psychological distress would decrease over time-1, as participants developed greater 
understanding and had less uncertainty about their illness as well as watch and wait as a 
form of care. The findings suggest that the there is an impact that such a diagnosis and 
form of care can have on an individual psychologically, and more research needs to be 
undertaken to understand this effect and how to better support these individuals with 
their diagnosis of cancer. 
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2.0 Introduction Chapter 
 
2.1 Introduction Overview 
 
The introduction chapter of this thesis provides important definitions, a systematic 
review of the literature, and the various aims and hypotheses of the research. 
Specifically, the introduction will attempt to provide the reader with an understanding of 
chronic lymphocytic leukemia (CLL) and low grade lymphoma (LGL) in terms of 
prevalence, incidence, causes, and different forms of intervention, including watch and 
wait. In addition, definitions of chronic illness and psychological constructs have been 
covered, specifically psychological constructs such as anxiety, depression, and trauma as 
they relate to those individuals who have a diagnosis of cancer. The chapter has also 
defined Mishel’s theory of uncertainty in illness and considers how her theory has been 
applied to cancer research. Following the broader definition of terms, the chapter 
contains an analysis of the current literature in terms of uncertainty in illness, anxiety, 
depression and trauma and considers how these constructs have been investigated in 
people with CLL and LGL. The analysis also includes how Mishel’s uncertainty in 
illness theory has been researched in individuals with other forms of cancer, as there 
were no papers from the literature that dealt with uncertainty in illness in individuals with 
CLL or LGL. A synthesized discussion of the current literature is provided as well as a 
methodological critique and, finally, the gaps in the current literature have been 
highlighted which provides a rationale as to why this research project has been 
undertaken 
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2.2 Chronic Lymphocytic Leukemia: Prevalence, Incidence, and Morbidity  
 
Chronic Lymphocytic Leukemia (CLL) is the most common Leukemia in the western 
world and it accounts for a third of all leukemia diagnoses in the UK, with an overall 
prevalence estimated to be upwards of 20,000 (Else et al., 2012; Cancer Research UK, 
2009). CLL occurs more frequently in men than in women; 90% of the individuals who 
are affected with CLL are over 50 years of age and the average age of initial diagnosis is 
approximately 65 years (Zent, Kyasa, Evans & Schichman, 2001; Holzner et al., 2004; 
Bhayat, Das-Gupta, Smith, McKeever & Hubbard, 2000). The cause of CLL is unknown 
and there has been no established links of a diagnosis of CLL to previous chemotherapy 
or radiation exposure, as can be seen with other forms of acute leukemia. There are also 
no clear connections to viral infection, nicotine use, or diet (Elphee, 2008). CLL is 
identified by an accumulation of lymphocytes within the peripheral blood, bone marrow, 
lymph nodes or tissue, and spleen, and these cells continue to grow and accumulate as 
they have “escaped” programmed cell death (Harris et al., 1990; Dighiero, 2003; 
Dighiero, 2005). Specifically, CLL begins in a type of lymphocyte called a B cell. In 
CLL, these B cells escape the body’s mechanisms that control how long cells live and 
how they are able to multiply, which can result in the cells not working correctly and 
multiplying uncontrollably. These B cells that multiply in an uncontrolled manner are 
referred to as ‘malignant B cells’ and, over time, these malignant B cells can accumulate 
and disrupt the production of normal blood cells as they build up in the bloodstream, 
bone marrow, and lymph nodes (Else et al., 2012). Approximately 75% of patients are 
diagnosed with CLL following a routine blood count and, at the time of diagnosis, they 
may not have any symptoms that are commonly related to the diagnosis (Matutes et al., 
1994; Kaufman, Rubin & Rai, 2009).   
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Throughout the course of this chronic illness, one-third of those diagnosed with CLL will 
never require any form of treatment; one third will require an intervention during the 
time they have the disease; and the final third, who present with symptoms, will require 
an immediate intervention at the time of diagnosis (Dighiero & Binet, 2000; Dighiero, 
2003).  However, for those individuals who will eventually require an intervention, 
symptoms tend to develop slowly and initial symptoms may include weight loss, swollen 
lymph nodes, fever and night sweats, excessive bruising, fatigue, weakness, shortness of 
breath or more frequent infections (Cheson et al., 1996; Cancer Research UK, 2009). 
Aside from CLL, the study will also be recruiting individuals who have a diagnosis of 
low grade lymphoma and who have also been placed on the watch and wait pathway.    
  
2.3 Low Grade Lymphomas: Prevalence Incidence and Morbidity 
Lymphomas are solid tumors of the immune system. Hodgkin's lymphoma accounts for 
about 10% of all lymphomas and the remaining 90% are referred to as non-Hodgkin 
lymphoma. Non-Hodgkin lymphomas have a wide range of clinical features at 
presentation and the course of lymphoma can vary based on the rate of growth. Non-
Hodgkin’s low grade lymphomas or indolent low grade - Lymphomas (LGL) tend to 
progress slowly and much like CLL, patients are often not symptomatic early in the 
course of the disease (Cheson et al., 2007; Cancer Research UK, 2008). For the purposes 
of this research, only individuals who have a diagnosis of non-localized indolent non 
Hodgkins lymphoma will be under study. The primary difference between those patients 
with a diagnosis of CLL and LGL is that the malignant B cell will typically proliferate 
preferentially in the lymph nodes rather than blood (Cheson et al., 2007).  
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Two-thirds of the patients who are initially diagnosed with the disease are over the age of 
60; the disease occurs equally in both men and women. Unlike CLL, there are more 
established risk factors for the onset of non-Hodgkin lymphoma and the most common 
risk factor is immune-suppression. (Horning & Rosenberg, 1984; Shakland, Armitage & 
Hancock, 2012). Also, whilst lymphoma can be seen in immune suppressed patients the 
vast majority of low grade lymphoma cases are idiopathic. 
 
2.4 Watch and Wait - Chronic Lymphocytic Leukemia (CLL) or Low Grade  
 
Lymphoma (LGL) 
 
As outlined above, after receiving a diagnosis of CLL or LGL, approximately one-third 
of patients will receive some form of direct intervention to deal with the illness 
(generally immunochemotherapy but radiotherapy for some localized LGLs). However, 
the remaining two-thirds of patients who do not require an immediate intervention are 
given the initial diagnosis of CLL and then are subject to an approach of “watch and 
wait”. It has been determined that, as conventional chemotherapy treatments do not cure 
the disease, a policy of watch and wait is utilized until the patients become symptomatic 
from the disease (Spaner et al., 2005; Binet et al., 2006). 
 
For those patients who have been given a diagnosis of CLL, the watch and wait approach 
will include periodic assessment to determine whether the disease is stable or beginning 
to progress. Features that would suggest progression of the disease include rapid increase 
in the number of lymphocytes in the blood, a decrease in the overall number of platelets, 
an increase in the size of the spleen or lymph nodes, worsening anemia, and other 
symptoms, such as weight loss, fatigue, fever, etc. (Spaner et al., 2005; Spaner et al., 
2007). The watch and wait approach is based on research that suggests immediate or 
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early treatment of patients with a ‘low or intermediate level’ of the disease does not 
prolong the life of the patient (Dighiero et al., 1998; Tam et al., 2014). CLL is an 
extremely heterogeneous disease and some patients can live for decades without any 
need for intervention; therefore, the goal of therapy for these patients is to maintain the 
highest quality of life (QoL) and avoid unnecessary treatment (Gribben, 2010). For 
clinicians to deviate from this watch and wait approach, the research would need to 
demonstrate either the benefits of earlier medical intervention (Hallek & German, 2005; 
Dighiero & Binet, 2010). 
 
Similarly, to CLL, many of the patients who are diagnosed with LGL are asymptomatic 
at the time of diagnosis and again similar to CLL, these patients are normally subject to 
the approach of watch and wait (Ardeshna et al., 2003; Armitage & Longo, 2016). In the 
past, different approaches have been used to treat these individuals who have been given 
the diagnosis of non-localized LGL; to date, none of these initial interventions have 
proven to result in a ‘long-term disease free’ outcome (Linch, 2001). The inability of 
either chemotherapy, even if combined with radiotherapy, to achieve a lasting cure has 
led researchers to question whether there is a need to immediately treat patients with 
LGL using such an aggressive intervention especially if there are no “distressing 
symptoms or life-threatening organ impairment” (Ardeshna et al., 2003; El-Galaly et al., 
2015). Much like CLL, the research does not indicate an overwhelming positive impact 
for immediate treatment; the patient’s QoL needs to be considered and it is deemed more 
prudent to place the patients on watch and wait until they become symptomatic from the 
disease (Horning & Rosenberg, 1994; Horning, 2000). Although it may seem perplexing 
to these individuals who are given the diagnosis of CLL or LGL, the main benefit for 
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these patients on watch and wait is that they are not exposed to a serious form of 
treatment before it is deemed necessary. Such an approach may seem counterintuitive to 
individuals in westernized cultures and to those who have just received a diagnoses of 
CLL or LGL in that the western approach to illnesses is to deal with it before the disease 
becomes too aggressive. Since the majority of individuals who have just received a 
diagnosis of CLL or LGL will not have any understanding of the research, and why early 
intervention may not result in an improved outcome for them, watch and wait can 
possibly lead to a degree of confusion, distress and uncertainty.  
 
2.5 Chronic Illness 
 
Both CLL and LGL are considered to be ‘chronic illnesses’ in that they are both an 
illness that an individual may have for a prolonged period of time and one does not 
spontaneously remit; and they are rarely cured completely (Centers for Disease Control 
and Prevention, 2003). As stated in the above definition, such chronic conditions such as 
CLL and most LGLs are incurable and the goal of any form of medical treatment is to 
avoid unnecessary treatment but when treatment does become necessary the aims are to 
induce durable remissions prolong survival and reduce the level of suffering. The World 
Health Organization (WHO) has stated that the burden of chronic diseases will be one of 
the greatest challenges that will face health care systems globally (WHO, 2005; Lupkin 
& Karsen, 2006). Increasing life expectancies, “modernization of lifestyle”, with an 
increasing exposure to different chronic disease risk factors, and the ever-improving 
ability of medical interventions to treat individuals who would have historically died, 
have all combined to change the burden of disease that are currently having a great 
impact on health-care systems (Wagner, Austin, Davis, Hindmarsh, Schaefer & Bonomi, 
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2001; Nolte & McKee 2008). Many of these chronic conditions (stroke, HIV, cancer, 
asthma, etc.) will require a “complex response” over an extended period of time which 
will most likely require involvement from a number of different health professionals 
(Wagner, Austin, Von Korff, 1996; Bodenheimer, Wagner & Grumbach, 2002; Unwin, 
Jordan & Bonita, 2004).  
 
As the prevalence and incidence of chronic diseases have been increasing globally, due 
to the aforementioned factors, research has also increased into the concept of QoL, for 
those individuals suffering with a chronic disease. The WHO defines QoL for an 
individual as: 
 
Perceptions of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns QoL 
is the feeling of overall life satisfaction, as determined by the mentally alert individual 
whose life is being evaluated” (WHO, 1996).  
 
 
A common factor that would impact on an individual’s QoL could be the level of 
uncertainty with regards to the illness. Such a degree of uncertainty can be understood in 
terms of the individual’s future health and the prognosis of their illness, what the 
symptoms may mean when a diagnosis cannot readily be made, and the speed of how 
quickly the illness may progress (Mishel, 1999).   
 
2.6 Uncertainty in Illness 
Mishel’s 1988 paper Finding Meaning: Antecedents of Uncertainty in Illness, put forth a 
theory about how an individual interprets an illness-related event. Mishel’s theory 
postulates that uncertainty in illness is defined as a cognitive state resulting from 
insufficient cues or knowledge; specifically, an individual is unable to form meaning to 
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the illness or illness-related event. The theory (1988) proposed that the ability of the 
individual to tolerate or cope with uncertainty could allow the individual to remain 
hopeful and decrease their level of anxiety or, conversely, the inability for an individual 
to manage uncertainty as it related to their illness can lead to an increase in an 
individual’s level of anxiety and lower one’s mood (Mishel & Braden, 1988). Mishel’s 
uncertainty in illness theory was initially influenced by cognitive psychologists (Bower, 
1978; Shalit, 1977) who conceptualized the construct of uncertainty as being a cognitive 
stressor for an individual and by (Budner, 1962) who described “ambiguous, novel, or 
complex stimuli” as being sources of uncertainty (Smith, 2013).  In addition, the original 
uncertainty in illness model comprised four distinct, yet connected forms: firstly, a level 
of ambiguity concerning the state of the illness; secondly, the degree of complexity 
regarding the treatment of the illness and the overall system of care that one finds oneself 
in; thirdly, a lack of information regarding the diagnosis or seriousness of the illness; and 
finally, the unpredictability with regards to the course of the disease or the initial 
prognosis (Mishel, Hottstetter, King & Graham, 1984).   
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Within the theory, there are two appraisal processes that the individual makes in regards 
to the above four different forms and the significance that is placed on the uncertainty: 
inference and illusion. Inference relates to the evaluation of uncertainty based on the 
examples the individual can draw upon from similar situations. Similarly, to what was 
highlighted previously, if the inferences are seen as positive, the uncertainty may be 
appraised as an opportunity. If the inferences are viewed to be ‘threatening’, then the 
uncertainty will be understood as being a danger. Secondly, illusion refers to the 
construction of beliefs that have an overall positive outlook. Due to the vague and 
nebulous nature of uncertainty, the illness-related events could be formed into an illusion 
that would indicate a positive outcome. Illusion is only used when the illness has a 
negative outlook or downward trajectory; wherein, any uncertainty the individual 
encounters may be understood and translated into a positive (Mishel, 1984; Mishel & 
Braden, 1988; Mishel, 1990; Mishel, Braden, Grant & Sorenson, 1991).  
 
Mishel’s initial research in regards to her uncertainty in illness construct and the 
theoretical underpinnings that she developed primarily focused on those individuals who 
were dealing with the acute phase of illness, or when their health was on a clear 
downward trajectory (Mishel, 1984; Mishel & Clayton, 2008). The initial focus of her 
theory did not address the experience of those people who were living with continuing, 
constant uncertainty as a result of having a chronic disease. The original theory 
postulates that the appraisal of uncertainty as an opportunity would only occur when 
there is a clear negative outcome. Essentially, the theory is highlighting something that is 
logical: when the outcome is certainly a negative then uncertainty would be a more 
‘preferable state’ (Mishel, 1990). However, there were conflicting findings (King & 
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Mishel, 1986; Mishel & Murdaugh, 1987; Mishel, 1988b), which led Mishel to re-
conceptualize the theory in one specific area: that is when an individual is suffering from 
a chronic illness with a long-term downward trajectory. The re-conceptualized theory 
highlighted that if one is dealing with a chronic illness with a downward trajectory, the 
individual may shift from the initial uncertainty experienced following diagnosis to a 
point where uncertainty becomes the “foundation within which the person’s sense of 
order is constructed”. Therefore, when it is thought that the chronic illness will have a 
negative outcome, the individual may reformulate their thinking and use uncertainty as a 
protective factor, hoping for a more positive outcome in relation to their chronic illness 
(Mishel, 1990, McCorkmick, 2002; Neville, 2003). Although not a major departure from 
the original theory, it is an important addition nonetheless, as it considers those patients 
who are dealing with a chronic condition.  
 
Since Mishel’s seminal work, research has been conducted using her theory in an attempt 
to understand how individuals are able to manage and interpret diseases such as cancer, 
where the outcome of the disease may be uncertain for the patient (Mishel & Sorenson, 
1991; Clayton, Mishel & Belyea, 2006; Bailey, Wallace & Mishel, 2008; Suzuki, 2012). 
Specifically, research has been conducted in various cancer related illnesses to examine 
the relationship of how an individual’s uncertainty in relation to their illness can have an 
impact on the individual’s psychological well-being (Nelson, 1996; Mishel et al., 2002; 
Bailey, Mishel, Beylea, Stewart & Mohler, 2004; Wellam & Degnar, 2007). 
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2.7 Psychological Constructs and Cancer  
2.7.1 Anxiety and Depression  
There has been much research undertaken to attempt to understand the impact of cancer 
on an individual’s mental health. Specifically, research has examined the level of anxiety 
and depression that an individual experiences following a diagnosis of cancer, as well as 
a large number of intervention type studies to support the individual with mental health 
difficulties that may be associated with a cancer diagnosis (Sheard & Maguire, 1999; 
Osborne, Demoncada & Fuererstein, 2006). Recent estimates give the prevalence to be 
between 15 – 40% of patients who have been diagnosed with cancer will have symptoms 
of anxiety and low mood, which will have an impact on their overall functioning (Massie 
& Holland, 1990; Parle et al, 1996). The research also indicates that even for those 
individuals who have been “ostensibly cured” of cancer, the rates of anxiety and 
depression are higher than those individuals in the general population (Linden et al., 
2012). It is also important to note that research on anxiety and depression in relation to 
cancer has highlighted that individuals suffering from mental health difficulties as a 
result of the cancer diagnosis tend to have longer hospitalization, higher mortality, and a 
decreased level of overall emotional well-being (Prieto et al., 2002; Pinquart & 
Duberstein, 2010; Reich, Lesur, & Perdrizet- Chevallier, 2008). There has also been 
research done to understand the mechanisms or thinking behind the distress associated 
with such a medical diagnosis. For instance, the perception of cancer as a threat is an 
important aspect in understanding anxiety and low mood; as the disease progresses, the 
threat as related to the illness becomes more serious and more debilitating and therefore 
and the individual’s level of anxiety and low mood will decrease (Harrison & Maguire, 
1994; Stark & House, 2000). Aside from perception of cancer as threat, the treatment for 
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cancer that one undergoes can be understood as being a serious contributor to emotional 
distress. Traditional treatments for cancer offer both negatives and positives and there 
can of course be a high degree of physical pain from the process of treatment (Loge, 
Abrahamsen, Ekeberg, Hannisdal & Kaasa, 1997; Stark & House, 2000). However, 
although the aforementioned factors are important in understanding the role cancer can 
play in relation to one’s mental health, it is a disease that has a tremendous impact on the 
individual and the distress that it can cause a patient is related to the meaning that the 
individual associates with his or her diagnosis. Again, as there is an individual element in 
regards to the type of cancer, course of the disease, how the cancer is controlled or 
treated, overall consequences, and how one identifies with the illness, the diagnosis of 
cancer is truly related to the meaning the individual prescribes to the disease (Lazarus, 
1993).  
 
2.7.2 Trauma and Older Adult Mental Health Estimates  
As a diagnosis, cancer can be understood as a traumatic event. Although, in comparison 
to psychological constructs such as anxiety and depression, there is not as much research 
on the psychological concept of traumatic stress as it relates to receiving a diagnosis of 
cancer. Systematic reviews have placed the estimated incidence rate of cancer related 
post-traumatic stress to be between 3 – 22%, wherein individual’s rate the cancer 
diagnosis and the subsequent treatment as being the major traumatic stressor that is 
impacting on their mental health (Alter et al., 1996; Andrykowski, Cordova, Studts, & 
Miller,1998; Smith, Redd, Peyser & Vogl, 1999; Abbey, Thompson, Hickish & 
Heathcote, 2014). There have been a number of studies that have attempted to determine 
the factors that mediate an individual’s vulnerability to cancer related post-traumatic 
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stress. A number of the factors that have been identified as playing a role are as follows: 
“lower social economic status, educational and intelligence level, gender, social support, 
and prior individual or familial psychological difficulties” (Thomson, Ecclestone & 
Hickish, 2001; Kangas et al., 2002; Girgis, Lambert, Johnson, Waller & Currow, 2012). 
There is also research to support the idea that a number of the aspects that lead to a level 
of vulnerability for developing cancer related post-traumatic stress also predispose 
individuals to receiving a diagnosis of cancer. For instance, lower socioeconomic status, 
excessive smoking, or alcohol use, may increase the likelihood of an individual 
developing cancer and also may predispose them to be more vulnerable to post-traumatic 
stress (Hoffman & Saski, 1997; Akechi et al., 2004). A framework that has been posited 
in relation to one developing post-traumatic stress following a diagnosis of cancer 
suggests that an individual diagnosed with cancer may be at risk of developing severe 
stress reactions because the individual has had to deal with a serious stressor for an 
extended period of time. Specifically, a diagnosis of cancer may disrupt one’s pre-
existing ideas, as they related to personal well-being and, if the course of the cancer is 
uncertain, one may not be able to develop thoughts of safety that would possibly be 
helpful in counteracting negative cognitions associated with one’s physical well-being 
and safety (Kangas et al., 2002; Mehnert, Berg, Henrich & Herschbach, 2009; Whitaker, 
Watson & Brewin, 2009). In addition to threats to one’s pre-existing ideas about safety, 
research has highlighted an avoidance or denial that is common in those who receive a 
diagnosis of cancer, which may impact on the “emotional processing” of the traumatic 
event (Wool, 1998; Amir & Ramati, 2002). As avoidance is known to be a tenant of post-
traumatic stress, the avoidance in relation to coming to terms with a diagnosis of cancer 
may limit “activation of aversive memories” associated with diagnosis, which may also 
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lead to difficulty with acceptance and facing the memories associated with the diagnosis 
and the treatment (Brewin et al., 1996; Cordova, Studts, Hann, Jacobsen & Andrykowski, 
2000; Kangas et al., 2002). In summary, a diagnosis of cancer can have a traumatic 
impact on the individual.  It is therefore important to conduct research that betters our 
understanding around cancer related traumatic stress in order to provide those diagnosed 
with cancer a greater level of informed support.  
 
It is important to also provide context in regards to mental health difficulties for those 
older adults who may also receive a diagnosis of cancer. A recent systemic review 
attempted to determine the prevalence of anxiety difficulties in a population of older 
adults (> 60 years old). The review found that the prevalence of older adults who suffer 
from mental health difficulties related to anxiety (diagnosis of anxiety disorder) in 
community samples ranged from 1.2% to 15%. In clinical settings, the range of anxiety 
related difficulties was higher, as one would expect 2% - 28% (Bryant, Jackson & Ames, 
2007). Another review examined the rates for individuals who would have a diagnosis of 
major depression in older adult populations (65 – 100 years old). The results from the 
study found that individuals who would meet criteria for such a diagnosis was 
approximately 4% in women and 2.5% in men. In addition, it was also found that the 
rates of other mental health illnesses related to depression were surprisingly low, and the 
combined point prevalence of both men and women was found to be 1.6% (Steffens et 
al., 2000). Finally, as it relates to trauma, the data is not as strong or has not been a 
widely studied. One study examined PTSD diagnosis and difficulties associated with 
PTSD in older adults (> 60 years old). The study cites the difficulty in finding prevalence 
estimates, as often PTSD is “not recognized or misdiagnosed”. However, the current 
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study found prevalence estimates to be 1% for those older adults with a diagnosis of 
PTSD and “sub threshold PTSD” at 13% (van Zelst et al., 2003).  
 
2.8 Literature Review Search 
A review was conducted to determine whether a relationship exists between uncertainty 
in illness and psychological well-being (anxiety, depression, and trauma) in individuals 
with a diagnosis of CLL or LGL.  
 
2.9 Method of Search 
Searches were carried out using the major psychological and medical research databases 
which included: Psych Articles, Psych Info, Medline, CINHAL, E-Journals. In addition, 
the majority of the reference lists from many of the initial relevant articles identified 
were searched in order to find additional articles in the area of interest.  
 
Table 1 highlights the search terms employed and the number of articles identified for the 
research papers that explored the relationship between uncertainty in illness in 
individuals with a diagnosis CLL or LGL.  Table 2 highlights the search terms employed 
and the number of articles identified for the research papers that examined psychological 
constructs associated with mental health in individuals with CLL or LGL.  
 
2.10 Data Extraction  
Figure 1 illustrates how many studies were removed at each stage of the process. In terms 
of critical appraisal tools, parts of the Downs and Black (1998) tool were used to assist in 
determining the methodological quality of the studies that were identified.  
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2.11 Results  
Overall, 16 studies met the inclusion criteria for more detailed examination. The studies 
that were selected for further review were completed in a number of different countries 
and included a number of different cancer diagnosis in relation to uncertainty in illness. 
Of the 16 studies selected, 4 of the studies were of longitudinal design and 12 were of 
cross-sectional design, with outcome measures being completed at one single time point. 
It is also important to note that while completing the above search, there were no studies 
that directly examine Mishel’s theory of uncertainty in illness with patients who have a 
diagnosis of CLL or LGL. Therefore, it was important to expand the search as it relates 
to uncertainty in illness to other forms of cancer, in order get a better understanding of 
how uncertainty in illness has been researched in other cancer-related diseases to inform 
the current study. All of the studies that met the inclusion criteria can be reviewed in  
Table 3.  
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2.12 Systematic Search: The Impact of a Diagnosis of Chronic Lymphocytic 
Leukemia or Low Grade Lymphoma on an Individual’s Mental Health 
Table 1: Uncertainty in Illness and Chronic Lymphocytic Leukemia or Low Grade 
Lymphoma  
 
Search 
Number 
Search Term CINHAL 
Complete 
Psych Info Psych 
Article 
MEDLINE 
1 “Uncertainty in 
illness” AND 
“Chronic 
Lymphocytic 
Leukemia” 
1 0 0 12 
2 “Uncertainty in 
illness” AND 
“CLL” 
1 0 0 16 
3 “Uncertainty in 
illness” AND 
“Low Grade 
Lymphoma” 
0 0 0 0 
4 “Uncertainty in 
illness” AND 
“Indolent 
Lymphoma” 
1 0 0 0 
5 Uncertainty in 
illness” AND 
“Cancer” 
209 176 86 1 
6 “Mishel” AND 
Cancer 
128 99 0 85 
7 “Mishel” and 
“CLL” 
0 0 0 0 
8 “Mishel” and 
“Indolent 
Lymphoma” 
1 0 0 0 
 
 
 
 
 
 
 
 
 
 
  
29 
Table 2: Anxiety, Depression and Trauma in Chronic Lymphocytic Leukemia or Low 
Grade Lymphoma 
 
Search 
Number 
Search Term CINHAL 
Complete 
Psych Info Psych 
Article 
MEDLINE 
1 “CLL” AND 
“Anx*” and 
“Depre” 
7 5 0 9 
2 “Indolent 
Lymphoma” 
AND “Anx*” 
AND “Depre” 
2 0 0 0 
3 “Low Grade 
Lymphoma” 
AND “ANX” 
AND “Depre” 
10 7 0 26 
4 “CLL” AND 
“Trau*” 
3 3 0 18 
5 “Low grade 
lymphoma” 
AND “Trau*” 
1 0 0 10 
6 “CLL” AND 
“PTSD” OR 
“POST 
TRAUMATIC 
STRESS 
DISORDER” 
0 0 0 2 
7 ““Low Grade 
Lymphoma” 
AND “PTSD” 
OR “POST 
TRAUMATIC 
STRESS 
DISORDER” 
0 0 0 1 
Combined results (duplicates removed) = 1,062 
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Search Limiters and Expanders 
1. English Language 
2. Journal articles 
3. Search within full-text 
Justification 
1. Translation unavailable 
2. Accessible empirical evidence wanted 
3. Identify full range of available research 
Inclusion Criteria 
1. Quantitative methodology 
2. Psychological constructs (uncertainty in illness, 
anxiety, depression and trauma) 
3. Mishel’s uncertainty in illness 
 
Justification 
1. Methods used in current research 
2. Constructs measuring in current research 
3. Not general uncertainty but related to having 
a disease (cancer) 
Exclusion Criteria 
1. Studies measuring impact of psychological 
Intervention studies 
2. Studies measuring impact of drug trials or surgical 
intervention 
3. Individuals with aggressive lymphoma as opposed 
to indolent or low grade lymphoma 
 
Justification 
1. Do not want intervention interfere with 
psychological constructs  
2. Drugs interfering or surgery with measuring 
of psychological constructs 
3. Different form of LGL, required treatment 
and more physically debilitating. 
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2.13 Figure 1: 
Search Diagram  
 
 
 
 
 
 
1062 articles identified 
916 articles screened out 
(limiters: adult population aged 
18+, full-text, and English 
language) 
146 articles identified 
for abstract screening 
95 articles screened out 
(inclusion criteria: quantitative 
methodology, psychological, 
constructs, uncertainty in 
illness measured) 
50 articles identified for 
full-text screening 
39 articles screened out 
(exclusion criteria: intervention 
or drug trial, not measuring 
with Misel’s theory) 
11 articles identified for 
for literature review 
5 articles identified 
from reference list of 
papers 
16 articles identified for 
for full literature review 
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2.14 Table 3: Studies Investigating Relationships Between Cancer, Uncertainty in Illness; Psychological Well-Being; and 
Watch and Wait   
 
Study Design Sample Outcome Measures Statistical Analysis Results 
1.Geffen, 
Blaustein, Amir 
& Cohen 
Case Control 
Study 
N = 36 LGL 
N = 44 controls who 
had diagnosis of 
PTSD 
PTSD Inventory 
SF – 36 HRQOL 
Chi-square analysis 
Pearson correlation 
MANCOVA  
Both groups correlated with 
lower QoL 
Significant increase in hyper 
arousal scale in the LGL 
group 
LGL group had significant 
lower physical health than 
LGL group, as measured by 
QoL scale 
2. Hall, Mishel 
& Germino, 
2014 
Cross -
Sectional 
Questionnaire 
study  
 
N = 313 breast cancer 
survivors 
2 – 4 Years Post 
Treatment  
Mean age 66 
 
MIUS, PANAS, ISI 
 
Hierarchical 
regression analyses 
controlled for relevant 
sociodemographic 
variables. 
 
Cancer-related uncertainty 
was significantly associated 
with more self-reported 
fatigue, insomnia, negative 
affect, and less positive 
affect.  
3. Holtzer – 
Goor et al., 
2015  
Longitudinal   Patients with 
diagnosis of CLL 
receiving treatment 
and on watch an wait 
General Population   
EORTC QLQ-C30, 
EQ-5D 
Not clearly specified  Patients with CLL worse 
than general population in 
fatigue and role function  
Active treatment worse 
HRQOL than those on watch 
and wait.  
4. Kazer et al., 
2012 
 
 
Longitudinal 
Follow-up 
Design 
Following 
treatment of 
cancer 
48, 60 and 72 
months after 
N = 338 men 
following treatment 
for prostate cancer  
MUIS, SCA, FLAS Relationships among 
measures were 
characterized by 
Spearman rank 
correlation 
coefficients ( r ). 
Lower level of education 
related to greater level of 
uncertainty. 
Greater level of uncertainty 
was associated with a greater 
perception of danger. 
High uncertainty and 
perceived danger correlated 
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treatment  with less satisfaction of 
treatment outcome. 
Younger patients 
experienced less uncertainty, 
but reported higher levels of 
perceived danger.   
5. Kurita et al., 
2014 
Cross -
Sectional 
Questionnaire 
study  
 
N = 49  
Diagnosed with lung 
cancer at least 6-
months  
Mean age = 64  
71 % female  
 
MIUS, PSS,  Regression analyses, 
adjusted for 
neuroticism. 
Higher levels of stress and 
poorer emotional well being 
were associated with higher 
levels of intolerance of 
uncertainty and higher 
perceived illness-related.  
Depressive symptoms were 
associated with higher levels 
of intolerance of uncertainty.  
Avoidance mediated  
intolerance of uncertainty 
with depressive symptoms 
and emotional well-being 
only.  
6. Levin et al., 
2007 
Cross - 
Sectional 
Questionnaire 
Study  
N = 105 diagnosed 
with CLL on watch 
and wait or active 
treatment 
Mean age = 58  
BAI, BDI, PHQ-9, 
SF-36 
Repeated measures 
Anova 
T- tests 
No significant difference 
between patients on watch 
and wait and active 
treatment. 
Younger patients had had 
levels of distress than older 
patients.  
7. Liao et al., 
2008 
Longitudinal 
study 
3 time points - 
Before biopsy  
After biopsy  
After 
N = 127 women 
diagnosed with breast 
cancer or diagnosed 
with benign tumors.  
Mean age = 48  
MIUS, SAI Chi-square test used to 
see differences in 
demographic 
attributes  
Repeated-measures 
analysis of variance 
The results showed that 
uncertainty and anxiety 
levels were significantly 
higher before than after 
diagnosis.  
At the 3 data collection 
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diagnosis of 
breast cancer  
Questionnaire 
study  
 
was used to examine 
changes in uncertainty 
and anxiety. 
Simple linear 
regressions and 
simultaneous multiple 
regressions were used 
to analyze predictive 
factors for uncertainty. 
times, uncertainty and 
anxiety were significantly 
lower for participants 
diagnosed with benign 
tumors than for those with 
malignant diagnoses. 
Uncertainty and anxiety were 
positively correlated. 
8. Lin Lin et al., 
2013 
Cross 
sectional 
Questionnaire 
Study 
N = 186 men and 
women with primary 
brain tumor at 
different stages of 
illness trajectory 
MIUS, PMS-SF, KPS Structural equation 
modeling was used to 
explore correlations 
among variables 
Results indicate those 
individuals earlier in the 
illness trajectory and who 
indicated lower functional 
status was associated with 
greater levels of uncertainty. 
Higher uncertainty and lower 
mood were associated with 
symptom severity related to 
the primary brain tumor.   
9. Mast, 1998 Cross-
sectional  
Questionnaire 
Descriptive  
Correlational 
N = 109 women  
1 – 6 years post 
treatment for breast 
cancer  
MIUS, FRQ, GTUS, 
POMS  
Descriptive, 
Correlational, 
Regression, ANOVA  
Uncertainty in illness 
positively related to 
emotional distress. 
Uncertainty explained over 
half of the variance in 
regards to emotional distress.  
 
10.Montgomery, 
Pocock, Titley 
& Llyod 
Cross-
sectional 
questionnaire 
study 
N = 51 patients with 
CLL 
HADS, MACS Regression analysis Individuals with higher 
levels of distress were 
deemed to have a more 
negative coping style.  
Associations were found 
between higher levels of 
anxiety and depression and 
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level of satisfaction in 
regards to information the 
patient received.  
11.Morrison et 
al., 2016  
Cross  - 
sectional 
questionnaire 
study 
N = 112 patients on 
watch and wait for 
CLL 
GAD, IES-R,  CES-D Multiple regression 
and moderation 
analysis.  
Linear regression highlighted 
that greater symptom burden 
covaried with anxiety, 
depression and stress. 
Low social support, lower 
relationship satisfaction 
reported greater symptoms of 
burden and psychological 
difficulties.  
 
12. Pashos et al., 
2013 
Cross-
sectional  
Questionnaire 
Study 
N = 1140  
Diagnosis of CLL 
beginning of 
treatment  
Mean age = 69  
BFI, FACT –LEU, 
EQ – 5D 
ANOVA Women reported greater 
fatigue than men.  
13. Sammarco, 
2001 
Cross-
sectional  
Questionnaire 
Study 
N = 101  
Diagnosis of breast 
cancer  
Under age 50  
 
MIUS, SSQ, FPQoL 
– Cancer  
Pearson product-
moment correlation 
and stepwise multiple 
regression 
 
Significant negative 
correlations were found 
between perceived social 
support and uncertainty, as 
well as time since diagnosis 
and treatment, 
Perceived social support and 
uncertainty accounted for a 
significant amount (27.2%) 
of variance of QoL, 
 
14. Sammarco 
& Konecny, 
2008 
Cross – 
Sectional 
Descriptive 
correlational  
N = 82 breast cancer 
survivors   
SSQ, MIUS, FPQOL-
Cancer III 
Pearson product 
moment 
correlation and 
multiple regression.  
Significant positive 
correlation was found 
between perceived social 
support and total QOL. 
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Questionnaire 
Study  
Post hoc data analysis  
analysis of variance 
(ANOVA) and an 
independent sample t 
test 
 A significant negative 
correlation was found 
between uncertainty and 
QOL.  
Social support predicted 
15.1% of QOL variance, and 
uncertainty predicted 10.4% 
of additional QOL variance. 
15.. Sammarco 
& Konecny, 
2010 
Cross - 
Sectional 
Descriptive 
correlational  
Questionnaire 
Study 
N = 280 (182 
Caucasian, 98 
Latina) 
 
MIUS, FPQOL-
Cancer III, SSQ 
Chi – square analysis  
Independent sample t 
test  
Caucasian women reported 
higher levels of QoL, 
perceived social support and 
lower levels of uncertainty. 
Mental health difficulties and 
lower level of education 
were noted as contributing 
factors in QoL.   
16. Suzuki, 
2012 
Longitudinal  
Questionnaire 
Study  
2 Time points 
– pre 
treatment and 
6 weeks after 
treatment  
N = 52 adults newly 
diagnosed with head 
and neck cancer pre 
treatment  
MIUS, FACT-H/N, 
PICS 
Multivariate analyses  
Regression Analysis  
Post-treatment QOL was 
lower than pretreatment. 
QOL was associated with 
uncertainty at Time 1 and 
Time 2.  
Uncertainty and QOL at the 
time of pretreatment were 
predictors of post-treatment 
QOL.  
 
MUIS, Mishel Uncertainty in Illness Scale; PANAS, Positive and Negative Affect Scale; ISI, Insomnia Severity Index; PSS, 
Perceived Stress Scale; IES, Impact of Event Scale; IUS, Intolerance of Uncertainty Scale; EPQ – R, Eysenck Personality 
Questionnaire – Revised; SAI, State Anxiety Inventory; CWS, Cancer Worry Scale; HADS, Hospital Anxiety and Depression 
Scale; SSQ, Social Support Questionnaire; FPQOL – Cancer III, Fearran & Power QoL Questionnaire – Cancer III; SCA, 
Service Satisfaction Questionnaire; FLAS, Folkman & Lazarus Appraisal Scale; EORTC QLQ-C30, European Oranization of 
Reseach and Treatment of Cancer QoL; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; SF-36, Standard Form 
Health Survey; PHQ-9, Patient Health Questionnaire – 9; BFI, Brief Fatigue Inventory; EQ-5D, General Health Related 
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QoL; FACT – Leu, Functional Assessment of Cancer Thereapy – Leukemia; STAI, State Trait Anxiety Index; QLI, QoL 
Inventory; FORS, Fear of Reoccurrence Scale; MOCFS, Medical Outcomes Cognitive Functioning Scale; GTUS, Growth 
Through Uncertainty Scale; POM – SF, Profile of Mood State Short-Form; FP, Karnofsky Performance Status Scale; MACS, 
Mental Adjustment to Cancer Scale; SF-36; Health Related QoL; PTSD Inventory, Post-Traumatic Stress Inventory; PTSD-C, 
Post Traumatic Stress Checklist; MOS-SSS, Medical Outcome Study Social Support Survey   
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2.15 Overview of Studies and Methodological Considerations  
The following will provide an overview of the studies that met inclusion criteria from the 
literature review search. Initially, an overview of the studies will be provided, 
highlighting what each study attempted to explore, the results, and an overall assessment 
of the methodological quality.  
 
It is important to note that within many of the following studies, QoL is used as an 
umbrella term, in that, the researchers tend to refer to QoL as being synonymous with 
psychological well-being, physical functioning, social relationships, and level of 
independence. As noted in the inclusion criteria, studies that were included in this review 
were ones that examined psychological well-being under the umbrella term of QoL.  
 
2.16 Cross Sectional Studies  
Relationship between Uncertainty in Illness and Psychological Well – Being in  
 
Cancer Patients: Pre – Intervention  
 
Kurita and colleagues (2014) studied the relationship between uncertainty and 
psychological adjustment in patients who had been newly diagnosed with lung cancer 
(less than 6-months). The researchers of this study hypothesized that poorer 
psychological adjustment (greater feelings of low mood, higher perception of stress, and 
poorer emotional well - being) following diagnosis would be associated with higher 
levels of uncertainty and higher perceived ambiguity in relation to one’s illness. The 
findings supported the initial hypotheses, in that, those individuals who had higher levels 
of stress and reported greater feelings of low mood also had higher levels of uncertainty 
in illness. The study had a relatively small sample size (N = 49) and had a cross-sectional 
design, which raises questions about the results from the multiple regressions. The study 
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also did not indicate statistical power needed and whether it was achieved. Additionally, 
the study collected data from women who were mainly of a higher socioeconomic status 
in the United States, which leads to better care and outcomes, and may not be 
representative of those who do not have access to the same care. However, the study used 
reliable and validated measures, and conducted the research in an understudied group of 
individuals. Overall, the study was of satisfactory methodological quality.  
 
Relationship between Uncertainty in Illness and Psychological Well-Being in  
 
Cancer Patients: Post - Intervention  
 
One of the first studies to explore uncertainty in illness and the relationship between 
psychological well-being was conducted by Merle Maste in 1998. The overall objective 
of the study was to explore the relationship between different variables such as 
uncertainty in illness and emotional distress for breast cancer survivors (Mast, 1998). 
Two of the major findings of the study were that: uncertainty in illness was positively 
related to emotional distress, and that an individual’s level of uncertainty in regards to 
illness explained over half of the variance (51%) in regards to the individual’s emotional 
distress. Two of the main limitations to this study were a lack of diversity in the sample 
as, out of the 109 participants, only 2 were non-white and there were essentially no 
women of low income. Also, for two of the measures that were used (FRQ, GTUS), there 
was limited data in regards to the measures psychometric value (reliability and validity). 
Maste’s study was one of the first quantitative studies to examine uncertainty in illness 
and emotional distress in cancer, and confirmed reports from previous qualitative 
research that related uncertainty to physical symptoms and fear of recurrence. Overall, 
due to the questionnaires used and the homogenous sample, methodologically, the study 
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was one of the weaker studies reviewed.  
 
Hall, Mishel and Germino (2014) conducted a study in breast cancer survivors 2-4 years 
following treatment. The goal of the research was to determine whether cancer related 
uncertainty had an impact on physical well-being (fatigue, insomnia), as well on an 
individual’s mood. Results from the study outlined that cancer related uncertainty in 
illness was associated with greater fatigue, insomnia, negative affect, and lower positive 
affect. One of the largest samples sizes of the reviewed studies (N = 344), and a 
relatively heterogeneous sample, where 50% of the participants were of African 
American and Caucasian heritage. The participants were also of varying socioeconomic 
and educational backgrounds. Additionally, the validity of the outcome measures were 
reported for each measure and the age of participants varied within the sample. Overall, 
the study was one of the strongest studies in terms of methodological quality, in 
comparison to the others that were reviewed.  
 
Dr Angela Sammarco has completed a number of studies that investigated the 
relationship between uncertainty in illness, social support, and psychological well-being 
in women who have a diagnosis of breast cancer (Sammarco, 2001). One of her first 
studies in this area (Sammarco, 2001) was done with young breast cancer survivors 
(younger than 50 years of age), and the specific goal was to examine the relationship 
between uncertainty in illness, social support, and psychological well-being. The study 
hypothesized that there would be a positive correlation between perceived social support 
and psychological well-being.  It was also hypothesized that uncertainty in illness and 
social support would explain most of the variance in terms of QoL and psychological 
well-being in comparison to each variable taken together. The results from the study 
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confirmed all three of the above hypotheses, as well as negative correlations between 
network size and uncertainty in illness, and time since diagnosis and uncertainty. It is 
also important to note that uncertainty in illness and social support were two variables 
that explained 27% of the variance in the regression model, which highlights that there is 
a ‘large amount’ of variance that remains unexplained. In terms of methodological 
limitation, the sample was predominately white (90%) which suggests a degree of 
sampling bias, as well as a high educational level for most of the sample, which can have 
an impact on level of uncertainty in relation to one’s illness (Mishel, 1997). Overall, the 
study used validated and reliable measures, collected a degree of demographic data, 
which the researchers used in the statistical analyses, and had a relatively large sample (N 
= 109), which met the power calculation reported in the paper. The study was of good 
methodological quality, and was one of the stronger papers in terms of the review. 
 
Sammarco and Konecny (2008) also conducted research on women who had a diagnosis 
of breast cancer, post treatment. The goal of the research was to examine the relationship 
between perceived social support, uncertainty in illness, and the individual and combined 
effects on QoL including psychological well-being among Latina breast cancer survivors. 
Results indicated that both perceived social support and level of uncertainty in relation to 
one’s illness had a significant impact on an individual’s QoL. In terms of methodological 
quality, the sample was rather homogenous, only dealing with Latina women of high 
socioeconomic and educational background and most were married. In addition, although 
the reliability and validity co-efficient were outlined in the paper, the socioeconomic 
subscale of the QLI-CV demonstrated questionable reliability. Yet, it was one of the few 
papers that clearly highlighted that power calculations were completed a priori and these 
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were met with 89 participants. Overall, the paper is of moderate methodological quality, 
but one of the stronger papers in terms of the other papers included in this review.  
 
In 2010, Sammarco and Konecny completed a follow-up study that included both Latina 
and Caucasian women who had survived breast cancer. The results from the study 
illustrated that Caucasian women reported higher levels of QoL as well as psychological 
well-being, perceived social support, and lower levels of uncertainty in illness. Also, the 
study highlighted that mental health difficulties and lower level of education were noted 
as contributing factors in individuals who reported lower QoL. Similar to the initial 
research study (2008), Sammarco and Konecny highlighted power calculations, effect 
sizes for comparisons, and the participants needed in both groups to meet these power 
calculations, which were met. Again, much like the previous study, this study used 
reliable and validated measures and indicated the alpha values in the paper and, overall, 
the article is of moderate methodological quality, but one of the stronger papers in terms 
of the other papers included in this review. 
 
Relationship between Uncertainty in Illness and Psychological Well-Being in  
 
Cancer Patients: Pre Treatment or Engaged in Treatment   
 
Lin Lin and colleagues (2013) completed a study examining the relationship between 
uncertainty related to one’s illness, mood state, and illness trajectory and symptom 
severity in individuals with a diagnosis of a primary brain tumor (PBT). A total of 186 
participants engaged in the research study, who were at different stages of the illness 
trajectory and who had varying symptom severity and different functional abilities as a 
result of the PBT. The results from the study indicated that lower functional ability and 
those individuals who were at an earlier point in the illness trajectory had higher levels of 
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uncertainty in relation to their illness and reported lower levels of mood. With regard to 
studies limitations, the sample was rather homogenous (white, high level of education 
and married) and the nature of the study was a secondary data analysis with a self-
selected sample. Secondary data analysis suggests a primary researcher collected the data 
and therefore the data may have been used for a different objective or to answer another 
research question, which could mean that the data may not be appropriate to answer a the 
above research questions (Denscombe, 2010).  
 
Psychological Well-Being in Patients with Chronic Lymphocytic Leukemia or Low  
 
Grade Lymphoma  
 
One of the first studies that examined psychological well-being and QoL in patients who 
have a diagnosis of CLL was conducted by Levin and colleagues (2007). Specifically, 
this study examined whether there were differences in QoL and psychological well-being 
(levels of anxiety and mood) in patients diagnosed with CLL who were either on watch 
and wait or engaged in active treatment. The researchers hypothesized that those patients 
who were in active treatment for CLL would have greater levels of psychological distress 
and worse QoL than those patients who were on watch and wait and this hypothesis is 
imbedded in the fact that those patients who were receiving a direct form of treatment 
have a more serious manifestation of the illness. However, the results indicated that there 
was no statistical significant difference in terms of psychological well-being and QoL in 
those patients who were on watch and wait or receiving treatment. Although a cross-
sectional study with a large sample, the study did not achieve statistical power and 
therefore any results need to be interpreted with a degree of caution. Overall, the study 
was of moderate methodological quality in comparison to the other studies reviewed.  
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A recent cross-sectional design study done by Morrison and colleagues (2016) examined 
the impact of physical burden in response to psychological difficulties which included 
anxiety, depression, and stress. The second aim of the study was to determine if 
individual differences (social support, relationship satisfaction) exist that could have an 
impact on the level of psychological distress for an individual diagnosed with CLL on 
watch and wait. In contrast to the Levin study (2007), the Morrison study (2016) found 
that higher physical symptom burden associated with the individual’s CLL had a greater 
impact on the level of psychological distress that the individual experienced. 
Additionally, it was found that those participants with less social support and less 
satisfaction in regards to relationships had higher levels of psychological distress 
following the diagnosis of CLL. A real strength of the study is that it was the first to look 
at elements of social support, psychiatric history, and psychological constructs of anxiety 
and depression in patients in CLL on watch and wait. The study indicated power 
calculations, used validated measures, and again was one of the first studies to consider 
traumatic stress as measured by the IES-R in the understudied group of individuals with 
CLL on watch and wait. Overall, the study was one of the strongest in terms of 
methodological quality 
 
A 2003 paper published by Montgomery and colleagues explored the relationship 
between coping style, QoL, and psychological well-being (anxiety and depression) for 
patients who had been diagnosed with CLL and LGL at various points of disease 
progression (watch and wait and active treatment). The results from the study highlighted 
that those individuals who had greater difficulty adjusting to the diagnosis of cancer also 
had significantly higher scores with regards to psychological well-being. The study 
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suffered from a number of methodological limitations, such as low power for the 
regression models as well as being cross sectional in design. The cross-sectional design is 
particularly limited in this study as it engaged people at different times of the disease 
process and the research indicates that those individuals with more severe forms of 
cancer, or who are further along in terms of illness progression, will have greater levels 
of psychological distress and lower QoL. Although this study is important as it is one of 
the few studies that has examined psychological well-being in patients with CLL and 
LGL it would still be considered to be one of the weakest in regards to methodological 
quality 
 
Pashos and colleagues (2013) completed a study that investigated whether there were 
differences in terms of gender, QoL, and psychological well-being in patients who had a 
diagnosis of CLL. The results from this study were varied, in that, women reported 
higher levels of anxiety and depression, worse global fatigue, and higher pain or 
discomfort; whereas, men reported lower family and social functioning, and lower 
engagement in activities. The sample for the study was large (N = 1,142), participants 
were recruited from 162 different centers, and the data was collected in a standardized 
fashion directly from American clinical centers. In addition, the data that was presented 
highlighted statistical significance as well as the overall effect size of the aforementioned 
differences between the different variables and gender. A particular limitation to the 
research was that, while the sample was large, it was rather homogenous, as 81% of the 
participants were white of higher socioeconomic and educational background. Another 
limitation to the study was the lack of information about whether patients were currently 
engaged in treatment or whether they were on watch and wait. Overall, this study was of 
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strong methodological quality, due to the strength of the reported data and the rigorous 
data collection.  
 
Post-Traumatic Stress in Patients with Low Grade Lymphoma  
The research conducted by Geffen and colleagues (2003) was one of the few studies that 
examined the construct of post-traumatic stress in individuals following a diagnosis of 
LGL. Specifically, the study examined those individuals with a diagnosis of LGL and 
those individuals who had experienced a traumatic event and who may have potential 
difficulties associated with post-traumatic stress, in order to compare the level and 
severity of the symptoms experienced by both groups. The study found that there were a 
higher proportion of individuals with a diagnosis of LGL, who would be classified as 
having post-traumatic stress in comparison to those who experienced a discrete traumatic 
event, although the differences between the two groups were not statistically significant. 
The results also indicated that those individuals with a diagnosis of LGL suffered higher 
levels of distress associated with intrusion and avoidance in comparison to those who 
experienced a singular traumatic event. Another important result of the research 
highlighted that the younger the individual the higher the experience of distress as it 
related to post-traumatic stress in both groups. A major limitation as cited by the authors 
was that the control group (discrete or singular traumatic eventmay not be an appropriate 
comparative group in comparison to those individuals who had LGL. Overall, the study 
is of particular importance as it attempts to understand post-traumatic stress; it relates to 
LGL and was of good methodological quality 
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2.17 Longitudinal Studies  
Uncertainty in Illness in Cancer Patients – Post Treatment  
Suzuki (2012) examined the relationship between uncertainty in illness, QoL, 
psychological well-being, and decision making in patients with head and neck cancer in 
pre and post treatment periods. Participants were recruited and data collection was 
completed during the initial consultation about treatment. Data was then collected 6-
weeks following treatment. The outcomes from the study were that post-treatment QoL, 
including psychological well-being were lower than pre-treatment; level of uncertainty in 
regard to the illness and QoL were both significant predictors of QoL and psychological 
well-being post-treatment, after the researchers controlled for variables such as 
‘unemployment, treatment used, and physician’. Finally, the participants’ perception of 
involvement in the decision making process was not significantly associated with 
uncertainty in illness or QoL. Specific limitations to the research were the small sample 
size and the number of dropouts that did not complete the study. Initially, 52 participants 
were recruited, but 35 participants completed questionnaires both pre and post treatment, 
which could have biased the results for those completers. Additionally, due to the 
varying nature of treatment, the time differed greatly for those participants involved in 
the study and, if there was a longer follow-up, these different time periods could have 
been better controlled. Strengths of the study were that the sample was rather 
heterogeneous in terms of cultural background and educationsince participants were 
recruited from 6 different hospital sites. The outcome measures were all tools that have 
been used in previous studies of uncertainty; QoL and cancer research and alpha values 
for each measure were highlighted within the paper. However, due to a relatively small 
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sample, and the high rate of drop-outs, the study would be considered one of the weaker 
studies in comparison to the other longitudinal studies that were reviewed.   
 
Kazer and colleagues (2012) completed another longitudinal study that examined 
uncertainty in illness, QoL, and psychological well-being in cancer patients. Specifically, 
the aims of this study were to determine what variables may be contributing to 
uncertainty in illness, QoL and psychological well-being, and to also investigate 
uncertainty and perception of danger following treatment of prostate cancer. The results 
were varied, in that, younger people reported less uncertainty in illness but greater 
perception of danger in regards to the treated prostate cancer. In addition, education was 
one of the more prominent variables, as there was a significant relationship between 
lower levels of education that was associated with greater uncertainty in illness. Another 
important finding was that there was a moderate association between all of the outcomes: 
greater uncertainty was associated with greater perception of danger and, as uncertainty 
and perception of danger increased, there was a noted decrease in satisfaction with 
treatment outcome. Limitations of the study were that there was no time-1 data collected 
at diagnosis or prior to treatment and the sample was not heterogeneous, as out of the 338 
participants, 300 were white. However, there are a number of methodological strengths: 
out of the 338 participants, 328 completed outcomes measures over the 3 time points 
following treatment (48 months, 60 months, and 72 months). What is of the utmost 
importance and a real strength in regards to the study is the length of follow-up, as other 
studies have focused on the period immediately after treatment. Overall, this study is one 
of the strongest longitudinal studies reviewed due to the large sample, the lengthy period 
of follow-up, and the amount of individuals who completed the study.  
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Uncertainty in Illness and Psychological Well-Being in Cancer Patients: Diagnostic  
 
Period 
 
Liao and colleagues (2008) investigated the level of uncertainty and psychological well-
being for women who had a suspected diagnosis of breast cancer over three time points: 
during the diagnostic phase (upon notice of breast biopsy), before biopsy, and after 
diagnosis. Findings from the study are as follows: levels of uncertainty in illness and 
anxiety were significantly higher before than after diagnosis (important for CLL); over 
the three time points uncertainty was much higher for those diagnosed with benign 
tumors than malignant diagnosis; uncertainty and anxiety were moderately correlated, 
and uncertainty was predicted by “age, marital status, education level, religious status, 
family history of benign breast tumour, regular breast self-examination, self-perceived 
probability of receiving a breast cancer diagnosis, and biopsy result”. A real strength of 
this study was that it was one of the only studies that investigated uncertainty in illness 
and psychological well-being during the diagnostic period, a that one would presume 
would be extremely anxiety-provoking and fraught with uncertainty. However, there are 
number of methodological limitations; the average time between times 1 to 3 was 8-days 
which is not much of a time period and one must wonder how much one’s emotional or 
psychological state will vary over such a short time period. Finally, 20% of the 117 
participants did not complete the questionnaires and the researchers query whether that 
led to underestimating the level of anxiety and uncertainty, and therefore the study is one 
of the weaker studies in terms of the longitudinal studies that were reviewed.  
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Psychological Well-Being in Patients with Chronic Lymphocytic Leukemia 
 
Another longitudinal study that dealt specifically with CLL and QoL was a study that 
was completed in the Netherlands by Holtze-Goor and colleagues (2015). The specific 
aims of the Holtzer-Goor study were to examine both HRQoL (fatigue, nausea, pain) and 
QoL (social functioning, emotional functioning, global QoL) in patients who were 
engaged in treatment and those who were not in treatment and compare the results with 
age-matched norms. The results indicated that overall both HRQoL and QoL were 
significantly lower in patients with CLL in comparison to the norms. The paper also 
reports that those patients who had a diagnosis and who were not in treatment (watch and 
wait) had reduced QoL in comparison to those individuals who were engaged in 
treatment (drug treatment). The study had a number of methodological limitations: the 
sample was not large enough in order to make statistically significant comparisons 
between groups, no power calculations were highlighted, the data collection or different 
time points was not clearly reported, nor was there any data reported in terms of the 
make-up of the sample. It is also important to note that although the study claims to be of 
longitudinal design, it was unclear whether the participants were given the same 
measures at different time-points or whether the participants were enrolled in the study 
and given the outcome measures at one time-point, which would suggest it was not 
longitudinal and therefore, the study is considered to be the weakest of the longitudinal 
studies that have been discussed. 
 
 
 
 
  
51 
2.18 Methodological Considerations  
In addition to a general overview of the studies, the following section will provide 
specific methodological limitations that were consistent across a number of studies in the 
review. 
 
2.18.1 Samples 
The majority of the cross-sectional studies that were reviewed had large samples which 
would suggest that the relationships that were detected between the different variables 
were accurate. However, there were a number of studies which had small sample sizes 
and also did not indicate whether or not the desired power was achieved. Kurita and 
colleagues is a cross-sectional study where the small sample was a major limitation to the 
generalizability of the results and the study’s authors did not indicate what power was 
required for the different statistical tests used. Similar to the Kurita (2014) study, the 
Suzuki (2012) study had N = 52, but the authors did indicate that they did not achieve 
power in regards to the varying statistical techniques used. Overall, the longitudinal 
studies that were reviewed had relatively large samples sizes and most seemed to achieve 
statistical power. The only study that had a small sample and did not provide detail in 
regards to the sample was Holtzer-Gooer and colleagues (2004), as it was unclear 
whether they had enough participants to be confident in the results, which did highlight a 
difference between groups (treatment versus watch and wait).  
 
Another important methodological factor in relation to the various samples in the studies 
reviewed was a lack of diversity in the subject populations of a number of the studies. 
Pathos and colleagues (2013) was a study whose sample was 81% Caucasian and the 
majority of that group were of higher economic status, with higher levels of education. 
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Out of the 109 participants in Maste’s (1998) study, only 2 participants were non-white, 
and there were essentially no women of lower economic status. Sammarco and 
Konecny’s (2008) first study was completely homogenous but, by design, as they were 
attempting to gain insight into uncertainty, social support, and QoL in Latina patients 
with breast cancer; a group that has not been well represented in the literature (Sammarco 
& Konecny, 2008; Sammarco & Konecny, 2010).  
 
Although a number of the above studies had difficulty with recruitment and had a lack of 
diversity in regards to the samples, it must be noted that attempting to recruit a 
vulnerable population of cancer patients into studies that are psychologically oriented, 
where there is essentially no immediate or direct benefit to the research participants, can 
prove difficult. A diagnosis of cancer can be a traumatic experience for any individual 
and following a new diagnosis, these individuals are most likely going to feel 
overwhelmed in attempting to understand the diagnosis, understanding the care that they 
will undergo, and of course, dealing with a number of individual and relationship factors 
which would also lead to a degree of stress (Moyer et al, 2009). Therefore, even those 
studies that attempt to provide psychological interventions to support individuals with 
cancer treatments have much difficulty in terms of recruitment, retention and research 
such as the above studies that offer no clear benefit or support are obviously going to 
struggle in recruiting such a vulnerable population (Moyer et al. 2010).  
 
2.18.2 Outcome Measures 
Overall, most of the studies used reliable and valid measures, which are common in 
cancer, uncertainty, and psychological well-being research. However, in a number of the 
studies, measures were used that were not as common in the literature and the researchers 
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did not provide Cronbach’s alpha values to highlight the validity and reliability of these 
measures. Specifically, Holtzer-Goor and colleagues (2015); Pashos and colleagues 
(2013); and Morrison and colleagues (2007) did not indicate the alpha values for the 
measures used and therefore one must question whether the measures are consistent in 
evaluating the constructs that they are expected to measure. As the studies under review 
are either cross-sectional or longitudinal, the measurement of certain variables is of 
specific significance and, therefore, the validity and reliability of the measures is of 
importance.  
 
As a number of the studies were completed in different countries, outcome measures had 
to be translated from the original language to a different language so the participants 
could answer the specific items. The first goal of translating an outcome measure is to 
produce a new version, in a new language, that is conceptually equivalent and maintains 
similar content-validity as the original. Another goal when translating an outcome 
measure to a different language is to ensure that the new outcome measure is ‘relevant in 
the new target culture’; essentially, ensuring the new outcome measure has the same 
construct validity for the new target population (Goggin et al., 2010).  A number of 
reviews (Grove et al., 2005; Acquadro et al., 2008) recommended the following in terms 
of translating outcome measures: translation of the original outcome measure to the new 
target language by two separate and independent translators and “reconciliation into one 
version (forward step)”; translating the reconciled version back into the original version 
(backward step); review the reconciled version of the instrument with the original 
developer; to test the new outcome measure on a number of participants in the target 
country (cognitive interview step); have the new measure reviewed by a number of 
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experts; and finalize the new translated instrument into an outcome measure (Acquadro, 
Bayles & Juniper, 2014).  
 
In terms of the studies that have been reviewed, two different studies had to translate 
outcome measures into a new target language. One study that took place in the 
Netherlands used outcome measures that had to be translated from English into Dutch, 
but provided no information on the methods used to translate the measure, or whether the 
measure had been translated by another study (Holtzer – Gooer et al. 2004). In contrast to 
the above study, the study conducted by Liao and colleagues (2008), which was carried 
out in Taiwan highlighted the paper that initially translated the Mishel Intolerance of 
Uncertainty Scale (MIUS) into Mandarin, from the original English. Although the Liao 
paper does not specifically indicate the steps that were taken to translate the MIUS in the 
original study, the paper, which the authors cite, was a psychometric study that tested the 
validity of the MIUS in Mandarin (Sheu & Hwang, 2006). When using measures that 
have been translated into a new language from the original language it is an important 
methodological consideration that the original studies be transparent about the process or 
the research used to ensure that the translated version had content validity as well as 
being reliable in the new language.   
 
2.19 Conclusions  
As noted previously, the studies that have been appraised in the literature review section 
of this introduction vary in quality and a number of the studies would be considered to be 
of low to moderate methodological quality. However, from the studies that were 
reviewed, there were specific patterns that emerged in regards to uncertainty, 
psychological distress, watch and wait, time, and cancer.  
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An initial pattern that emerged from this literature is that a number of studies reported no 
significant differences in terms of psychological well-being in patients with CLL or LGL 
who were either engaged in treatment or placed on watch and wait (Holzter – Goor et al., 
2015 & Levin et al., 2007).  The Levin (2007) study dealt specifically with individuals 
who had a diagnosis of CLL, and again highlighted no significant differences between 
those participants in treatment and on watch and wait. Although difficult to generalize 
from two studies, it is nevertheless surprising that those engaged in an active treatment 
and who would therefore have a more threatening form of cancer would not have higher 
levels of distress and worse psychological well-being. The lack of difference between 
watch and wait and a direct form of intervention may highlight the powerful impact of a 
diagnosis of cancer and watch and wait as a form of care, regardless of the perceived 
level of severity. 
 
Another important pattern that was determined from the studies that were reviewed was 
the impact of uncertainty in relation to an individual’s diagnosis of cancer and 
psychological well-being. Higher levels of stress, negative affect, and poorer emotional 
well-being were correlated with higher levels of illness uncertainty in relation to cancer 
(Hall, Mishel & Germino, 2013; Kurita et al., 2014; Liao et al. 2008; Lin et al., 2013; 
Maste, 1998; Sammarco & Konecny, 2008) 
 
Finally, in regards to the impact of time, a number of the longitudinal studies were able 
to indicate the impact of uncertainty in illness and psychological well-being at diagnosis 
and how these variables may have changed over time. Suzuki (2012) and Kazer and 
colleagues (2012) highlighted the higher levels of uncertainty and psychological well-
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being following a diagnosis were predictive of post-treatment psychological well-being 
and treatment satisfaction. Furthermore, the study conducted by Liao (2008) indicated 
that level of uncertainty in relation to one’s cancer and anxiety were higher following 
diagnosis, over time.  
 
2.20 Rationale for Current Study  
From reviewing the literature, there is a dearth of quantitative research in the area of CLL 
or LGL, uncertainty in illness, psychology well-being, the impact of the diagnosis, and 
watch and wait. Moreover, there does not seem to be any quantitative, longitudinal 
studies that focus on CLL or LGL and the construct of uncertainty in relation to one’s 
illness.  
 
The lack of studies is relatively surprising as CLL and LGL are two of the most common 
forms of cancer and the gold standard for those individuals who are not symptomatic at 
the time of diagnosis is watch and wait, which means a high proportion of patients with 
CLL or LGL will not be receiving any form of direct intervention. As highlighted 
previously, receiving a diagnosis of cancer and being told that one will not be receiving 
treatment is in contrast to a westernized medical model, and most likely to an 
individual’s understanding of how cancer is normally treated. Therefore, one would 
hypothesize that being put on watch and wait could potentially lead to a degree of 
uncertainty and confusion following the initial diagnosis.  
 
Based on the above rationale, and due to a lack of research, it was deemed important to 
conduct a study that examined the psychological impact on those individuals with CLL 
or LGL who have been placed on watch and wait to determine the associations between 
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uncertainty in illness and psychological well-being, and whether or not these 
psychological constructs increase or decrease over time, following an initial diagnosis of 
CLL or LGL.  
 
2.21 Overall Aims  
Aim 1 
The first aim of the study is to identify levels of anxiety, depression, and trauma 
following a diagnosis (time-1) of CLL or LGL.   
 
Aim 2 
The second aim of the study was to determine whether relationships existed between 
initial levels of uncertainty in illness and levels of anxiety, depression, and trauma 
following an initial diagnosis of CLL or LGL. 
 
Aim 3 
The third aim was to determine whether psychological variables such as uncertainty in 
illness, anxiety, depression, and posttraumatic stress at time-1 were predictive of the 
same psychological variables at 6-months following the initial diagnosis of CLL or LGL. 
 
Aim 4 
The final aim of the study was to determine whether change occurred over time 
(following diagnosis to  6-months) in relation to the psychological variables under study 
(uncertainty in illness, anxiety, depression, and posttraumatic stress). The goal for this 
aim was to determine if the mean group values, as well as individual values, significantly 
increased or decreased over time.  
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3.0 Methods Chapter 
 
3.1 Methods Overview 
 
The following methods chapter will include the research design (longitudinal cohort 
study), the methodology (quantitative), and the epistemological position (positivist) of 
the thesis. In addition, specifics have been outlined in regards to the procedure for 
collecting data, how participants were recruited, and how informed consent was obtained 
from the participants. As the thesis was a quantitative study, the measures that were 
selected and used are highlighted and the psychometric properties of each measure are 
outlined. The chapter also provides an overview of how the data were analyzed, what 
considerations were made in regards to the ethics of the research process, and how the 
results will be disseminated to the participants and the wider public. Finally, the chapter 
will conclude with information in relation to the overall participant sample (age, gender, 
diagnoses, ethnicity, employment, education, relationship status). 
  
3.2 Longitudinal Research  
 
 Similarly, to a cross-sectional research design, a longitudinal design can be 
observational, in that, the researchers do not interfere or place any particular conditions 
on the participants. However, in contrast to cross-sectional research where data is 
collected at one-time point, in longitudinal research, data is collected from the participant 
over time and employs continuous or repeated measures to follow a single participant or 
group of people (Taris & Kompier, 2014; Caruana, Roman, Hernadez-Sanchez & Solli, 
2015). Because the data is collected for predefined groups of participants or an 
individual, suitable statistical techniques can be used in order to understand change over 
time for a particular group or for an individual participant (Montero & Leon, 2007; 
  
59 
Caruana et al., 2015). There can be advantages to conducting longitudinal research in 
contrast to cross-sectional research. For instance, when one uses the cross-sectional 
research design, data for one or more variables are collected at one specific time point; 
whereas, for longitudinal research, the data are collected for one or more variables at two 
or more distinct time periods, and therefore, the analysis of the data involves comparison 
between time periods (Menard, 2002; Menard, 2007). A longitudinal research design can 
provide insight into the causes of distinct phenomena, or attempt to determine specific 
antecedents and consequences. As such, the temporal ordering of events is quite often the 
closest that researchers can get to causality. In addition, longitudinal designs can also 
provide better insight into the causal relationships that may exist between data sets that 
have been collected in a specific study (Pettigrew, 1997; Ruspini, 2002). 
 
3.3 Cohort Design Studies  
 
Although scientifically rigorous, controlled trials (RCTs) are not always a viable option 
to evaluate clinical and behavioural outcomes (Mann, 2003; Grossman & Mackenzie, 
2005; Scriven, 2008; Guest & Namey, 2015).  In a cohort study, the researchers chose a 
group of individuals to participate who have a common ‘exposure’ that the investigators 
wished to study and, by definition, the cohort are those who share that common 
characteristic (ie. diagnosis CLL or LGL) (Hadorn, Baker & Hodges, 1996; Warner & 
Dee, 2015).  
 
There are two common types of cohort studies: prospective and retrospective, and one 
type which is far less common-‘ambidirectional’. These different types of studies are 
defined by the time-point at which the follow-up begins. The prospective cohort study, 
often referred to as a longitudinal cohort study, attempts to observe and gather data on 
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individuals following identification of the specific characteristic(s) that define the cohort. 
The retrospective cohort study, often referred to as a historical cohort study, attempts to 
collect data and make interpretation on the participants prior to the participants attaining 
the specific characteristic related to the makeup of the cohort. Lastly, the 
‘ambidirectional’ cohort study makes observations and collects the data using both a 
prospective and retrospective approach (Glenn, 2005; Warner & Dee, 2015).  
 
3.4 Current Study  
The current research study utilized a longitudinal cohort design. The use of a longitudinal 
cohort design was chosen because it allowed the analysis of changes in different 
variables. Initial time-1 data were planned to be collected following the participant being 
told that they have a diagnosis of CLL or LGL and placed on the ‘watch and wait’ 
standard pathway. The importance of this initial data collection time-point was to obtain 
time-1 data as close to the date that the participant was told of their diagnosis. The 
subsequent time points (3-months post diagnosis, 6-months post diagnosis, 12-months 
post diagnosis) were determined in order to collect data when patients visit the 
Hematology Clinic for their clinical reviews. These time points not only allowed one to 
determine change over time, but were also deemed to be the least taxing form of data 
collection for patients (they complete the questionnaires whilst in clinic) and the most 
efficient means of data collection for the clinical research nurses who assisted in the data 
collection process.  
 
Longitudinal research designs can be associated with a number of disadvantages. For 
example, there can be a high level of drop-out from the original sample (Rogosa, 1995; 
Ruspini, 2000; Taris & Kompier, 2003); specifically, those with a diagnosis of CLL or 
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LGL may become too unwell and require a more direct intervention and no longer meet 
eligibility criteria, or may become too unwell to participate in the research. The 
participants may also move to a different area, or may, over time, lose interest in the 
research and no longer wish to participate. Research indicates that the longer the study 
goes on, the higher the potential for dropout (Schmidt & Teti 2001; Taris & Kompier, 
2003), and due to all the aforementioned factors, it can be difficult to determine the rate 
of attrition that may occur over the 12-month time-period. In addition, longitudinal 
research designs can be more expensive and time-consuming than other methodologies. 
The current research study utilized a staggered recruitment process, due to practicality, 
and this resulted in data collection that was extended over a 15-month period. Another 
important potential disadvantage that must be highlighted is that of ‘panel conditioning’, 
which is when an individual’s response is influenced due to previous questionnaires or 
interviews (Ruspini, 1999; Lavrakas, 2008; Warren & Halpern – Manners, 2012). The a 
priori assumption for this type of longitudinal research is that “attitudes, behaviors, and 
statuses of respondents to longitudinal surveys are not altered by the act of measuring 
them”. Yet, the theory of ‘panel conditioning’ is that the participant may be influenced 
by their response to the previous set of questionnaires or surveys and this can lead to 
bias, and assigning causal relationships where one may not exist (Warren & Halpen-
Manners, 2012). In this specific longitudinal cohort study, the research is attempting to 
generalize the findings to other cohorts with a diagnosis of CLL or LGL; however, the 
particular cohort may be unique (geographical location, age, other forms of illness) and it 
therefore may be difficult to generalize the findings from this one specific research study 
(Farrington, 1991).  
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Quantitative Research  
 
3.5 Empirical: Deductive Theory  
 
Longitudinal quantitative research designs are associated with the idea of empirical 
research and deductive theory. Empirical research is based on experimentation or 
observation in order to test a particular hypothesis, or to answer a specific question. In 
deductive theory, the research begins with abstract concepts or a specific theoretical 
proposition that could outline a ‘logical connection between concepts’. Therefore, when 
utilizing deductive theory, one would evaluate different concepts and propositions 
utilizing concrete evidence – moving in a linear fashion from the initial idea, to the 
hypotheses, towards observable empirical evidence, and finally, the conclusions that are 
developed (Hayes, 2000; Gelo, Braakmann, & Benetka, 2008; Neuman, 2014). Within a 
deductive theory framework, the hypotheses that are being tested will contain variables 
such as: behaviours, thoughts, and specific characteristics that may be displayed by a 
cohort and then the researcher will attempt to determine if a relationship exists between 
these variables. Once the data is gathered from the cohort, and it is analyzed, the results 
will either provide confirmation of the initial hypothesis or evidence that refutes it 
(Crowley, 2008). 
 
3.6 Ontological Position: Objectivism  
 
The quantitative research and the longitudinal design utilized in this study are associated 
with the ontological position (how one views reality) of objectivism. Objectivism can be 
defined as: ‘an ontological position that implies social phenomena confront us as external 
facts that are beyond our reach or influence’, where the phenomena and the specific 
‘categories’ that are discussed in daily discourse exist independently or separately from 
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the actors (Healy & Perry, 2000; Krauss, 2005; Bryman, 2015). From an individual 
perspective, as one develops and matures over time, so does their understanding of the 
differences between thoughts and the external reality of the surrounding world. In his 
work: Contemporary Philosophy of Social Science, Brian Fay states that as one ages and 
grows an ‘epistemic maturation’ occurs; wherein, one not only learns to make 
distinctions between the reality of the external world and one’s own thoughts, but one 
comes to seek and value truth, in opposition to what he Fay states is a ‘sea of illusion’ 
(Fay, 1996; Johnson & Onwuegbuzie, 2004). The objectivist position posits that an 
objective external reality already exists, that there are ‘pre-existing structures’ of this 
external reality, and an individual needs to accumulate more information to have a more 
complete understanding of these structures. In order to accumulate more information 
about the objective external reality, it is necessary to generate hypotheses and test these 
hypotheses while attempting to remain objective, and by remaining objective, one does 
not allow subjective interpretations to impact on this process (Krauss, 2005; Clark et al., 
2014). 
 
3.7 Epistemology: Positivism 
 
Positivism is the epistemology (the nature of knowledge) of this quantitative research, 
and it is an epistemology that is associated with the ontological position of objectivism. 
The positivist paradigm postulates that social observations that occur should be examined 
in the same manner that physical or natural scientists treat physical or natural phenomena 
(Ponterotto, 2005; Mackenzie & Knipe, 2006; Muijs, 2010). Positivism evolved from a 
nineteenth-century philosophical approach which identified with the idea that the purpose 
of conducting research is ‘scientific explanation’. Positivists approach the social sciences 
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as a method for linking deductive logic with experimental observations of human 
behavior in order to verify a pre-existing set of ‘probabilistic causal laws’, which can 
then be used to predict and generalize certain patterns of human activity (Michell, 2003; 
Ryan, 2006; Morgan, 2007). As previously outlined with regards to objectivism, 
positivism attempts to add to the understanding that all patterns of social reality are 
understood to be constant, and all novel discoveries via experimentation are added to the 
knowledge of these social constants (Winter, 2000; Sale, Lohfeld, & Brazil, 2002; 
Neuman, 2003; Tuli, 2010).  
 
Attempts have been made to capture the specific tenets of positivism and the following 
can be considered general characteristics of the research paradigm. The characteristic of 
phenomenalism emphasizes that what one is to ‘count as knowledge’ can only be 
determined by what the researcher can perceive by his or her senses. The rule of 
nominalism asserts that abstract concepts that one may use when attempting to make 
scientific explanations must be derived from observation and one’s experience. The 
notion of general laws states that scientific theories can be understood as a: ‘set of highly 
general, law like statements’, and therefore, the goal of science is to form a set of general 
laws. Atomism is a characteristic of positivism that highlights that the entities of 
observation should be regarded as distinct and independent events that make up the 
central foundations of the world. The characteristic of value judgments and normative 
statements suggests that the researcher must make a distinction between facts and 
individual values and that values cannot be considered knowledge. Specifically, values 
have no empirical content, as the validity of values cannot be tested through direct 
observation. An extremely important characteristic of the positivist paradigm is 
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verification. Verification is how ‘truth and falsity’ of scientific investigations can be 
determined, in that, generalizations are made from the initial observation and further 
confirmed by more and more evidence. The greater the amount of evidence that can be 
accumulated, the more weight is given to the researchers conclusions. Lastly, causation, 
which is another central characteristic of positivism, stipulates that there are only 
‘predictabilities’ and the idea that specific ‘events’ will always be followed by a specific 
event of another kind – one event will follow another (Blaikie, 2007). These concepts 
illustrate how those who approach research from a positivist perspective embrace the 
idea that knowledge is determined via empiricism and that what they deem to be logical, 
and therefore, one’s knowledge is guided by the natural sciences and the logical by 
mathematics and logic.  
 
3.8 Limitations of the Positivist Research Paradigm 
The positivist approach to research used as a means to understand human behaviour has 
been much debated and criticized. Philosophical thinkers from different backgrounds 
contest the tenants of positivism and, in many ways, destabilized the notion of absolute 
truth, provable hypotheses, and unbiased, value-free researchers (Giddings & Grant, 
2007). In their work Comparing Paradigms in Qualitative Research, Guba and Lincoln 
outline the primary limitations to positivist quantitative research, and a number of these 
limitations will be highlighted in this section. Guba and Lincoln address the idea of 
context stripping, in that, positivist tend to focus on a particular subset of variables, and 
in doing so possibly remove other variables that would provide more context and a 
degree of generalizability to the research (Guba & Lincoln). Another limitation is the 
idea of the exclusion of meaning and purpose, arguing that human behaviour cannot be 
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understood unless one understands the motivations behind the individual actors 
conducting the research. A central limitation to positivist methodology is the proposition 
of the inapplicability of general data to individual cases - that although the 
generalizations of the research data may prove to be statistically significant, it does not 
mean that it will be applicable to each individual case. The critique of ‘value-ladenness 
of facts’ proposes that as theory and facts are not independent, neither are values and 
facts. The separation of values and facts is a central characteristic of positivist research, 
but it is suggested that theories in themselves are value statements, and therefore, it is 
illogical to state that facts and values can be completely independent. A final, and 
possibly the most important limitation of the positivist research approach, is the proposed 
interactive nature of the inquirer and inquired into dyad. The goal of positivist research 
is to be a ‘silent observer’ of natural phenomena and record it objectively and when 
positivist research is done correctly the researcher does not influence the phenomena, or 
vice versa. However, critics highlight that it is a near impossibility that the researcher not 
influence what is being observed or what is being observed influences the researcher and 
the idea of complete objectivity has been disproved in natural sciences (Heisenberg 
uncertainty principle). Therefore, in the social sciences, when one is observing people, it 
is much more difficult to achieve that level of ‘complete objectivity’. The counter-
argument to this final limitation is that research findings are not only discovered through 
objective observation, but also, and maybe more importantly, through the social 
interaction of the observer and the phenomena (Guba & Lincoln, 1994; Van Ness, Fried 
& Gill, 2011). 
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A longitudinal cohort research study is able to provide one with insight into social 
phenomena and additionally it is a methodology that can improve one’s understanding of 
causal inferences over time.  In contrast to cross-sectional designs, which are often 
limited due to problems of ‘ambiguity’ with regards to the direction and the power of the 
causal interpretations made from the data. Although longitudinal research does not 
account entirely for the problem of ambiguity when attempting to make causal 
inferences, the methodology does allow the researcher to identify independent variables 
at ‘time-point one’, and because of this one may be able to infer effects at ‘time-point 
two’ (Bryman, 2007).  As outlined above, there are a number of limitations to 
longitudinal research and the conclusions that one can derive from using such a 
methodology can be imperfect; however, empirical research conducted in traditional 
epistemology of positivism allows the research to test specific hypotheses, which may 
provide greater insight into the pre-existing structure that this type of research attempts to 
expound. It is accepted that longitudinal research is useful when the researcher is 
attempting to delineate causal findings on individual behaviour. The aforementioned 
acceptance is associated with the understanding that longitudinal research studies can 
highlight the “nature of growth, trace patterns of change, and possibly give a true picture 
of cause and effect over time” (Rajulton, 2001). Social processes have become 
increasingly complex and if one would like to grasp this complexity, one needs 
longitudinal data for establishing temporal order, measuring change, and making stronger 
causal interpretations 
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3.9 Design 
The research design was a longitudinal cohort study that used quantitative methodology 
for collecting and analyzing the data.  
 
3.10 Procedures 
 
Role of Participant  
1. Time-1 (Visit 1) – Participant Inclusion and Exclusion Criteria  
a. Inclusion Criteria: Watch and Wait  
i. Patients were 18 years of age. 
ii. Patients had a confirmed diagnosis of chronic lymphocytic leukemia or low grade 
lymphoma who were on “watch and wait” pathway. i.e. not requiring active treatment 
of their disease. 
iii. Were literate in English.  
iv. Had capacity to give informed written consent to participate. 
v. Patients diagnosed with CLL or LGL within the last 3 months. 
vi. Patients who were willing to attend possible additional meeting with researcher to 
complete questionnaire. 
b. Exclusion Criteria 
i. Patients who were too unwell, symptomatic, or distressed to participate- as judged by 
clinical team (Consultant Hematologist and Clinical Nurses). 
ii. Patients who did not speak English or are not able to read English. 
iii. Any patient who had received prior treatment for chronic lymphocytic leukemia or 
low grade lymphoma.   
iv. Any patient who was unwilling to provide informed written consent. 
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v. Any patient who was unwilling to complete research assessment tools ie 
Questionnaires. 
vi. Any patient who had severe, concurrent diseases or mental health difficulties that 
could interfere with their ability to participate in study. 
2. Time point 1: Time-1 
a. Following initial diagnosis  
b. Approached for Consent to participate and given participation 
information sheets.  
c. If they gave consent, questionnaires were administered.  
3. Time point 2: (3-months). Questionnaires were administered following the initial 3-
month medical follow-up or next visit to clinic with the consultant or clinical nurse.  
4. Time point 3: (6-months). Questionnaires were administered following the 6-month 
review. If disease remains stable and no evidence for intervention the patient will 
continue on trial. 
5. Time point 4: (12-month) Questionnaires were administered following 12- months 
review as long as patient did not required treatment during the period prior to 12-
month review. However, for the purpose of this study only 6-month data was used for 
the group analysis and 12-month data was used for reliable and clinical significant 
change analysis.  
6. Clinical research nurses attempted to gather data as close to the time points as 
possible.  
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3.11 Identification and consent:  
1. Participants were approached during the standard visit for management of their 
disease. They were screened in the first instance by a member of their clinical team 
against the inclusion and exclusion criteria of study. If they were screened as 
appropriate and eligible by the clinical team, the potential participants were invited to 
join the study and given an information sheet by clinician or researcher. This 
information included rationale, design, and personal implications of the trial. 
Potential participants had the opportunity for further discussion with the clinical trial 
nurse outside the clinic and sufficient time to ask questions. 
2. It was clearly stated on the information sheet (Appendices - B) that participation is 
completely voluntary and that potential participants could withdraw consent at any 
time, without providing any reason. If they chose to withdraw, participation in the 
research project ended immediately and no further information was collected. 
Participants will continue on the watch and wait pathway and there was no 
consequence for withdrawal from the study. 
3. Following the verbal briefing, potential participants were given a copy of the 
information sheet and the informed consent form. They were offered as long as they 
needed to consider participation and will be encouraged to discuss the study with 
their family. All potential participants were given at least 24 hours to consider their 
decision.  
4. Potential participants were followed up by a telephone call from clinical trials nurse 
(at least 24 hours later). If they expressed interest in participating in study, they were 
invited back to the hospital to provide informed written consent. Informed written 
consent was taken by the hematology consultant or clinical trials nurse. This visit 
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would be additional to routine care and participants will not receive any payment to 
cover costs. 
5. If participants had any questions about the collection and use of information, or any 
general questions in regards to the research, participants were able to contact the 
primary investigators of the study.  
 
3.12 Documentation of Study Participation: 
All participants who gave written consent to participate were given a copy of the 
information sheet to retain and keep and they were also offered a copy of their signed 
consent form to keep. A copy of the signed consent form was filled out in their medical 
notes. The research team also retained the original signed consent form in site file. All 
site files were kept in the locked office of research team. 
 
3.13 Collection of Demographic Data 
Participants who gave written informed consent had demographic data collected. This 
included age, gender, ethnicity, religion, occupation, previous education, and marital 
status. This information was collected directly from participants and through extraction 
from clinical records. A unique study identification number was on the demographic 
form including date of recruitment and interview setting ie. clinic or ward or day unit. 
 
3.14 Outcome Measures (Appendices - A) 
 
The following outcome measures were administered at the 4 time points in order to 
determine the participant’s levels of anxiety, depression, and trauma.   
 
 
 
  
72 
Anxiety and Depression  
1. Hospital Anxiety and Depression Scale (HADS): The HADS (Zigmond & Snaith, 1983) 
is a quantitative measure used to detect states of anxiety and depression in patients who 
are being treated for a number of physical health problems in different hospital settings. 
The measure was initially developed by its authors in order to isolate ‘caseness’ among 
patients who would not be in a psychiatric hospital setting. The full outcome measure 
consists of 14 items total, which is further divided into 2 subscales that assess anxiety 
and depression and each subscale consists of 7-items. The items are based on the relative 
frequency of symptoms over the past week, using a 4-point Likert scale ranging from 0 
(not at all) to 4 (very often indeed). Overall the measure can be distributed into 3 
different scores: a depression subscale score between 0 and 21, an anxiety subscale score 
between 0 and 21, and finally, a total score combining the two subscales between 0 and 
42. Again, the authors of the original study, ZIgmond and Snaith (1983) recommended 
specific cut-off points when one uses the outcome measure: a score of 7 – 8 on either 
scale would possibly indicate mild anxiety or depression, a score of 10 – 14 would 
indicate moderate levels of anxiety and depression, and a score of 14 – 21 would indicate 
more severe levels of anxiety and depression. Similar to the other questionnaires, the 
HADS is easy for the investigators to administer and for the participants to complete. 
Those individuals who developed the HADS did not include “physical or biological 
indicators of emotional distress”, such as experiencing weigh loss. The rationale for this 
was that it may be that the physical symptom could lead to “false positive scores”, and 
this is important to consider when attempted to discern psychological difficulties in a 
population of individuals who have a physical illness such as cancer (Crowley, 2008; 
Hermann, 1997). In terms of reliability the internal consistency of the anxiety subscale is 
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excellent, (Cronbach’s α = 0.85), and internal consistency on the Depression subscale is 
in the adequate to excellent range (Cronbach’s α = (0.79-0.81) (Berry & Kennedy, 2003; 
Woolrich et al., 2006).  
Another literature review conducted by Bjelland and colleagues (2002) examined the 
significant psychometric information of the HADS. Initially identifying 747 studies that 
used the HADS, and finally focusing on 71 specific studies in order to examine the 
psychometric properties of the measure. The review determined that the sensitivity and 
the specificity of both the anxiety and depression subscales were 0. and the authors also 
highlighted that, as a screening tool, the HADS optimal balance between sensitivity and 
specificity when the caseness was defined by a score of 8 or above on both the anxiety 
and depression subscales (Bjelland et al., 2002). 
 
2. Mishel’s Uncertainty in Illness Questionnaire – Short Form (MUIS - SF): The original 
MUIS (Mishel, 1983) is a 30-item self-report questionnaire, each item using a 5-point 
Likert scale that was developed in an attempt to measure the individual’s uncertainty in 
symptomatology, diagnosis, treatment, relationship with caregivers, and planning for the 
future for patients with cancer. Scale development was based on theoretical framework 
of cognitive appraisal model and perceived uncertainty in illness model, as well as 
interviews with patients. The internal consistency of the MUIS is excellent and it has 
been determined to have a Cronbach’s α that ranges from 0.89-0.91.  However, for the 
purpose of the current study, and attempting to remain cognizant of the participants’ 
time, the Mishel Uncertainty in Illness Short Form (MUIS-SF) was used in order to 
determine level of uncertainty in regards to the participants’ illness.  The MUIS –SF is a 
5-item questionnaire that was developed in 2013, taken from the original Mishel 
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questionnaire in an attempt to provide a less invasive tool in measuring the ambiguity 
concerning the state of the individual’s illness and the complexity regarding the treatment 
and system of care (Mishel, 2012). The 5-items represent: “ambiguity; concerning the 
state of the illness, and complexity; regarding treatment and system of care, the 
controllability of the illness” (Hagen 2009). 
 
A recent study conducted by Hagen and colleagues (2009), assessed the psychometric 
properties of the MUIS-SF on a sample of 209 breast cancer patients.  Face validity of 
the SF-MUIS appeared “satisfactory both from the “experts” and patients' point of view”. 
The SF-MUIS correlated significantly with scores on anxiety (r = 0.35), depression (r = 
0.28), social support (r  = 0.27), emotional well-being (r  = 0.30). Additionally, the SF-
MUIS discriminated significantly in regards to those breast cancer patients who had 
anxiety (n = 36) (HADS-A > 8) reported more illness uncertainty than those (n =173) 
without anxiety (HADS-A < 8), (mean and 95% confidence interval) 13.5 (12.4 -14.5) 
and 11.4 (10.9 -11.8) respectively, p < 0.0001. In terms of reliability, the ordinal 
coefficient alpha for the SF-MUIS was 0.70. One would consider the scale to be 
reasonably consistent if its alpha is in the range of 0.65 and 0.90 (Streiner, 2003). 
Overall, the results indicate that the 5 items SF-MUIS for assessment of illness 
uncertainty performed acceptably in patients who have a diagnosis of breast cancer. 
Ordinal alpha was deemed to be satisfactory and the scale correlated significantly with 
“anxiety and depression, quality of information, emotional well-being and social support; 
factors that are well known to interact with uncertainty in illness” (Hagen et al., 2009).  
3. Impact of Event Scale – Revised (IES-R): The IES-R (Weiss & Marmar, 1997) assesses 
the frequency of avoidance, intrusive thoughts, and hyperarousal to stressful life events. 
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Scale scores are formed for the three subscales, which reflect intrusion (8 items), 
avoidance (8 items), and hyperarousal (6 items). IES-R is made up of 22 items, an 
increase of 7-items from the original IES, as the original did not measure symptoms of 
arousal (Weiss & Marmar, 1997). The IES – R measures symptoms of: ‘intrusion 
(dreams about the event), avoidance and numbing (effort to avoid reminders of the 
event), and hyperarousal (feeling watchful and on guard) with respect to a particular life-
threatening event’ (Brunet, St-Hilaire, Jehel, & King, 2003) and the subjects rate each 
item on a 5-point Likert scale (0-4), the amount the items apply to their experience 
(Weiss & Marmar, 1997). Not a diagnostic tool, the IES-R highlights greater degree of 
distress for individuals who have possibly experienced a traumatic event. Therefore, 
higher scores indicate greater levels of distress. It is recommended that mean scores be 
used for the subscales, with higher scores indicating greater distress, and an overall score 
ranges from (0-88). Cut-offs have been recommended for the overall scores: a score >24 
may have potential symptoms of distress in relation to their trauma experience. Scores 
>33 could possibly represent potential symptoms of trauma that are in keeping with an 
individual who has posttraumatic stress disorder (PTSD) (Hutchins, & Devilly, 2005).  
The IES-R has a high degree of intercorrelation (rs = .52 to .87). High levels of internal 
consistency have been previously reported (Intrusion: Cronbach’s alpha = .87 – .94, 
Avoidance: Cronbach’s alpha = .84 – .87, Hyperarousal: Cronbach’s alpha = .79 – .91, 
(Creamer et al., 2003; Weiss & Marmar, 1997). 
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3.15 Aims and Analyses 
Analyses and Power Calculation  
Aim 1 
Identify time-1 (following diagnosis) levels of anxiety, depression, posttraumatic stress, 
and uncertainty in illness following a diagnosis of CLL or LGL.  
 
Analyses  
Descriptive statistics analyses were used to determine initial levels of anxiety, 
depression, posttraumatic stress, and uncertainty in illness following diagnosis and being 
placed on watch and wait.   
 
Aim 2 
Examine if any relationships exist between psychological variables at time-1, following 
an initial diagnosis of CLL or LGL to determine the strength and the shape of the 
relationships.  
 
Analysis 
Correlation analyses were used to determine the strength and the shape of any detected 
relationships.  
 
Power Calculation 
Based on previous research (Sammarco, 2001; Sammarco & Konecny, 2008; Morrison 
et. al., 2016), power was set at 0.80 with a medium effect size of 0.30, and significance 
criterion set at 0.05, the minimum sample needed for the analysis was 82 participants.  
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Aim 3 
Multiple regressions were run to determine if any of the psychological variables at time-1 
are predictive of a specific psychological variable at 6-months following a diagnosis of 
CLL or LGL.  
 
Power Calculation  
An a priori sample size calculation was calculated for the multiple regression analyses 
using the G*Power software 3.1. A medium to large effect size of 0.45 (based on Cohen, 
1988) which was take from research of Kurita and colleagues that highlighted a moderate 
effect in terms of uncertainty and psychological distress. Using three predictors, a total of 
43 participants were needed to detect a medium effect size f  = .45, and  power set at 
95%.   
 
Aim 4 
To determine both group level and individual level change of the psychological variables 
over time (following diagnosis, 3-months and 6-months).  
 
Analyses 
Repeated measures ANOVA was used to determine group level change and Jacobson and 
Truax’s Reliable Change Index was used to determine if any individual level change 
occurred.   
 
Power Calculation 
Again, using G*Power software 3.1, another a priori sample size calculation was 
completed for the repeated measures analysis to determine how many participants were 
needed to detect significance change over time and a moderate effect. Within subjects 
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repeated measures ANOVA was the analyses used and a medium effect was used based 
on (Cohen) and longitudinal research conducted by Liao and colleagues. Over 3 different 
points, using the probability level of p<0.05, power set at 95%, and the estimated effect 
size f = 0.40, the calculation indicated that 18 participants were required to accurately 
determine if change occurred over time.  
 
3.16 Ethical considerations 
Ethical Considerations  
 
Potential Risks and Benefits to Human Subjects 
  
It was possible that participants may become distressed or difficulties may be raised for 
them whilst completing the questionnaires, but the researchers did assess the risk of any 
potential harm to be low. The proposed measures for this research study have not been 
reported to cause psychological or physical distress. If the participant demonstrated any 
signs of distress, the research team would have gained consent from the participant to 
discuss matters with the relevant members(s) of the clinical team, such as: treating 
Hematologist, Clinical Nurse Specialist, or General Practitioner. Aside from 
psychological distress, it was also important for the investigators to remain cognizant of 
physical difficulties which may have an impact on the participants. Although the 
individuals who were recruited to participate in the study were not at a level of acute 
illness to result in a more direct form of intervention for their CLL or LGL, there still 
could be physical symptoms that could have resulted in the participants experiencing a 
level of impairment or distress. Therefore, it was important for the investigators to 
verbally consult with the participants to ensure that the undertaking of completing the 
necessary questionnaires was not proving to be too physical taxing for them.  Participants 
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were informed that they would receive no direct benefit from this study or receive any 
financial payment. However, participants were informed that taking part may provide 
insight and help those individuals seeking assistance with their potential levels of 
anxiety, depression, and trauma as it applies to their diagnosis of CLL or LGL whilst on 
the watch and wait pathway of standard care.  
 
Ethical Approval 
 
Ethics for the study were initially submitted to NHS East of England – Essex Research 
Committee (REC) in July 2016, and were reviewed by the REC in September 2016. The 
REC deemed that changes needed be made to the initial protocol and resubmitted for 
further evaluation. The principle investigator was also requested to meet before the REC 
to discuss the ethical implications of the study, and at this point further recommendations 
were made by the committee to amend certain aspects of the proposed research. 
Following the recommendations and subsequent amendments, the investigators received 
ethical approval from the REC and the Health Research Authority in October 2016, 
which allowed the investigators to begin recruitment and data collection. The ethics 
approval form can be found in the appendices; this form includes the REC reference 
number as well as the Integrated Research Application System (IRAS) project ID 
(Appendices - B).  
 
3.17 Dissemination 
Dissemination of Work  
 
Dissemination of the research is a critical aspect of any research project and it is essential 
that the method of dissemination be appropriate and attuned to the audience who will be 
accessing the research. Therefore, the practical needs, level of knowledge, and the 
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language and terminology of the target audience must be considered.  
 
Community Dissemination  
Service Users and Participants   
Following completion of the research, the findings and outcomes from the project should 
be presented to those who participated in the research study and should be accessible to 
those who have a diagnosis of CLL or LGL. In person dissemination should be 
considered a strategy, such as hosting a community event where the research is presented 
in a manner that is accessible to those who may not have psychological knowledge.  
 
NHS community newsletters (online) or brochures may be another method of 
dissemination for those individuals who have a diagnosis of CLL or LGL. Again, the 
brochure or newsletter must be written and organized in a manner that is accessible and 
free of psychological or academic jargon in order for those community members to 
understand the research question, the process, and the conclusions drawn.  
 
Academic Dissemination  
Consultant Hematologists and Clinical Research Nurses  
A brief research report and summary of the findings and the impact of said findings 
should be developed for the consultant hematologists and research nurses who work with 
patients with CLL or LGL.   
 
University of Essex Post-Graduate Research Day(s) 
The department of Health and Human Sciences at the University of Essex holds an 
annual research day where research is presented and discussed amongst the post-graduate 
students and University lecturers. As part of the Doctorate in Clinical Psychology 
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Program, it is required during year one and year two that trainees engage in a poster 
presentation and interact with other students who are conducting research in the 
department. In the final year of training, trainees are required to do a formal presentation 
about their specific area of research, which may include the research process, the 
methodology used to complete the study, and discuss any preliminary results, as well as 
the potential impact of the research.  
 
Peer-Reviewed Journals and Conference Abstracts  
As the research deals with the psychological difficulties (symptoms of anxiety, 
depression, and trauma) in those patients with CLL or LGL, the research should aim to 
be published in journals that have a focus on Health Psychology. Journals such as: The 
Journal of Health Psychology, Health Psychology, The International Journal of Clinical 
Health Psychology, Psychology and Health would be appropriate to target for 
publication. Conferences such as the yearly European Health Psychology Society and the 
International Society of Hematology provide an opportunity to present an abstract or 
poster to two different disciplines. 
 
3.18 Data Collection and Participant Information  
Sampling 
Non-probability, purposive sampling will be used in order to recruit patients who have 
been newly diagnosed (<3months) with CLL or LGL, who are being followed up on 
standard pathway of watch and wait.  
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Data Collection 
Participants were recruited and data was collected from patients who were attending 
Colchester General Hospital for treatment. Specifically, the researcher nurses from the 
Hematology Department conducted all of the participant recruitment, data collection, and 
also ensured that questionnaires were filled out correctly and collected at each given time 
point. For the purpose of this thesis, data was collected from October 2016 until January 
2018. However, it is important to note that as the study was longitudinal in design, all of 
the time points had not been collected from all of the participants who had been 
recruited, and therefore, data was still being collected by the other members of the 
research team. As was outlined in the participant information sheet, participants knew 
that data could be withdrawn from the study, and that the participants could request that 
the data that they had submitted not be used for the purposes of this research project. At 
four separate time-points during the data collection process, the data was input on a 
password-protected computer and uploaded onto SPSS version 21 for preliminary 
analyses.  
 
3.19 Demographic Information  
 
 In total, 33 participants were recruited to participate in the study from September 2016 
until January 2018. Out of the 33 total participants, only 3 completed the questionnaires 
at time 4 (12-months follow-up). There were 23 participants who completed the data at 
time 3 (6-months), 26 participants who completed the questionnaires at time 2 (3-
months), and 33 participants who completed the questionnaires at time-1 (< 3-months).  
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Table 4: Participant Age 
Mean Age (Yrs) (n = 33) Standard Deviation (S.D) 
70.48 11.54 
 
 
Table 5: Gender  
 
Gender (n = 33) Frequency Percentage (%) 
Male 19 57.6 % 
Female 14 424 %  
 
 
As illustrated in the two tables above, the average age of the participants in the study was 
approximately 70 years old, which is in keeping with the older population who are 
diagnosed with CLL or LGL. The youngest participant in the study was 50 years of age 
and the oldest participant in the study was 89 years of age. The average age and the 
frequency of men and women that were recruited into the study were close to keeping 
with recent CLL demographic data from the UK. Cancer Research UK reported that the 
largest proportion of individuals diagnosed with CLL fall within the age range of 70 – 74 
and the percentage of men diagnosed was estimated to be 62% in comparison to the 
percentage of women diagnosed was estimated to be 38% (Cancer Research UK, 2014).  
 
Table 6: Diagnosis (CLL or LGL) 
Diagnosis (n = 33) Frequency Percentage (%) 
Chronic Lymphocytic 
Leukemia  (Watch and 
Wait) 
25 75.8 % 
Low Grade Lymphoma 
(Watch and Wait) 
8 24.2 %  
  
 
Over three-quarters of the participants in the present study had a diagnosis of CLL and 
were placed on watch and wait as a form of intervention.  
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Table 7: Ethnic Composition of Participants  
Ethnicity Frequency Percentage (%) Valid Percentage 
(%) 
White British 28 82.4 % 96.6 % 
White Irish 0 0 0 
Black African 0 0 0 
Black Caribbean 0 0 0 
White and Black 
African 
0 0 0 
White and Black 
Caribbean 
0 0 0 
Indian 0 0 0 
Pakistani 0 0 0 
Bangladeshi 0 0 0 
Chinese 0 0 0 
Other 1 2.9 % 3.4 % 
Missing 5 14.7 % 0 
 
 
Essentially, the entire sample was of “White British” ethnicity and only one other 
individual identified as “other”. In addition, 4 participants selected to not fill out the 
ethnicity portion of the demographic data sheet and were therefore recorded as missing 
data. The overall ethnic composition of the study does compare with the UK census data 
from 2011 of the area from which the population were drawn (Colchester), where 92% of 
the population identified as being “White” (UK Census Data, 2011). It is important to 
note that such a high proportion of “White British” individuals who participated in the 
study are not indicative of the wider ethnic diversity of those presenting with CLL or 
LGL. Although research has reported that CLL and LGL are higher in those individuals 
who identify as being White or Black in comparison to other ethnicities, it is not as high 
as reported in those study (Cancer Research UK, 2014), and is therefore a limitation in 
terms of the generalizability of the data. 
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Table 8: Marital Status of Participants  
 
Marital Status (n = 33) Frequency Percentage (%) 
Married 21 61.8 % 
Single 4 11.8 % 
Divorced 3 8.8 % 
Widowed 5 14.7 % 
 
 
The largest proportion of individuals within the current study were married and the  
 
second largest proportion of individuals were widowed.  
 
 
Table 9: Educational Level of Participants  
 
Educational Level (n = 33) Frequency Percentage (%) 
Secondary 24 72.7 % 
Post-Secondary 8 23.5 % 
Graduate  1 2.9% 
 
 
Of the total 31 participants, the largest proportion had completed secondary level 
education, and second largest proportion of the sample had completed post-secondary 
education.  
 
Table 10: Current Employment Status  
Current Employment Status 
(n = 33) 
Frequency Percentage (%) 
Currently Working  10 30.3 % 
Retired 22 66.7 % 
  
 
Given the mean age of the sample, 71 years old, it is in keeping that two-thirds of the 
participants who had been recruited for this study are no longer employed and are 
currently retired.  
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Finally, the sample from which our current population was drawn from (33 total 
participants) was representative of those individuals who were presenting to the CGH 
with CLL or LGL. Specifically, throughout the recruitment process, 41 individuals were 
approached to participate. Out of the 41 individuals who were approached to participate, 
5 individuals declined and 3 individuals were deemed ineligible to participate as their 
physical symptoms associated with the diagnoses were deemed to be too serious.  
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4.0 Results Chapter 
 
4.1 Results Chapter Overview   
 
This chapter will provide an overall analysis of the data that has been collected and 
describe the different analyses used to answer the aims that were set out in the 
introduction chapter. In addition, the results chapter has made interpretations of the 
findings and how these interpretations relate to the overall aims of the research. The 
results in this chapter will describe the data collected from questionnaires administered in 
this longitudinal research, over the 6-month period of data collection. The results chapter 
will initially look at the descriptive data at time-1, to determine levels of uncertainty in 
illness, anxiety, depression, and posttraumatic stress measures, following a diagnosis of 
CLL or LGL. The analyses will be presented (correlation, multiple regressions, repeated 
measures ANOVA) and will identify how the results from these analyses are in keeping 
with the overall aims of the research study. Finally, an overall summary of the results 
will be presented. All of the data were analyzed using Statistical Package for the Social 
Sciences Version 21 (SPSS v.21). 
 
4.2 Data Input 
Data were input at the Colchester General Hospital where the data were transferred from 
the paper copies of the questionnaires to a password protected Microsoft Word 
document. While the data was being input onto the personal computer of the researcher, 
the data were checked for missing items and incorrect scoring. At different intervals 
throughout the data collection process, the data were input to SPSS v.21, where again 
data were screened to ensure that all the correct entries had been made.  
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4.3 Internal Reliability of Measure 
Table 11: Internal Reliability of Scales and Subscales: Time Point 1 (following 
diagnosis), Time Point 2 (3-Months), and Time Point 3 (6-months)  
 
 Cronbach’s Alpha 
Scales Time-1 (N  = 33) Time-2 (N = 26) Time-3 (N = 23) 
HADS – Anxiety .902 .935 .917 
HADS – Depression .791 .880 .810 
HADS – Total  .900 .943 .918 
IES-R – Intrusion .911 .945 .961 
IES-R - Avoidance .885 .910 .831 
IES-R - 
Hyperarousal  
.888 .907 .921 
IES-R – Total .931 .960 .970 
MIUS-SF .734 .791 .869 
 
HADS Hospital Anxiety and Depression Scale, IES Impact of Event Scale - Revised, 
MIUS – SF Mishel’s Uncertainty in Illness Scale – Short Form  
 
Internal reliability of all of the scales and subscales that were used in the analyses were 
calculated using Cronbach’s alpha scores, as in the absence of reliability, it is impossible 
to have validity in terms of the scores of a scale (Fields, 2014).  All of the subscales have 
Cronbach’s greater than 0.7 and were therefore considered as having good internal 
reliability (Fields, 2013 & Gray & Kinnear, 2014). 
 
4.4 Parametric Analysis 
Normality of Variables 
Prior to inspecting the descriptive data, the data were explored to determine whether it 
met the assumptions for parametric analyses and to determine the most accurate measure 
of central tendency. Data for variables at time-1 were explored (anxiety, depression, 
HADS total, intrusion, avoidance, hyperarousal, IES-R total, and uncertainty), and data 
were also explored for each variable at each time point (following diagnosis, 3-months, 
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6-months). To determine whether the data met assumptions, “Normality test with plots” 
were run, and for a variable to be normally distributed the z-scores must fall within the 
range of -1.96 and +1.96 (Fields, 2013). Upon inspecting the z-scores, it was clear that a 
number of the variables, at some time-points, fell out of the required range. Therefore, 
the histograms, box plots, and q-q plots were examined which also indicated a number of 
the variables had positively skewed distributions, as well as being heavily tailed in 
regards to kurtosis (Appendices – C and D). 
 
4.5 Psychological Variables at Time-1 
Aim 1  
Identify levels of anxiety, depression and trauma following a diagnosis of CLL or LGL 
and subsequently being placed on the standard pathway of watch and wait:  
 
Descriptive Data on Questionnaire Scales and Subscales  
One of the goals, as outlined in the methods chapter, was to illustrate the descriptive data 
(measure of central tendency) for all of the questionnaires that were administered to 
participants over the different time points of the study.  
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Table 12: Median for Scales and Subscales and Time Point 1 (following diagnosis) N = 
33  
 
Scale and Subscale Median Clinical Cut-Off % > Clinical Cut-
Off 
HADS – Anxiety 5 8 43.8% 
HADS – Depression 3 8 11.7% 
HADS – Total 9 -  
IES-R – Intrusion 8 -  
IES-R – Avoidance 9 -  
IES-R – Hyperarousal 3 -  
IES-R – Total 20 24 44% 
MIUS-SF 11 11.7 41% 
HADS Hospital Anxiety and Depression Scale, IES Impact of Event Scale-Revised, MIUS 
– SF Mishel’s Uncertainty in Illness Scale – Short Form  
 
Data were collected from 33 participants at time point1 and the median and clinical cut-
off scores can be seen in Table 12. Scores on the HADS anxiety and depression scales 
between 0-7 would be considered to be in the normal range, a score between 8-10 would 
be considered to be mild and borderline level of anxiety or depression, scores between 
11-14 would suggest moderate level of anxiety or depression, and scores between 15-21 
would be considered to be a severe level of anxiety or depression (Snaith and Zigmond, 
1994). The median score for time-1anxiety was 5, and the median score for time-1 
depression was 3; both subscales of the HADS. Although the median score is outside of 
the clinical norm, 43% of the participants would have been considered to be in the 
clinical range at time-1for the anxiety outcome, and approximately 12% would have been 
in the clinical range for the depression. As 43% of the participants would be considered 
to be above the clinical cut-off for anxiety, one would hypothesize that the diagnosis of 
CLL or LGL had an impact on these individuals’ level of anxiety.  
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In regards to the IES-R, an overall score higher than 24 would indicate symptoms that are 
associated with post-traumatic stress, a score of 33 and higher would identify an 
individual who is experiencing post-traumatic stress disorder, and a score of 37 and 
above would be considered to be a high level of post-traumatic stress (Weiss & Marmar, 
1997). The subscale scores (avoidance, hyper-arousal, intrusion) were also recorded, but 
there are no clear guidelines on cut-offs in the literature, and it is suggested that 
clinicians use them for identifying specific clinical targets, or for using them as indicators 
of change over time, as is being attempted in this present study (Christianson & Marren, 
2012). The median score for the participants at time-1 was 20, but 44% of participants 
would have been considered to be in the mild range for experiencing difficulties related 
to posttraumatic stress. An important percentage was that out of the 33 participants at 
time-1, 27% would have been in the severe range for posttraumatic stress as measured by 
the IES-R, which could be related to the impact that a diagnosis of CLL or LGL can have 
on an individual.   
 
Research that has been undertaken using the MIUS has suggested that a score greater 
than 50% in relation to the total score is considered indicative of a moderate level of 
uncertainty in illness; however, recent research conducted by Hagan and Colleagues 
(2014) in individuals who have received a diagnosis of breast cancer, and that used the 
MIUS-SF, suggested that 47%, or a score of greater than or equal to11.7 should be 
considered to be a moderate level of uncertainty in illness. The median score for the 
MIUS-SF was 11, which is just below the clinical cut-off for moderate level of anxiety as 
suggested by Hagan and colleagues (2014). Yet again, and similar to the anxiety scores 
and IES-R total scores, the percentage of individuals who were over the recommended 
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clinical cut-off for uncertainty in illness was 41%, which suggests that almost half of the 
participants were experiencing moderate levels of uncertainty in illness following their 
initial diagnosis of CLL or LGL.  
 
4.6 Associations between Uncertainty and Psychological Distress following 
Diagnosis (Time-1)  
Aim 2 
 
The second aim of the study was to determine if relationships existed between the 
psychological variables following an initial diagnosis of CLL or LGL and being placed 
on watch and wait.  
 
Assumptions: Correlation Analysis  
  
Normality of Variables  
As the initial data indicated above, the time-1 data for the psychological variables were 
positively skewed and for the correlation analyses, the Shapiro-Wilks statistic was also 
taken into account, highlighting a number of significant values which confirmed that the 
data violated the assumption for normality. Out of the 24 possible variables, 15 had 
statistically significant values (p < .05) on the Shapiro-Wilks test for normality, and only 
two of the dependent variables (avoidance and uncertainty in illness) had non-significant 
values at each one of the three time points (Appendices - C). 
 
Outliers - Log Transformation 
Following the initial inspections, the box-blots were explored to look for outliers and it 
was clear a number of the dependent variables had extreme values, which could have an 
impact on the normality of the data. The outliers were converted to the means of the 
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particular dependent variable, at the particular time point. Once these outliers were 
identified and converted, the data remained positively skewed, violating the assumptions 
for normality, and again, only avoidance and uncertainty in illness had non-significant 
values based on the Shapiro-Wilks test at each time point.  
 
The data were then log10 transformed to attempt to make the data less skewed and in the 
hope of meeting the assumption to run the parametric analysis (Fields, 2013; Gray & 
Kinnear. 2012). After log transforming the data, the data were explored using the same 
method described above, “normality tests with plots”, and the different variables were 
examined to determine if they were normally distributed and met the assumptions for 
parametric analysis. Of the 6 log transformed dependent variables that were explored, 4 
of them met the assumptions for being normally distributed, while also having non-
significant values on the Shapiro-Wilks Test (Appendices - E). 
 
Assumption: Linearity  
Following transforming the data, the variables were explored to determine which 
variables had a linear relationship, so one could determine the strength and shape of that 
relationship (Fields, 2013). To determine whether a linear relationship existed between 
the variables, scatter plots were examined between the variables and each time point 
(time-1, 3-months, 6-months). Scatterplots were included for those relationships that 
were deemed to be linear (Appendices - F). From examining the variables at each time 
point it was clear relationships existed between the variables. At time-1, a number of 
relationships between variables met the assumption for linearity (anxiety – intrusion, 
anxiety-avoidance, anxiety – uncertainty in illness, HADS total – intrusion, HADS total - 
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IES-R total, intrusion – hyperarousal, intrusion – uncertainty in illness, avoidance – IES-
R total, hyperarousal – uncertainty in illness and IES-R total – uncertainty in illness). 
Table 13: Associations between Psychological Variables at Time-1, N = 33 
 Anx* Dep* HADS 
total 
Intrusion Avoidance Hyperarousal IES-R 
Total 
Uncertainty 
in illness 
Anxiety 1 .526* .720** .618** .587** .124 .624** .349*  
Depression  1 .406* .159 .017 .032 .160 .184 
HADS total - - 1 .660** .419* .075 .562** .339 
Intrusion - - - 1 .551** .174 .907** .513** 
Avoidance - - - - 1 .073 .693** .196 
Hyperarousal - - - - - 1 .100 .201 
IES-R total - - - - - - 1 .311 
Uncertainty 
in illness 
- - - - - - - 1 
*p < 0.05, ** p < 0.01  
 
Time 1: Following Diagnosis  
Due to the fact that the hyperarousal and uncertainty in illness time-1 data were still 
skewed following the transformation of the data, the non-parametric equivalent, 
Spearman’s r correlation coefficient was used to assess the relationship whenever those 2 
variables were being examined. Of specific interest was the relationship between an 
individual’s uncertainty in illness and the other psychological variables (anxiety, 
depression, traumatic stress).  
 
The relationship between variables at time-1, following a diagnosis of CLL or LGL are 
shown in Table 13, and one can see that there are a number of strong correlations 
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between these variables. The participants’ level of anxiety, as measured by the HADS 
questionnaire was strongly associated to the psychological construct of intrusion as it 
relates to traumatic stress, highlighting that higher levels of anxiety were associated with 
higher levels of intrusion. In addition to intrusion, the psychological construct of 
avoidance as it relates to traumatic stress was strongly associated with anxiety and 
therefore, as one of these indicators of distress increased, so would the other. As 
expected, given the relationship between anxiety and the two subscales of the IES-R 
(avoidance and intrusion), anxiety was also strongly related to IES-R total score. The 
only psychological construct associated with traumatic stress that anxiety was not 
associated with at time-1 was hyperarousal. Lastly, anxiety was also moderately related 
(r = .349) to uncertainty in illness, as measured by the MIUS-SF. Again, such a positive 
relationship indicates that as either of these indicators of psychological distress increase, 
one would expect the other to increase as well.   
 
The HADS-total score showed a similar pattern of correlations with the IES-R and 
uncertainty in illness. Specifically, the HADS was strongly associated with intrusion and 
the IES-R total score and was also moderately associated with avoidance. Similar to 
anxiety, there was no statistically significant relationship that was detected between 
hyperarousal and the HADS total score. In regards to Mishel’s theory of uncertainty in 
relation to one’s illness and HADS total score, there was not a statistically significant 
association between the two variables.  
 
As expected, time-1 scores for the subscales of avoidance and intrusion were all strongly 
associated with the IES-R total score. In addition, the subscales intrusion and avoidance 
were strongly related, but no statistically significant relationship was detected between 
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either intrusion or avoidance and hyperarousal. Essentially, the above associations 
illustrate that as the two subscales related to traumatic stress increase one would also 
expect the overall score for traumatic stress as measured by the IES-R to increase. It must 
be noted that the hyperarousal subscale was not related to the other subscales, which is 
not what one would initially expect. Upon reviewing the raw data, it is clear that the 
items that dealt with hyperarousal were detected to be much lower than the other 2 
subscales. One may hypothesize that any physical discomfort experienced by the patient 
diagnosed with cancer may be attributed to their physical illness as opposed to 
experiences related to a traumatic event and therefore not rated as highly.  
 
In regards to uncertainty in illness as measured by MIUS-SF, there was only one 
statistically significant association related to traumatic stress, avoidance, but no 
significant association was identified for hyperarousal, intrusion, and IES-R total score 
with uncertainty in illness. 
 
4.7 Multiple Regression Analyses   
Aim 3 
The third aim of the current study was to determine which of the psychological 
constructs at time-1 would be predictive of psychological distress at time-3, 6-months 
following initial diagnosis of CLL or LGL. To complete this aim, multiple regression 
analyses were completed with the psychological variables of uncertainty in illness, 
anxiety, depression, and posttraumatic stress.  
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Assumptions: Multiple Regression Analyses  
The assumptions for regression analyses differ in comparison to the earlier analyses 
completed in this study, as one is attempting to determine if a linear relationship exists 
between the outcome and predictor variables. One must also determine multivariate 
normality, whether the residuals are normally distributed. It is also important to examine 
whether there is multi-collinearity between the independent variables. Finally, one needs 
to check for homoscedasticity) and this can be done by examining a scatter plot of the 
residuals versus the predicted values. 
Assumption: Linearity between Outcome and Predictor Variables 
The data that had not been log-transformed were initially inspected to determine if linear 
relationships existed between the outcome and predictor variables; however, upon 
inspection, and in comparison to the log-transformed data, it was determined that the log-
transformed data were better suited for the multiple regression analyses (Fields, 2013). 
Scatterplots were initially examined to see if the outcome variable had a linear 
relationship with the predictor variables, from the inspection, it was determined that the 
uncertainty in illness at 6-months was the only outcome variable in comparison to the 
other psychological measures of distress that did not have a linear relationship with the 
predictor variables (anxiety time-1, depression time-1, IES-R time-1). Therefore, 3 
multiple regression models were run, where anxiety at 6-months was the outcome 
variable and uncertainty in illness, depression, and IES-R total score at time-1 were the 
predictors. A second multiple regression was completed, where IES-R total score at 6-
months was the outcome variable and uncertainty in illness, depression, and anxiety at 
time-1 were the predictor variables. A third multiple regression where depression at 6-
months was the outcome variable and uncertainty in illness, anxiety, and IES-R total 
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score at time-1, were the predictor variables. Also, as there were no clear theoretical 
guidelines, due to the fact that these specific psychological constructs of uncertainty in 
illness, posttraumatic stress, anxiety and depression had been used in individuals with 
CLL or LGL on watch and wait, forced entry was used for inputting the data into the 
regression models.   
 
4.7.1 Multiple Regression 1: Trauma Outcome Variable  
Assumptions: Linearity, Homoscedasticity, Normality, Multi-Collinearity  
 As the data met the initial assumptions for linearity and unusual cases, the initial 
regression was run and further assumptions were investigated to determine the suitability 
of the model. Visual inspection of the P-P plot and of the histogram for the outcome 
variable residuals (IES-R total 6-months) indicated a normal distribution (Appendices - 
G). The lack of a curved formation when inspecting the partial plots illustrated the 
linearity of the data and indicated a positive relationship between uncertainty in illness 
and anxiety at time-1. A *ZRESID vs *ZPRED graph was generated, which highlighted 
a sufficient array of scatter plots, with no data point above or below +3 or -3, providing 
confirmation that the assumption for homoscedasticity had been met (Appendices - G) 
(Fields, 2013). In regards to multicollinearity, there were no strong correlations between 
the predictor variables and the mean variance inflation factor (VIF) was 1.15, which does 
not violate the assumption of multicollinearity as set out by Fields (2013).    
 
Independence   
In order to determine independence, the Durbin-Watson test statistic was used. The 
Durbin-Watson test statistic tests for serial correlations between errors and the value in 
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output was 2.06, which falls within the recommended boundaries of >1 and <3 (Durbin 
& Watson, 1951; Fields, 2013).  
 
As the assumptions were met, a multiple linear regression was calculated in order to 
determine if one could predict posttraumatic stress at 6-months based on time-1 levels of 
depression, anxiety, and uncertainty in illness.  A non-significant regression equation was 
found (F (3,19) =  2.133, p = 1.30, with an R
2 
.252. As a non-significant regression 
equation was found, the model was not further explored and, based on this data, one can 
draw the conclusion that anxiety, depression, and uncertainty in illness at time-1 is not 
predictive of posttraumatic stress at 6-months following diagnosis of CLL or LGL.  
 
4.7.2 Multiple Regression 2: Anxiety Outcome Variable 
Assumptions: Linearity, Homoscedasticity, Normality, Multi-Collinearity  
 Yet again, the data met the initial assumptions for linearity and unusual cases, the 
regression was run, and further assumptions were investigated to determine the suitability 
of the model. Visual inspection of the P-P plot and of the histogram for the outcome 
variable residuals (anxiety 6-months) indicated a normal distribution (Appendices - G). 
The lack of a curved formation when inspecting the partial plots illustrated the linearity 
of the data and indicated a positive relationship between uncertainty in illness and 
anxiety at time-1. A *ZRESID vs *ZPRED graph was generated, which highlighted a 
sufficient array of scatter plots, with no data point above or below +3 or -3, providing 
confirmation that the assumption for homoscedasticity had been met (Appendices - G) 
(Fields, 2013).  When checking the assumption for multicollinearity, there were no 
strong correlations between the predictor variables and the mean variance inflation factor 
(VIF) was 1.2, and again, this does not violate the assumption (Fields, 2013).  
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Independence   
The Durbin-Watson test statistic tests for serial correlations between errors and the value 
in output was 1.76, which once again falls within the recommended boundaries of >1 and 
<3 (Durbin & Watson, 1951; Fields, 2013).  
 
Again, as the above assumptions were met, a multiple linear regression was calculated in 
order to determine if one could predict anxiety at 6-months based on initial levels of 
IESR-total score, depression, and uncertainty in illness. A significant regression equation 
was found and the results of the regression indicate that the three predictors, predicted 
62% of the variance, (R
2 
= .622, F (3,22) = 1.88, p = .00). It was found that IES-R total 
score at time-1 predicted anxiety at 6-months (ß = .810, p = .00). In addition to IES-R 
total score, it was also found that depression score at time-1 predicted anxiety at 6-
months (ß = .416, p = .012).  
 
4.7.3 Multiple Regression 3: Depression Outcome Variable 
Assumptions: Linearity, Homoscedasticity, Normality, Multi-Collinearity  
 Visual inspection of the P-P plot and of the histogram for the outcome variable residuals 
(depression 6-months) indicated a normal distribution (Appendices - G). The lack of a 
curved formation when inspecting the partial plots illustrated the linearity of the data and 
indicated a positive relationship between uncertainty in illness and anxiety at time-1. A 
*ZRESID vs *ZPRED graph was generated, which highlighted a sufficient array of 
scatter plots, with no data point above or below +3 or -3, providing confirmation that the 
assumption for homoscedasticity had been met (Appendices - G) (Fields, 2013.  Finally, 
checking for multicollinearity, there were no strong correlations between the predictor 
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variables and the mean variance inflation factor (VIF) was 1.41 and again, this does not 
violate the assumption (Fields, 2013).  
 
Independence   
The Durbin-Watson test statistic tests for serial correlations between errors and the value 
in output was 1.59, which once again falls within the recommended boundaries of >1 and 
<3 (Durbin & Watson, 1951; Fields, 2013).  
 
The above assumptions were met; a multiple linear regression was calculated in order to 
determine if one could predict depression 6-months based on initial levels of IESR-total 
score, anxiety, and uncertainty in illness. Similar to anxiety outcome multiple regression, 
a significant regression equation was found and the results of the regression indicate that 
the three predictors predicted 33% of the variance, (R
2 
= .334, F (3,22) = 4.68, p = .013). 
It was also found that uncertainty in illness, as measured by the MIUS-SF, significantly 
predicted depression at 6-months (ß = .401, p = .014).  
 
4.7.4 Summary of Multiple Regression Results  
The various regression models highlighted that for both anxiety and depression at 6-
months’ time there were specific psychological variables that acted as significant 
predictors at time-1. Specifically, uncertainty in illness, depression, and IES-R total score 
were all seen to be predictive of different psychological outcomes. The highest 
percentage of variance was for the regression model when anxiety was the outcome 
variable, and both depression and IES-R total score were statistically significant 
predictors. The variance for when depression was the outcome variable was half of what 
it was for anxiety at 6-months, and uncertainty in illness was a statistically significant 
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factor. Finally, when IES-R total at 6-months was the outcome variable, the regression 
model was not statically significant. Overall, it was determined that anxiety and 
depression at 6-months can be predicted by a number of psychological variables at time-
1 within this data set.  
 
4.8 Change over Time: Psychological Variables 
Aim 4  
The fourth aim of this research study was to determine if the participants’ level of 
uncertainty in illness, anxiety, depression, and traumatic stress following a diagnosis of 
CLL or LGL, who have been placed on the watch and wait pathway, would increase or 
decrease over time.  
 
Time Points 
The initial goal of the research was to analyze if a change had occurred over a 12-month 
period, and data were collected at 4 different time points (time-1, 3-months, 6-months, 
and 12-months). However, for the purposes of this thesis, and given the specific time-
constraints, the researchers collected data for as long as possible, but were unable to 
collect enough data for participants at 12-months that would allow for meaningful 
repeated measures analysis. It was therefore decided to use 6-months as the final data 
collection point for the repeated measures analyses; however, for the individual change 
analyses, 12-month data were used.  
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Table 14: Change Over Time (Means and Standard Deviations) 
 
Psychological Variable Mean Standard Deviation 
Anxiety Time-1 .723 .367 
Anxiety 3-Months .750 .308 
Anxiety 6- Months .744 .356 
Depression Time-1 .465 .329 
Depression 3-Months .523 .349 
Depression 6-Months .516 .337 
HADS Total Time-1 .957 .234 
HADS Total 3-Months .893 .402 
HADS Total 6-Months .931 .360 
Intrusion Time-1 .872 .367 
Intrusion 3-Months .842 .437 
Intrusion 6-Months .821 .379 
Avoidance Time-1 .912 .352 
Avoidance 3-Months .940 .343 
Avoidance 6-Months .918 .355 
Hyperarousal Time-1 .737 .418 
Hyperarousal 3-Months .582 .452 
Hyperarousal 6-Months .570 .448 
IES-R Time-1 1.25 .395 
IES-R 3-Months 1.29 .387 
IES-R 6-Months 1.22 .396 
MIUS-SF Time-1 1.02 .128 
MIUS-SF 3-Months 1.03 .118 
MIUS-SF 6-Months 1.04 .127 
 
Parametric Analysis:  
Anxiety (Log Transformed Data) (Following Diagnosis, 3-Months, 6-Months) 
A one way within-subjects repeated measures ANOVA was conducted to determine if 
anxiety levels of participants significantly increased or decreased over the three time 
points (following diagnosis, 3-months, and 6-months). Prior to determining if a 
statistically significant result had been found, the assumption of sphericity had to be 
determined. The assumption of sphericity assumes that the variation within the 
experimental conditions is relatively similar and that “no two conditions are any more 
dependent than any other two” (Fields, 2013). To ensure that the repeated measures 
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ANOVA met the assumption for sphericity, the Maulchy’s test of sphericity statistic was 
checked in the SPSS output and, if the test is statistically significant (p <0.05), one can 
reject the null hypothesis and accept that the variance of the differences is not equal 
(Fields, 2013). The Maulchy’s test of sphericity statistic in this current analysis was non-
significant (p = 0.892), which met the assumption for sphericity. In regards to the 
repeated measures analysis, there was a non-significant effect of time on the level of 
anxiety (Wilk’s Lambda = 0.986, F (2, 21) = .154, p = 0.859). As this was a non-
significant result, no post-hoc analyses were conducted to determine which time point 
had the greatest impact on change in level of anxiety.  
 
4.8.1 Group Change: Depression Over Time (Following Diagnosis, 3-months, 6-
months) (Log Transformed Data)  
A one-way repeated measure ANOVA was completed to determine if depression levels 
as measured by the HADS increased or decreased over the three time points. The 
Maulchy’s test of sphericity statistic in this current repeated measures analysis was non-
significant (p = 0.764), which met the assumption for sphericity. The repeated measures 
analysis indicated that there was a non-significant effect of time on the level of anxiety, 
(Wilk’s Lambda = 0.952, F (2, 21) = 0.538, p = 0.595). Yet again, because the analysis 
demonstrated a non-significant result, no post-hoc analyses were completed.  
 
4.8.2 Group Change:  HADS-Total Over Time (Following Diagnosis, 3-Months, 6-
Months) (Log Transformed Data)  
Another one-way repeated measures ANOVA was done to determine if the HADS total 
data changes in any statistically significant way over the three time points. To confirm 
that the assumption of sphericity had been met, the Maulchy’s test statistic was 
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examined, which indicated a statistically non-significant value (p = .892). Similar to the 
data with regards to anxiety and depression, there was a non-significant effect of time on 
HADS total score, (Wilk’s Lambda = 0.986, F (2, 21) = 0.154, p = 0.895). Once again, 
no post-hoc analysis was done, as the results from the repeated measures analysis were 
non-significant.  
 
4.8.3 Group Change: Avoidance over Time (Following Diagnosis, 3-Months, 6-
Months) 
As the data for avoidance subscale on the IES-R did not violate the assumptions for 
normality, it did not require that the data be log-transformed in order to run a parametric 
analysis, and therefore, the data were analyzed using the means from the initial data. The 
Maulchy’s test statistic was a non-significant value (p = 0.479), meeting the assumption 
for sphericity. Although the data for avoidance decreased over each time point, the 
analysis demonstrated a non-significant result, (Wilks-Lambda = 0.942, F (2, 21) = 
0.616, p = 0.058). Yet again, as no statistically significant results were demonstrated 
from the analysis, no post-hoc analysis was required.  
 
4.8.4 Group Change: Intrusion Over Time (Following Diagnosis, 3-Months, 6-
Months) (Log Transformed Data)  
For the intrusion subscale of the IES-R another within-subjects, repeated measures 
ANOVA was used to determine if the participants’ level of intrusion as it relates to post-
traumatic stress increased or decreased over the three time-points. The data met the 
assumption for sphericity, as Maulchy’s test statistic was non-significant (p = 0.827). 
Similar to the avoidance subscale, the intrusion subscale of the IES-R decreased over the 
three different time-points, over the 6-month period of data collection; however, this 
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change was not statistically significant (Wilks Lambda = 0.904, F (2, 21) = 1.104, p = 
0.398). 
 
4.8.5 Group Change: Uncertainty in Illness over Time (Following Diagnosis, 3-
Months, 6-Months) 
Similar to the avoidance subscale, uncertainty in illness as measured by the MIUS-SF did 
not require the data to be log transformed in order to meet the assumption for normality. 
The repeated measures analysis used the means from the initial data to determine 
whether any change occurred over the 6-month time period in regards to the participants’ 
level of uncertainty in illness. The Maulchy’s test statistic was a non-significant value (p 
= 0.479), meeting the assumption for sphericity and, as the mean scores were consistent 
across each of the three time points, there was no statistically significant change as a 
result of the independent variable over time, (Wilks Lambda = 0.996, F (2, 21) = 0.44, p 
= 0.957). Again, similar to the previous non-significant results, uncertainty in illness data 
was not further explored.  
 
4.9 Non Parametric Analyses: Freidman’s ANOVA 
As the data for both hyperarousal and IES-R total score did not meet the assumption for 
normality both in regards to the initial data and also after the data had been log 
transformed, it was required that non-parametric analysis be used in order to determine if 
a change occurred over the three time points. Similar to the one way repeated measures 
ANOVA, the Friedman’s ANOVA is used in testing the differences that exist between 
“conditions”, where there are more than two conditions of the same unit, and the units 
have provided scores in all of the conditions. Specifically, the Freidman’s ANOVA is 
used when the researchers wish to counteract the presence of unusual cases found in the 
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data and when the data has violated the other assumptions for the repeated measures 
ANOVA that have been listed previously in this chapter (Fields, 2013; Gray & Kinnear, 
2014).  
 
4.9.1 Group Change: Hyperarousal over Time (Following Diagnosis, 3-Months, 6-
Months)  
To determine if change had occurred in the participants’ level of hyperarousal over the 6-
month time period, a non-parametric Friedman’s ANOVA of differences among repeated 
measures was used. Although the overall score of hyperarousal as measured by the IES-R 
decreased over each time point, the data rendered a Chi-Square value of 1.315, which 
was determined not to be a statistically significant change (p = 0.518). Similar to the 
parametric repeated measures tests that were described above, as the results were non-
significant, no post-hoc analyses were required in order to determine which time point 
had the greatest impact on change in the participants’ level of hyperarousal.  
 
4.9.2 Group Change to IES-R Total Score over Time (Following Diagnosis, 3-
Months, 6-Months) 
For the total score of the IES-R the Friedman’s ANOVA was the analysis used to 
determine if change occurred in regards to the participants’ level of post-traumatic stress. 
The overall score on the IES-R decreased over the three time points during the 6-month 
data collection period, and the data demonstrated a Chi-Square value of 7.292 that was 
determined to be statistically significant level of change (p = 0.019).  
 
4.9.3 Post-Hoc Analysis: Wilcoxon Signed-Rank Test  
As the data highlighted a significant level of change over the three time-points, post-hoc 
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analyses were done in order to specifically determine at which time point the statistically 
significant change had occurred. In order to determine where the change occurred, 
Wilcoxon’s signed-rank test was used. The Wilcoxon signed-rank test does not assume 
that the data is normally distributed and it is considered to be the non-parametric 
equivalent to the dependent t-test. Firstly, the Wilcoxon signed-rank test was used to 
determine if the statistically significant change occurred between time-1 IES-R total data 
and 3-months IES-R total data. The results from the analysis indicated that scores 
increased slightly from time-1 to 3-months and were not statistically significant. The test 
was used again to determine if a difference between the scores at time-1 and 6-months 
following a diagnosis of CLL or LGL were significantly different and the results 
demonstrated a statistically significant change (p = 0.001). A final Wilcoxon signed-rank 
test was used in order to determine if a statistically significant change occurred in IES-R 
total from 3-months to 6-months following diagnosis of CLL or LGL. The results from 
this analysis also demonstrated a statistically significant change (p = 0.039). When 
evaluating the data in a longitudinal frame, it is clear that a statistically significant 
decrease in participants’ post-traumatic stress as measured by the IES-R occurred 
between 3-months post diagnosis to 6-months post diagnosis.  
 
4.9.4 Summary of Group Change over Time Data 
The above analyses indicate that there was not much group change that occurred over 
time in relation to the psychological constructs that were being used in this research. 
Specifically, out of the 8 constructs that were measured, 7 did not show any statistically 
significant change using both the parametric and non-parametric analysis. However, the 
IES-R total score that includes all of the subscales (avoidance, hyperarousal, intrusion) 
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demonstrated a significant change from 3-months to 6-months following the participants’ 
diagnosis of CLL or LGL and after being placed on watch and wait pathway. Although 
post-traumatic stress as measured by the IES-R decreased over time, the results from the 
repeated measures and Freidman’s ANOVA do not support the initial hypothesis that 
psychological distress would decrease over-time following an individual’s initial 
diagnosis. 
 
4.10 Individual Change over Time to Psychological Variables 
Due to the relatively small sample, and that the mean data may not be indicative of 
change over time, the Jacobson and Truax (1991) methods for calculating clinically and 
reliably significant change were also used in order to determine level of change in the 
participants. Jacobson and Truax’s (1991) reliable change index (RCI) was used in order 
to determine more individual change that occurred in relation to the independent 
variable: time. In addition to exploring individual change as opposed to mean change, 
this method allowed the exanimation of the data from 6-months to 12 months. Table 16 
shows that reliable and clinical change outcomes can fall into one of four categories 
(Wise, 2004). The data were analyzed by using the Leeds Reliable Change Index 
Calculator (Agostinis, Morley, & Dowzer, 2008). 
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Table 15: Reliable and Clinically Significant Change Outcomes 
Recovered Reliable change is significant and the individual has passed the 
normative score of the measure. 
Improved but not 
recovered 
Reliable change is significant, but the participant remains in the 
“dysfunctional” range. 
No change RCI is not significant. 
Deterioration Reliable change, but worsening of scores. 
 
4.10.1 Reliable and Clinically Significant Change (RCSC) 
HADS Total, Anxiety Subscale, Depression Subscale  
When attempting to determine RCSC it is important to use normative data (means and 
standard deviations) of a population that best represents the population used in one’s 
research. As the current population are individuals who have been diagnosed with CLL 
or LGL, and not a mental health population, and it was attempted to find data on the 
HADS questionnaire that had been validated in a population with individual with CLL or 
LGL. However, there was no data for the HADS on individuals with a diagnosis of CLL 
or LGL, and therefore data from a large scale study on individuals with cancer were used 
to produce normative data for the HADS in a cancer population (Osborne, Elsworth & 
Hopper, 2003). Jacobson and Truax also indicate three methods one can use in assessing 
RCSC, and as there are normative data for the cancer or clinical group and the 
comparison group, criterion c is recommended; wherein, the individual level of 
functioning should move the individual closer to the mean of the normative group rather 
than the mean of the clinical group (Agostinis, Morley, & Dowzer, 2008).  
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Table 16: Means and Standard Deviation Cancer for Normative Population  
 Cancer Population (Cronbach’s 
Alpha) 
General Population 
(Cronbach’s alpha) 
Variable Mean SD Mean  SD 
Anxiety 6.73  4.40 6.14 (0.82) 3.46 
Depression 3.88   3.40 3.68 (0.77) 3.07 
HADS-Total 11 (0.90) 3.90 9 (0.86) 2.50 
 
Table 17: Reliable and Clinical Pre and Post Effect Size (Anxiety, Depression, and 
HADS-total) 
 
Variable (Time) Pre Mean (SD) Post Mean (SD) Effect Size 
Anxiety (time-1 – 3 
Months) 
7.35 (5.30) 7.04 (4.99) 0.06 
Anxiety (3 Months – 
6 Months) 
6.91 (5.28) 7.17 (4.80) -0.05 
Anxiety (6 Months – 
12 Months) 
4.33 (3.79) 3.00 (2.65) 0.35 
Anxiety (time-1 – 6 
Months) 
7.17 (5.20) 7.17 (4.80) 0.00 
Depression time-1– 3 
Months) 
3.42 (3.43) 4.31 (4.09) -0.27 
Depression (3 
Months – 6 Months) 
4.43 (4.09) 3.65 (3.48) 0.20 
Depression (6 
Months – 12 Months) 
2.00 (1.73) 2.33 (2.31) -0.19 
Depression (time-1 – 
6 Months) 
3.70 (3.43) 3.65 (3.48) 0.05 
HADS (time-1 – 3 
Months) 
10.15 (5.55) 11.19 (8.72) -0.20 
HADS (3 Months – 6 
Months) 
11.17 (8.72) 11.30 (8.32) -0.01 
HADS (6 Months – 3 
Months) 
6.33 (4.73) 5.33 (4.04) 0.21 
HADS (time-1 – 6 
Months) 
10.17 (5.3) 11.30 (8.32) -0.20 
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Table 18: Individual Change: HADS (Anxiety)  
 
ID Time-1 – 3-Months 3-Months –   
6-Months 
Time-1- 6-
Months 
6-Months –  
12-Months 
1 Improve (CSC) No change No change No change 
2 No change No change No change No change 
3 No change Improve Improve No change 
4 Deteriorate Improve No change  
5 No change No change No change  
6 Improve No change No change  
7 No change No change No change  
8 Deteriorate No change Deteriorate  
9 Improve (CSC) Deteriorate No change  
10 No change No change Deteriorate  
11 No change No change No change  
12 No change No change No change   
13 No change No change No change  
14 Deteriorate No change Deteriorate  
15 No change No change No change  
16 No change No change No change  
17 No change No change Deteriorate  
18 No change No change No change  
19 No change No change No change  
20 Improve (CSC) No change Improve  
21 No change No change No change  
22 No change No change No change  
23 No change No change No change  
24 No change    
25 No change    
26 No change    
Clinical Significant Change (CSC) 
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Table 19: Individual Change: HADS (Depression) 
 
ID Time-1 – 3-Months 3-Months –   
6-Months 
Time-1 –  
6-Months 
6-Months –  
12-Months 
1 No change No change No change No change 
2 No change No change No change No change 
3 No change Improve (CSC) No change No change 
4 Deteriorate Improve No change  
5 No change No change No change  
6 No change No change No change  
7 No change No change No change  
8 No change No change No change  
9 Improve (CSC) No change Improve  
10 Improve (CSC) No change No change  
11 Improve (CSC) No change Improve  
12 No change No change No change  
13 Deteriorate No change No change  
14 Deteriorate No change Deteriorate  
15 No change No change No change  
16 No change No change No change  
17 No change No change No change  
18 No change No change No change  
19 No change No change No change  
20 Deteriorate No change No change  
21 Deteriorate Improve No change  
22 No change No change No change  
23 Deteriorate No change No change  
24 Deteriorate    
25 Deteriorate    
26 No change    
Clinical Significant Change (CSC) 
 
  
As table 17 indicates, the largest effect that occurred was a decrease in anxiety level 
between 3-months following a diagnosis to 6-months following a diagnosis; but 
according to Cohen’s guidelines on effect size, it would still be considered a small effect 
(Cohen, 1988). Overall, there was no consistent pattern in regards to whether anxiety 
increased or decreased over time as measured by the reliable change index. Specifically, 
there were 2 time points where there was a small effect in terms of psychological distress 
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decreasing (anxiety 3-months – 6-months and depression 3 – months to 6-months) and 
there were 3 time points with a small effect where psychological distress increased 
(depression time-1 – 3 months, HADS total time-1 – 3-months and HADS total time-1to 
6-months).  
 
In regards to individual change as indicated by tables 18 and 19, it is clear that there was 
no real impact of time on an individual’s psychological well-being following a diagnosis 
of CLL or LGL.  There were 2 time points where 3 individuals had a clinical significant 
improvement in regards to anxiety and depression. It is also important to note that there 
were 4 individuals who deteriorated in terms of level anxiety (time-1 – 6-months). Again, 
there was no clear pattern in terms of whether levels of anxiety and depression increased 
or decreased over time, and it is clear that the impact of time as an independent variable 
had no significant effect on the vast majority of participants.   
 
4.10.2 Reliable and Clinically Significant Change (RCSC) 
 
Post-Traumatic Stress (IES-R Total and Subscales) 
 
As highlighted previously, when attempting to determine RCSC one attempts to find 
normative data (means and standard deviations) of a population that best represents your 
population under study, as well as a comparison or community sample. For the IES-R 
and the subscales (intrusion, avoidance, hyperarousal) there were data that highlighted 
the means, standard deviations, and alpha coefficient in a population of individuals who 
have received a diagnosis of cancer, but not a specific diagnosis of CLL or LGL 
(Mystakidou et al., 2007).  When one only has access to the clinical sample data and not 
the comparison sample, Jacobson and Truax indicate that criterion-a is the only option 
available when attempting to determine reliable change. When using criterion-a, reliable 
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change occurs when the data falls out of the range of the clinical population (1.96 
standard deviations) (Agostinis, Morley, & Dowzer, 2008). 
 
Table 20: Mean Standard Deviation IES-R Cancer Population  
 
 Cancer Population (Cronbach’s Alpha) 
Variable Mean SD 
IES-R Total 24.14 (0.85) 18.34 
Avoidance 12.32 (0.77) 4.88 
Hyperarousal 7.92 (0.85) 3.48 
Intrusion  12.40 (0.72) 4.60 
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Table 21: Reliable and Clinical Pre and Post Effect Size (IES-R Total, Intrusion, 
Avoidance, Hyperarousal) 
 
Variable (Time) Pre Mean (SD) Post Mean (SD) Effect Size 
Intrusion (Time-1 – 3 
Months) 
10.54 (7.60) 10.31 (8.31) 0.03 
Intrusion (3 Months 
– 6 Months) 
10.74 (8.62 9.17 (7.91) 0.18 
Intrusion (6 Months 
– 12 Months) 
3.00 (2.65) 3.67 (2.52) -0.25 
Intrusion (Time-1– 6 
Months) 
10.78 (7.60) 9.17 (7.91) 0.20 
Avoidance (Time-1 – 
3 Months) 
10.15 (6.28) 9.42 (7.39) 0.12 
Avoidance (3 Months 
– 6 Months) 
9.52 (7.39) 9.22 (6.54) 0.04 
Avoidance (6 Months 
– 12 Months) 
4.67 (4.36) 5.33 (1.53) -0.16 
Avoidance (Time-1 – 
6 Months) 
10.22 (6.24) 9.22 (6.54) 0.16 
Hyperarousal (Time-
1 – 3 Months) 
5.54 (6.00) 5.38 (5.71) 0.03 
Hyperarousal (3 
Months – 6 Months) 
5.74 (5.89) 4.39 (4.11) 0.23 
Hyperarousal (6 
Months – 12 Months) 
1.67 (1.53) 2.33 -0.44 
Hyperarousal (Time-
1– 6 Months) 
5.96 (6.20) 4.39 (4.11) 0.25 
IES-R (Time-1 – 3 
Months) 
25.00 (16.84)  25.88 (19.05) -0.03 
IES-R (3 Months – 6 
Months) 
25.35 (19.11) 22.35 (17.01) 0.30 
IES-R (6 Months – 
12 Months) 
9.33 (8.08) 10.33 (5.51) -0.12 
IES-R (Time-1 - 6 
Months) 
26.30 (17.03) 22.35 (17.01) 0.33 
 
 
 
 
 
 
 
 
  
117 
Table 22: Individual Change: IES-R (Avoidance) 
 
ID Time-1 – 3-Months 3-Months –   
6-Months 
Time-1 –  
6-Months 
6-Months –  
12-Months 
1 Improve No change Improve No change 
2 No change No change No change No change 
3 No change No change No change No change 
4 No change No change No change  
5 No change No change No change  
6 No change No change No change  
7 No change No change No change  
8 No change No change No change  
9 No change No change No change  
10 No change No change No change  
11 Deteriorate No change No change  
12 No change No change No change  
13 No change No change No change  
14 No change No change No change  
15 Improve No change No change  
16 No change No change No change  
17 No change No change No change  
18 No change No change No change  
19 No change No change No change  
20 No change No change No change  
21 No change No change No change  
22 Deteriorate No change No change  
23 No change No change No change  
24 No change    
25 No change    
26 No change    
Clinical Significant Change (CSC) 
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Table 23: Individual Change: IES-R (Intrusion) 
 
ID Time-1 – 3-Months 3-Months –   
6-Months 
Time-1 –  
6-Months 
6-Months –  
12-Months 
1 No change No change No change No change 
2 No change No change No change No change 
3 No change Improve Improve No change 
4 No change Deteriorate Deteriorate  
5 No change No change No change  
6 No change No change No change  
7 No change No change No change  
8 No change No change No change  
9 No change No change No change  
10 No change No change No change  
11 No change No change No change  
12 No change No change No change  
13 No change No change No change  
14 No change No change No change  
15 No change No change Improve  
16 No change No change No change  
17 No change No change No change  
18 No change No change No change  
19 No change No change No change  
20 No change No change No change  
21 Deteriorate No change No change  
22 No change No change No change  
23 No change No change No change  
24 No change    
25 No change    
26 No change    
Clinical Significant Change (CSC) 
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Table 24: Individual Change: IES-R (Hyperarousal) 
 
ID Time-1 – 3-Months 3-Months –   
6-Months 
Time-1 –  
6-Months 
6-Months –  
12-Months 
1 Improve (CSC) No change No change No change 
2 No change No change No change No change 
3 No change Improve Improve No change 
4 No change No change Improve  
5 No change No change No change  
6 No change No change No change  
7 No change No change No change  
8 No change No change No change  
9 No change No change No change  
10 No change No change No change  
11 No change No change No change  
12 Improve No change No change  
13 No change No change No change  
14 No change Improve Improve  
15 No change No change Improve  
16 No change No change No change  
17 No change No change No change  
18 No change No change No change  
19 Deteriorate No change No change  
20 No change No change No change  
21 No change No change No change  
22 No change No change No change  
23 No change No change No change  
24 No change    
25 No change    
26 No change    
Clinical Significant Change (CSC) 
 
As can be seen in Table 21, there were 6 points where there was a small effect due to 
change in time. The greatest effect was an increase in regards to hyperarousal from 6 
months – 12 months; however, there were only 3 people measured between those two 
time points, and one must be cautious about placing a degree of significance on such a 
result. There was a small effect of time on the IES-R total score between 3 months – 6 
months and also time-1 to 6 months. In addition to IES-R total, there was also a small 
effect of time on hyperarousal at 2 different time points 3-months – 6-months and time-1 
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– 6-months. Overall, and in contrast to anxiety and depression, there seemed to be more 
of a positive impact of time on traumatic stress following a diagnosis of CLL or LGL.  
 
Tables 22, 23, and 24 highlight individual change that occurred in regards to an 
individual’s post-traumatic stress following a diagnosis of CLL or LGL. Similar to 
anxiety and depression, time did not seem to have a great impact on whether an 
individual’s post-traumatic stress following a diagnosis of CLL or LGL would increase 
or decrease. There was essentially no change that was clinically significant, but there 
were 13 people who improved, as opposed to 9 people who deteriorated. Overall, there 
was no real change in the vast majority of participants as measured by the reliable change 
index.   
 
4.10.3 Reliable and Clinically Significant Change (RCSC) 
Uncertainty in Illness  
Similar to the IES-R, data could only be found for the MIUS-SF in regards to the clinical 
population, and again, this population was not specific to CLL or LGL, but was validated 
on a population of women who had received a diagnosis of breast cancer. As there was 
only data on the clinical population and not on the comparison population, again, 
criterion A was used to analyse the data, where reliable change occurs when the data falls 
out of the range of the clinical population (1.96 standard deviations) (Agostinis, Morley, 
& Dowzer, 2008).  
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Table 25: Mean and Standard Deviation MIUS-SF  
 
 Cancer Population (Cronbach’s Alpha) 
Variable Mean SD 
MIUS – SF  11.00 (0.70) 7.34 
 
Table 26: Reliable and Clinical Pre and Post Effect Size (Uncertainty in Illness) 
 
Variable (Time) Pre Mean (SD) Post Mean (SD) Effect Size 
MIUS-SF (Time-1 – 
3 Months) 
11.15 (2.98) 11.15 (2.94) 0.00 
MIUS-SF (3 Months 
– 6 Months) 
11.22 (3.10) 11.17 (3.28) 0.01 
MIUS-SF (6 Months 
– 12 Months) 
11.00 (5.57) 10.67 (6.03) 0.06 
MIUS-SF (Time-1 – 
6 Months) 
10.91 (2.89) 11.17 (3.28) -0.09 
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Table 27: Individual Change: MIUS-SF (Uncertainty in Illness) 
 
ID Time-1 – 3-Months 3-Months –   
6-Months 
Time-1  –  
6-Months 
6-Months –  
12-Months 
1 No change No change Deteriorate No change 
2 No change No change No change No change 
3 No change Improve Improve No change 
4 No change No change Improve  
5 No change Deteriorate Deteriorate  
6 No change No change No change  
7 No change No change No change  
8 No change No change No change  
9 No change No change No change  
10 No change Deteriorate Deteriorate  
11 No change No change No change  
12 Deteriorate No change No change  
13 No change No change No change  
14 No change Deteriorate No change  
15 No change Improve No change  
16 Deteriorate No change No change  
17 No change No change No change  
18 Improve Improve No change  
19 No change No change No change  
20 No change No change No change  
21 No change No change No change  
22 Improve No change No change  
23 No change No change No change  
24 No change    
25 Improve    
26 No change    
Clinical Significant Change (CSC) 
 
 
Table 26 highlights how there were essentially no effect of time on the psychological 
construct of uncertainty in relation to one’s illness. The greatest effect of time on 
uncertainty in illness was between time-1 to 6-months following diagnosis and there was 
an increase in uncertainty in illness, which is not what had been initially hypothesized. 
However, to take an overall perspective on the uncertainty in illness data, there seems to 
be no positive or negative change on the participant following their cancer diagnosis.  
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In regards to more individual change as it relates to uncertainty in illness, again, there 
was no overall pattern of an increase or decrease with regards to the MIUS-SF score. To 
be specific, there was no clinical significant change detected by the RCSC analyses and 
there were also the same exact number of individuals who improved and deteriorated (7) 
over the 12-month time period.  
 
4.10.4 Summary of RSCS Results  
In keeping with the results from the repeated measures analyses, the RCSC analyses 
indicated some small changes in terms of effect size in variables associated with anxiety, 
depression, and traumatic stress, although the change that was detected was not 
consistent across variables. Once again, and similar to the repeated measures analyses, 
IES-R total score had the strongest effect size in terms of change over time and the 
largest effect found (d = 0.33) in the RSCS analyses was in keeping with the most 
significant change in the post-hoc repeated measures analysis (3-months – 6-months).  
 
In regards to individual improvement, the highest percentage of improvement as 
measured by clinical change indicators was HADS-total and depression, although these 
numbers were a small percentage in comparison to the percentage of individuals where 
there was no reliable or clinical change detected 
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5.0 Discussion Chapter 
5.1 Discussion Overview 
The following chapter will provide a summary and will also outline the findings that 
were yielded from the current study. It will also be determined whether the findings were 
in keeping with the initial aims and hypotheses of the current research. The chapter will 
also investigate whether the findings are in keeping with the previous research and 
consider the clinical and theoretical implications of the study. Finally, the discussion 
chapter will highlight the limitations and strengths of the current research, and will 
provide recommendations on how research in this area can possibly move forward.  
 
5.2 Aim 1: Psychological Variables at Time-1 
 
The first aim of the research was to determine the impact of a diagnosis of CLL or LGL 
and then being placed on the standard watch and wait pathway would have on the 
individual’s level of anxiety, depression, traumatic stress, and uncertainty in illness. The 
initial hypothesis was that the mean data for the psychological variables would be 
indicative of psychological distress, which could possibly be attributed to the diagnosis 
of CLL or LGL. To determine the impact of the diagnosis, certain psychological 
variables were measured: uncertainty in illness, anxiety, depression, and post-traumatic 
stress. To achieve this aim, the measure of central tendency was examined for the 
psychological variables, and how the median value of the data compared with the 
recommended clinical cut-offs of the outcome measures. However, as the data were 
positively skewed, and the standard deviations for each of the psychological variables at 
time-1 were quite high, and it was determined that the measure of central tendency 
(median) would not be indicative of the participants’ initial level of distress. Therefore, it 
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was deemed prudent to go beyond the measure of central tendency and further explore 
the data. Therefore, the frequency of the psychological variables at time-1 were 
examined, in regards to percentage of participants who would be above the clinical cut-
offs as recommended by the different outcome measures. When the median values for the 
clinical cut-offs were initially examined, they were all under the clinical cut-off for what 
would be considered mild levels of distress, and many of the variables were under it by a 
distinct margin. However, when examining the percentage of individuals who were 
above the clinical cut-off; the initial understanding shifted, as there were a high 
percentage of participants who were above the recommended clinical cut-offs for the 
outcome measures. For anxiety, uncertainty in illness, and post-traumatic stress, 
approximately 40% of individuals were over the recommended clinical cut-offs, which 
could be considered to be a high proportion of the participants under study. Of note was 
that 41% of individuals would be considered to be in the moderate range as it relates to 
uncertainty with regards to their illness. As MIUS-SF is a measure directly related to the 
individual’s diagnosis of cancer and such high levels of uncertainty in illness at time-1 
would suggest that there could be difficulty in understanding the approach and process of 
managing the CLL or LGL. Another important finding was that a high percentage of 
individuals scored in the severe range for anxiety and post-traumatic stress following 
their diagnosis. Specifically, 15% of the participants would be considered to be in the 
severe range for level of anxiety as measured by HADS. What was even more surprising 
was that 27% of participants would be considered to be in the severe range for post-
traumatic stress as measured by the IES-R. Such high levels of severity, as it relates to 
psychological distress, would suggest that the diagnosis of CLL or LGL, and being 
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placed on the watch and wait pathway could be factors attributing to the psychological 
distress of the participants.  
 
5.2.1 Support for Hypothesis 1  
 
It is difficult to determine whether or not the hypothesis for the initial aim had been met, 
as median data for the psychological variables at time-1 did not accurately capture the 
level of distress, due to the high level of variance and the data being skewed. As reported 
above, the percentages of individuals who were above the clinical cut-off for anxiety, 
uncertainty in illness, and post-traumatic stress were quite high. Because of what was 
deemed to be a high portion of the study population who indicated psychological distress 
at time-1 in terms of anxiety, post -traumatic stress, and uncertainty in illness, it was 
determined that the hypothesis was partially met, and the diagnosis of CLL or LGL had 
an impact on the psychological well-being of the participants.  
 
5.2.2 Aim 1: Theoretical Perspective and Past Research 
 
The previous research in regards to the impact of a diagnosis of CLL or LGL and then 
being placed on the watch and wait pathway in relation to psychological well-being are 
rather varied. One of the difficulties with the previous research in relation to 
psychological well-being and CLL or LGL were the variation in regards to disease 
progression, as some patients were on watch and wait and others were involved in active 
treatment. Three of the previous studies (Montgomery et al., 2003; Levin et al., 2007; 
Morrison et al., 2016) used data that specifically examined anxiety and depression for 
those individuals’ diagnosed with CLL or LGL, who were on the watch and wait 
pathway. The data from the aforementioned two studies in terms of those participants 
who would be considered in the clinical range for anxiety and depression were different. 
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For the Montgomery and colleagues (2003) study, the data demonstrated that 14% of 
participants would meet “caseness” for anxiety and depression, as measured by the 
HADS; whereas, for the Levin and colleagues (2007) study, the participants’ mean scores 
on the Beck Anxiety Inventory (BAI) and the Beck Depression Inventory (BDI) found 
the participants in the “normal range” for anxiety and depression. For the most recent 
study conducted by Morrison and colleagues (2016), 13% of participants were above the 
clinical cut-off for depression as measured by the Center for Epidemiology Studies 
Depression Scale (CES –D) and 4% of participants were above the clinical cut-off for 
anxiety as measured by the Generalized Anxiety Disorder Questionnaire (GAD-Q). The 
data from the above studies was not in keeping with what was found in the current study, 
as the percentage of individuals who were above the clinical cut-off was much higher 
than the studies cited above, although the median level of depression was similar to what 
was found by Montgomery and colleagues. An important distinction between the current 
study and the previous research was that the data that were collected from our 
participants immediately following the diagnosis of CLL or LGL. Additionally, in the 
other studies, the distinction is not made in terms of how long they have had the 
diagnosis or how long the participants have been on the watch and wait pathway. 
Therefore, the finding from the current study that approximately 40% of participants 
were above the clinical cut-off level of anxiety following a diagnosis of CLL or LGL is 
novel, and it is important in understanding the level of anxiety that is possibly associated 
with not only the diagnosis, but the impact of time, as it relates to the diagnosis and then 
being placed on the watch and wait pathway.  
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Once again, and similar to the previous research with anxiety and depression, the various 
studies that have attempted to determine post-traumatic stress following a diagnosis of 
CLL and LGL found variable results. The two studies (Geffen et al. 2003; Morrison et 
al., 2016) that examined post-traumatic stress in individuals with a diagnosis of CLL or 
LGL had results that were completely different. The initial study that was completed by 
Geffen and colleagues (2003), found that approximately 24% of the individuals in their 
sample would be considered as having difficulties related to posttraumatic stress as 
measured by the Post- Traumatic Stress Disorder Checklist (PTSD-C), but the mean data 
from the Morrison and colleagues (2016) study found the participants to be in the 
“normal range” as measured by the IES-R. An important difference between the two 
studies was that the Geffen and colleagues study (2003) was completed with participants 
who had survived LGL and no information was given about what course of treatment 
they had received and the level of severity of the cancer; whereas, the Morrison (2016) 
study examined participants with CLL who were on the watch and wait pathway. The 
sample from the current study was similar to that of the Morrison study (2016), as the 
participants were on the watch and wait pathway, although the findings from the current 
study were different as they relate to post-traumatic stress. As noted above, in the current 
study, 43% of participants with a diagnosis of CLL or LGL on watch and wait would be 
considered as having difficulties relating to post-traumatic stress and 27% of the same 
participants would be considered to have severe difficulties related to post-traumatic 
stress. Similar to the above findings related to anxiety, the findings in this study relating 
to post-traumatic stress are novel, in that, there seems to be no previous research in the 
literature that measured post-traumatic stress immediately following a diagnosis of CLL 
or LGL and being placed on watch and wait, as the current study has done. What 
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differentiates the current findings from previous research is again, time, as the previous 
research was not clear on how long individuals had the diagnosis of CLL or LGL, and 
the implications of the current findings could be that one’s anxiety and stress are high not 
only because they have received a diagnosis of cancer, but because it is also so close to 
having received this diagnosis.  
 
As there has been no previous research into uncertainty in illness with patients with a 
diagnosis of CLL or LGL, it was important to draw comparisons to other form of cancers 
that have used Mishel’s uncertainty in illness theory and her developed outcome 
measures. The problem is that there is a mix of different cancers that have been used in 
the theory, which have studied the participants at different time-points along the illness 
trajectory, and where the physical severity of the cancer is also quite varied. Because of 
this level of variation, it is difficult to draw conclusions or make generalizations about 
the findings, as they relate to uncertainty in illness and cancer. However, if one is 
attempting to draw on specific themes, one of them would be that those individuals who 
had survived the treatment for cancer or their cancer was deemed benign had seemingly 
lower levels of uncertainty in illness (Maste et al., 1998; Sarmmarco, 2001; Sammarco & 
Konecny, 2008; Liao et al., 2008; Kazer et al., 2012; Hall et al., 2014). The other trend 
among papers that studied uncertainty in illness, as it relates to a diagnosis of cancer, was 
that those who were involved in treatment or had greater physical illness reported higher 
levels of uncertainty in illness as measured by Mishel’s outcome measures (Suzuki, 
2012; Kurita et al., 2014; Lin Lin et al., 2014). It is also important to note that the means 
were examined for the studies and this is not to suggest that a statistically significant 
difference exists between the two groups, or a relationship was found in terms of greater 
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physical symptoms being predictive of greater uncertainty in illness. The research 
suggests that when individuals have higher severity or are engaged in a direct form of 
intervention, it could possibly result in greater uncertainty in relation to one’s illness, 
especially as it relates to the overall outcome. Based on previous literature, this is the 
only study that has attempted to look at the impact of the uncertainty in illness as  
it relates to CLL or LGL and being placed on watch and watch and wait and therefore the 
findings that a relatively high percentage of individuals would be considered to have 
moderate levels of uncertainty is new for the literature.  
 
Overall, when one is comparing the percentages of anxiety, uncertainty in illness, and 
post-traumatic stress following a diagnosis, it would be helpful to provide context in 
regards to how these percentages compare to other cancer diagnosis and mental health 
populations. A recent meta-analysis attempted to determine prevalence of mental health 
difficulties (depression, anxiety and adjustment difficulties) in oncology and hematology 
settings; the results from the study were that the percentage of individuals who would 
have difficulties related to depression was 16.3% and those with difficulties associated 
with anxiety was 10.3%, which is a lower percentage from what was found in the current 
study (Mitchell et al., 2011). When compared to percentage of individuals dealing with 
mental health difficulties drawn from normative population, without a diagnosis of 
cancer, the percentages indicate that individuals identified with having difficulties 
associated with anxiety at being approximately 6% and with low mood at approximately 
4% (Alonso et al., 2000; Kessler et al., 2007). However, one must be cautious making 
comparisons between studies and using percentages as an indicator, as different studies 
of course use different measures, different cut-offs, and different standards for what is 
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deemed as being “difficulties” with anxiety or mood. Yet, while remaining cautions and 
skeptical, the percentages in the study compared to previous research seem to be high, 
and therefore one must attribute a degree of the anxiety, stress, and uncertainty in illness 
in this current sample to the diagnosis of CLL or LGL.  
 
5.3 Aim 2: Relationship between Psychological Variables at Time-1 
Another goal of the study was to determine the relationships that existed between 
uncertainty in illness and indicators of psychological distress (anxiety, depression, and 
traumatic stress) following a diagnosis of CLL or LGL. At time-1, following the 
diagnosis of CLL or LGL, there was only a moderate positive relationship with anxiety 
but not depression as measured by the HADS. The above result suggests that the more 
uncertainty the individual had about their diagnosis of cancer and subsequent treatment, 
the greater the level of anxiety.  
 
Relationship between Uncertainty in Illness and Post-Traumatic Stress  
One of the primary goals of the study was to determine the relationship between 
uncertainty in illness and post-traumatic stress as measured by the IES-R. At time-1, the 
only relationship that was detected in relation to post-traumatic stress was between 
uncertainty in illness and the intrusion subscale of the IES-R, where there was a 
moderate positive association between the two variables. Such an association between 
these two variables would lead one to make the determination that as uncertainty in 
relation to one’s illness increases, so would intrusive thoughts, which could be thoughts 
that are related to the individual’s diagnosis of cancer.  
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Relationships between Anxiety, Depression and Post-Traumatic Stress 
While uncertainty in illness was the primary psychological construct of interest of this 
current study, it is also important to outline the relationships that were found between the 
other psychological variables: anxiety, depression, and traumatic stress. Initially 
following a diagnosis of CLL or LGL, both anxiety and the HADS total score had a 
positive and moderate relationship with intrusion, avoidance, and the IES-R total score. 
Therefore, as the level of anxiety increased for the participant, one would expect that 
their levels of intrusion, avoidance, and IES-R total score would increase as well. 
 
5.3.1 Support for Hypothesis 2 
The relationships that were identified between the psychological variables (anxiety, 
depression, post-traumatic stress, and uncertainty in illness) provide support for the 
second hypothesis of the current research. Specifically, the primary construct of study, 
uncertainty as it relates to one’s illness was associated with anxiety, intrusion, and IES-R 
total scores at time-1. It is also important to note that although a number of moderate to 
strong relationships were found between the psychological variables, it does not infer a 
causal relationship, in that, one cannot state that uncertainty in illness is causing anxiety 
or that anxiety is causing one’s uncertainty in relation to their illness, as all the 
statistically significant relationships that were found only imply an interaction between 
the two variables. Further exploration of the variables in individuals with CLL or LGL 
would need to be undertaken to better understand causality. 
 
5.3.2 Aim 2: Theoretical Perspective and Past Research  
A number of studies have explored the relationship or associations between variables for 
those individuals with a diagnosis of CLL or LGL and uncertainty and other forms of 
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cancer. The results from these studies are in keeping with what one would expect: that 
higher uncertainty in illness would be associated with greater levels of emotional 
distress. Different studies have found that greater uncertainty in illness using Mishel’s 
outcome measures and outcome measures that focus on emotional distress (anxiety, 
depression, stress), have determined the strength of the relationships to be small to 
moderate (Sammarco, 2001; Liao et al, 2008; Sammarco & Konecny, 2008; Suzuki, 
2012; Lin Lin et al., 2013). Yet, all the above studies that measured uncertainty in illness 
and the relationships with psychological variables were not with a sample of patients 
who had a diagnosis of CLL or LGL and were not on a watch and wait pathway. Other 
studies highlighted the relationships between psychological variables such as post-
traumatic stress, depression, and anxiety (Geffen et al., 2004; Levin et al., 2007; 
Morrison et al., 2016). Theoretically, one may hypothesize that as uncertainty in illness is 
related to an individual being unable to predict outcomes to specific situations (illness 
related events), and when there are a lack of specific cues or prior knowledge, one would 
also expect that the inability to predict the outcome of the illness would lead greater 
psychological distress. As was found in the current study, the strongest relationships that 
were detected in relation to uncertainty in illness were both anxiety and intrusive 
thoughts, which one would hypothesize could develop from an inability to predict the 
future in regards to the cancer diagnosis or a difficulty understanding watch and wait as a 
form of intervention. There has been research to suggest that intrusions increase 
following a traumatic event, and these intrusions have been described by individuals as 
being “relatively brief sensory fragments” of the traumatic event, which take the form of 
“visual images, sounds, smells, taste of bodily sensations” (van der Kolk & Fisler, 1995; 
Ehlers et al., 2002). Although intrusions are common following a traumatic event, it is 
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also important to note that frequency or presence of intrusions are not strong predictors 
of post- traumatic stress (Shalev, 1992; Michael, Ehlers, Halligan & Clark, 2005), which 
places more emphasis on the important relationships that were detected at time-1. There 
is not enough data or information that would make the above inferences definitive in the 
current study, but it is important that future research possibly examine a relationship 
between uncertainty about one’s illness and intrusions as it relates to post- traumatic 
stress.  
 
5.4 Aim 3: Psychological Variables at Time-1 Predictive of Psychological Distress at 
6-months 
The aim of the multiple regression analyses was to determine whether psychological 
variables following the initial diagnosis would be predictive of psychological distress at 
6-months follow-up. It was hypothesized that uncertainty in illness would be the 
psychological variable that was most predictive of psychological distress at 6-months 
following an initial diagnosis of cancer; however, it is clear that the results were not as 
straightforward as was initially hypothesized. The only outcome variables that were 
analyzed were anxiety, depression, and trauma, as uncertainty in illness did not meet the 
initial assumption for linearity. Of the three regression models that were run, only two of 
the models were deemed to be statistically significant and, of those two, anxiety at 6-
months was the outcome variable wherein the predicted variance was the highest (62%). 
Within the regression model where anxiety at 6-months was the outcome variable, post-
traumatic stress at time-1 was the strongest predictor when compared to depression, 
which was also a statistically significant predictor of anxiety at 6-months. Although 
uncertainty in illness did not have the overall impact that was initially hypothesized, it 
  
135 
was a statistically significant predictor of depression at 6-months. As the findings from 
the multiple regression models were varied, it is difficult to draw well-defined 
conclusions in regards to the predictability of distress following a diagnosis of CLL or 
LGL with the current data. However, as posttraumatic stress was such a strong predictor 
of anxiety and depression, further analyses may benefit from hierarchal regression where 
outcomes associated with post-traumatic stress are input into the model first.  
 
5.4.1 Support for Hypothesis 3  
The findings from the regression analyses were not in keeping with the initial hypothesis, 
as it was thought that uncertainty in illness at time-1 would be the strongest predictor of 
psychological distress at 6-months, following diagnosis of CLL or LGL. Though 
uncertainty in illness was not the strongest predictor of distress, it was a predictor of 
depression at 6-months and was also one of the variables that played a role in predicting 
anxiety at 6-months. Therefore, one could conclude that the hypothesis of the regression 
analyses were partially met, due to the fact that uncertainty in illness was a factor in 
predicting psychological distress, even though it was not the strongest psychological 
predictor.   
 
5.4.2 Aim 3: Theoretical Perspective and Past Research 
A number of studies that were examined in the literature review attempted to determine 
factors that predict psychological distress or uncertainty in illness as they relate to one’s 
diagnosis of cancer. Certain studies from the literature review found that uncertainty in 
illness was predictive of psychological distress; however, the majority of these studies 
were with patients with CLL or LGL who were on a watch and wait pathway, but with 
other forms of cancer (breast, lung, head and neck, prostate), with differing levels of 
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severity (Sammarco, 2001; Sammarco & Konecny, 2008; Liao et al., 2008; Suzuki, 2012; 
Hall et al., 2014). The studies that used regression analyses to understand what variables 
could be predictive of CLL or LGL did not use the construct of uncertainty in illness and 
also did not use psychological variables as predictor variables; specifically, the two 
previous studies looked at physical symptom burden as being a coping style, and whether 
these areas were predictive of post-traumatic stress, anxiety, and depression 
(Montgomery et al., 2003; Morrison et al., 2016). Another important factor is that the 
majority of the studies that have been reviewed were cross-sectional in their design, and 
did not examine whether certain variables had an impact on other outcome variables at a 
later time-point within the same individual. The results in the study, although preliminary 
and underpowered are novel in that they highlight a number of psychological variables 
(uncertainty in illness, post-traumatic stress and anxiety) that could possibly play a role 
in predicting psychological distress for those individuals with CLL or LGL who have 
been placed on the watch and wait pathway of care.  
 
5.5 Aim 4: Change in Psychological Variables over Time 
The findings in regards to change over time were not what had been initially anticipated, 
as it was initially theorized that psychological distress related to a diagnosis of CLL or 
LGL would decrease over time, as participants would gain more knowledge about the 
watch and wait approach to treatment. It was thought that once the participants had 
received the diagnosis of CLL or LGL that their level of uncertainty, anxiety, depression, 
and post-traumatic stress would be at the highest point at time-1. The basis for the 
hypothesis was that it was believed that being told that you have a diagnosis of cancer, 
but that there would be no direct intervention, would be antithetical to how individuals in 
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western societies conceptualize or understand cancer and the subsequent treatment of 
cancer. For the outcome measures that attempted to capture the psychological constructs 
of anxiety, depression, and uncertainty in illness, there were higher scores at time-point 3 
(6-months) than at time-point 1 (following diagnosis), but the increases that were found 
were not statistically significant, as the data were rather similar over the three time 
points.   
  
For the IES-R total each of the three subscales that the outcome measure attempts to 
capture (avoidance, intrusion, and hyperarousal), there was a decrease between the time-
1 scores to 6-months following initial diagnosis. However, the decreases in the scores on 
the three subscales, over the three time-points, were not found to be statistically 
significant by the repeated measures analyses. In regards to the IES-R total score, the 
decrease over the three time-points was found to be statistically significant and, from the 
post-hoc analysis, the largest, significant decrease occurred between 3-month to 6-
months. In addition, the scores at both 3-months and 6-months following diagnosis 
dropped out of the area of clinical concern as measured by the IES-R, which could 
suggest that these participants would no longer be struggling with post-traumatic stress 
that could be associated with their diagnosis of CLL or LGL.  
 
Individual Change over Time – Reliable and Clinically Significant Change 
It was decided to investigate whether change occurred at an individual level using 
Jacobson and Truax’s reliable and clinically significant change analysis. Due to the fact 
that there was a relatively small sample, and because the data were positively skewed 
with high standard deviations, it was deemed important to investigate the individual 
participants in more depth, since the means may not be as indicative of change as 
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researchers had initially thought. Firstly, in regards to anxiety, the same amount of 
individuals improved and deteriorated (8-participants) over the three time points. In 
relation to depression as measured by the HADS, there were a greater number of 
individuals who improved over the three time points in comparison to those who 
deteriorated. However, it is important to highlight that in comparison to the other 
psychological variables that were measured using RCSC, depression had the highest 
number of participants who deteriorated between 2 time-points and this occurred 
between time-1 and three-months following diagnosis.  
 
In addition to more individual level change that was investigated in relation to anxiety 
and depression, the post-traumatic stress individual outcomes indicated changed had 
occurred. As a whole there were not substantial differences in terms of number of 
participants who improved in comparison to the number of participants who deteriorated 
over the different time-points, but when examining all of the subscales (avoidance, 
intrusion, hyperarousal) and the IES-R total, more individuals improved as opposed to 
deteriorated. The highest number of individual improvement was seen in hyperarousal 
and the IES-R total score, and the most significant time point that saw improvement was 
between 3 – 6 months (hyperarousal) and time-1 to 6-months (IES-R total).  
 
The final variable that was investigated in terms of individual change outcomes was 
uncertainty in relation to one’s illness. Similar to the post-traumatic stress variables, there 
was essentially no difference between those individuals who improved and those 
individuals who deteriorated, as 1 more participant deteriorated when compared to those 
who improved. This result was the most surprising finding, as one would have expected 
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that individually, the participants’ uncertainty in illness would have decreased as they 
became more educated about CLL or LGL and the process of watch and wait.  
 
5.5.1 Support for Hypothesis 4 
 
With the exception of one of the variables (IES-R total), the other variables associated 
with anxiety, depression, post-traumatic stress, and uncertainty in illness in this current 
population of participants, with a diagnoses of CLL or LGL, did not change in a 
statistically significant way over the 3 time-points. Although there was a trend with a 
number of the variables that highlighted a decrease from 3-months to 6-months, one 
wonders whether any trend would have continued at the 12-month follow-up time-point. 
Once data has been collected for all the participants and analyses re-run, it will be 
important to gain insight into whether any significant increase occurred. Yet, for the 
purposes of this current thesis, and the current write-up, the data does not support the 
initial hypothesis that there would be a significant decrease in psychological distress as 
time progressed, as individuals possibly developed a better understanding of CLL or 
LGL and watch and wait as a form of care. Overall, there was no clear significant trend 
of whether the participants in this current study improved or deteriorated over time. 
Although when examining the group data there is a general improvement for most 
variables over time and for the individual change data more people improved over time, 
the differences were negligible and not definitive in a way as to draw any specific 
conclusions.  
 
5.5.2 Aim 4: Theoretical Perspective and Past Research 
Previous research has attempted to examine uncertainty and psychological variables 
associated with well-being in cancer patients, and whether or not these variable increase 
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or decrease over time. However, as psychological research in cancer patients is not 
deemed to be of the utmost importance, there are not many studies that have examined 
uncertainty in illness and also patients with a diagnosis of CLL or LGL who are on the 
standard watch and wait pathway. The studies that have researched Michel’s construct of 
uncertainty in illness and whether or not the uncertainty in relation to one’s illness 
changed over time have been varied, as two of the studies found that uncertainty in 
illness decreased over time (Liao et al., 2008; Kazer et al., 2012) and the other study 
(Suzuki, 2012) found that uncertainty in illness increased, although the increase was not 
deemed to be statistically significant. The issue with generalizing the results from the 
above study is that each of the study populations had a different diagnosis of cancer 
(prostate, head and neck, and breast), and each of the studies were at a different time 
point in the disease process (pre-diagnosis (biopsy stage), during treatment, after 
treatment) (Liao et al., 2008; Kazer et al, 2012; Suzuki, 2012). Interestingly, the study 
where uncertainty in illness increased was the study where the participants had been 
treated for prostate cancer (Suzuki, 2012). The study that examined individuals with a 
diagnosis of CLL who were on watch and wait or active treatment was not clear about 
the change over time in the participants; the questionnaires were given out to the 
participants at different points making it unclear whether the same participants were 
given the same questionnaires at another time period, and therefore the results are not 
helpful in regards to change over time (Holtzer – Goor et al., 2015). Although the forms 
of cancer were different and the participants were at different points of the disease 
trajectory, the general trend was that psychological distress and uncertainty in illness 
would decrease over time, which is not in keeping with the findings from the current 
study.  
  
141 
 
A hypothesis as to why the previous research in this area has found a decrease in 
psychological distress and uncertainty in illness may be related to post-traumatic growth, 
where individuals have perceived positive changes or personal growth following a 
traumatic event or a serious crisis in one’s life (Tedeschi & Calhous, 1996; Bellizzi, 
2004). There has been recent research that has examined post-traumatic growth in 
individuals who have been diagnosed with cancer and who have undergone treatment. 
The research suggests that a number of these individuals may experience positive 
changes and a decrease in psychological distress due to the fact that they have challenged 
or changed their core-assumptions about the world. Such growth may lead to positive 
changes in interpersonal relationships, their overall life perspective, how the individual 
perceives themselves, and their own ability to cope with such a debilitating illness such 
as cancer (Brix et al., 2003; Morrill et al., 2008; Barskova & Oesterreich, 2009; Morrison 
& Shakespeare – Finch, 2011).  As highlighted previously, and in contrast to the above 
research, the data from this current study was not in keeping with the previous research 
in uncertainty in illness and CLL or LGL, as there was no statistically significant pattern 
or decrease found over time. One must hypothesize as to why this occurred, and some 
explanations could be that there is still concern about the outcome, that the participants 
may eventually require a more invasive form of active treatment, and therefore cannot 
reconceptualise their uncertainty or anxiety in a more positive frame. As one can only 
speculate, it will be important to analyze the 12-month follow-up data, as it may help 
with the understanding in relation to psychological change over time.   
 
As there was no distinct or clear pattern in regards to whether psychological distress 
increased or decreased over time or whether certain psychological variables are 
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predictive of psychological distress following a diagnosis, it is important to explore if 
other factors can play a role in how an individual reacts to a diagnosis of cancer. It is also 
important to note that those individuals who participated in the study remained medically 
stable throughout and therefore any change that was detected by the RCSC analyses need 
to be attributed to other factors. There has been research done that has examined how 
individuals respond to a cancer diagnosis and what factors may be predictive of 
emotional well-being following such a diagnosis. In regards to a diagnosis of CLL or 
LGL, a number of studies indicated that greater social support was predictive of 
psychological well-being following an individual’s cancer diagnosis (Sammarco, 2001; 
Sammarco & Konecny, 2008; Sammarco & Konecny, 2010; Morrison et al., 2016). 
These studies found that lower social support resulted in greater psychological distress; 
conversely, greater social support was a protective factor that resulted in less 
psychological distress following a diagnosis of CLL or LGL. However, similar to the 
findings in the current study, there were no other clear patterns in regards to factors that 
had an impact on emotional well-being following the cancer diagnosis. Therefore, it was 
helpful to explore research into other forms of cancer to determine if there are other 
factors, which are predictive of psychological well-being. The research into other forms 
of cancer highlighted a number of factors that may be helpful in determining how an 
individual will cope after their diagnosis. Specifically, certain factors that were consistent 
in different studies: social support, physical well-being, severity of the cancer, 
hopefulness (personal outlook), and ability to function physically (physical activity) 
(Clutton, Pakenham & Buckley, 1997; Moyer & Salovey, 1999; Dirksen, 2000; 
Balderson & Towell, 2003; Blank & Bellizzi, 2005; Lynch, Stegingna, Hawkes, 
Pakenham & Dunn, 2007; Iwatani, Matsuda, Kawabata, Miura & Matsushima, 2013; 
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Valdes – Stauber, Vietz & Kilian, 2013). Although not as pervasive in the research as the 
above factors, there has been other research to suggest that previous experiences of 
trauma, and previous mental health difficulties or diagnoses, are also predictive factors 
for psychological well-being following a cancer diagnosis (Green, Krupnick, Rowland, 
Epstein, Stockton, Spertus & Stern, 2000; Kornblith et al., 2001; Palmer, Kagee, Coyne 
& DeMichele, 2004; Okamura, Yamawaki, Taniguchi & Uchitomi, 2005; Alfano & 
Rowland, 2006). In terms of future research and based on the above factors, it may be 
helpful to undertake studies that attempt to investigate the above factors in patients with a 
diagnosis of CLL or LGL on the watch and wait pathway. Although, it is important to 
note that it is difficult to generalize the above results, as the research was done with 
different diagnoses of cancer of varying severity and one must be weary not to conflate 
these findings for the purposes of future research 
 
5.6 Limitations of Current Research  
5.6.1 Sample Size  
There are a number of limitations that need to be addressed with regards to the research 
that was undertaken and the methods used to collect and analyze the data. Firstly, due to 
the small sample, it is difficult to be definitive in regards to the different relationships 
that were discovered between the different variables. Although retention rate was high 
for those individuals who were initially approached to participate in the study, the 
number of people who were presenting to the Hematology Unit following a diagnosis of 
CLL or LGL was much lower than we had initially anticipated. The research team made 
potential participant estimates based on monthly data from the three previous years, for 
those patients referred to the Hematology Clinic at the local hospital following a 
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diagnosis of CLL or LGL, and who were subsequently placed on watch and wait 
pathway. However, during the year that researchers attempted to recruit individuals into 
this study, the number of individuals presenting to clinic with stage-1 CLL or LGL was 
markedly lower than what the data had indicated from previous years.  
 
As indicated above, the study did not reach the sample needed to be confident that a 
relationship existed between the variables based on the a priori power calculations; 
specifically, the study was underpowered in regards to the correlation analyses and in 
regards to the multiple regression analyses, and there were not enough participants to be 
confident in the specific findings.  
 
5.6.2 Homogenous Sample  
As was the expectation, there was a lack of diversity in terms of the overall sample as 
97% of the sample was White-British. Although the sample was indicative of the 
population from which the sample was drawn in terms of the diversity in the 
geographical location of the hospital. A problem with much psychological research is the 
lack of representation from minority and culturally diverse populations. Such an 
underrepresentation can lead to incorrect assumptions in terms of generalizability as well 
as “ethnocentric interpretations” which can lead to stereotyping of these 
underrepresented groups (Mak, Law, Alvidrez, & Perez-Stable, 2007; Richmond et al., 
2015). There is a dearth of research where the primary focus is attempting to determine 
the psychosocial needs of those individuals from culturally diverse or minority 
backgrounds (non-white populations) that have a diagnosis of cancer. However, there 
have been qualitative and quantitative studies that have attempted to gain insight into the 
needs of such under-represented populations after they have been diagnosed with a form 
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of cancer. Specifically, there has been research completed that highlighted that, following 
a diagnosis of cancer, individuals of an ethnic minority background may be less likely to 
inform members of their extended family of their diagnosis for fear of burdening them. 
Although these individuals can report higher levels of integration within their family, 
they may be less likely to use the family structure for support following such serious 
diagnoses and therefore may require greater support from the staff that provides care 
(Ashiwa – Giwan et al. 2007; Molina & Beresford, 2014; Molina et al, 2016).  
 
5.6.3 Outcome Measures  
The self-report measures used to measure psychological distress (HADS, IES-R) were 
selected because they have been used in many other psychological well-being and cancer 
research studies. The measures are also relatively short, not considered to be too time 
consuming for the participants, and the measures have also not been shown to cause 
participants any level of distress. In addition, the reliability and the validity of both the 
HADS and the IES-R have assessed in a number of different studies (Berry & Kennedy, 
2003; Woolrich et al., 2006; Creamer et al., 2003; Weiss & Marmar, 1997). The other 
self-repot measure that was used in this research, MIUS-SF, has not been as widely used 
as the HADS or the IES-R, and it has only been validated in what is known to be one 
study. The MIUS-SF was selected as a measure to determine level of uncertainty in 
illness for the participants, as put forth by Mishel’s uncertainty in illness theory. The 
short-form version of this measure was used because it was understood as being less 
invasive and time-consuming for the participants, who received no direct benefit from 
the research. Although, it was deemed important to be mindful of participants who are 
getting no direct benefit from the study when selecting measures, it is also important to 
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highlight the limitations of using a measure that has not been widely used in the 
literature. It was believed that the items on the MIUS-SF were “clear, concise, and 
specific” (Peterson, 2000; Podsakoff, 2003), but attempting to measure a construct as 
complex as uncertainty in illness, with an outcome measure of only 5-items, could of 
course be understood as being a limitation of the current research. 
 
5.6.4 Normative Data – Reliable and Clinically Significant Change  
Another limitation of the current study is directly related to Jacobson’s and Truax’s 
reliable and clinically significant change (RCSC) analyses, as it relates to the normative 
data that were used for the clinical. Specifically, the data that were used to provide 
clinical norms for MIUS-SF and the IES-R were not from individuals who had a 
diagnosis of either CLL or LGL. Also, the individuals who provided the normative data 
were not on a watch and wait pathway, and had a more serious form of cancer related 
illness than the participants in the current study. Therefore, the clinical norms that were 
used would have presumably been higher due to the fact that the individuals in the 
studies where the measures were validated could have been experiencing higher levels of 
distress, as they had a more serious form of illness. Essentially, the impact on the 
analyses would be that it would have been statistically more possible to detect a 
significant change due to the fact the mean score of the clinical population would be 
higher than the CLL or LGL participants. Although, one should not overstate the impact 
of the clinical norms as the findings from the RCSC analyses did not detect much change 
across all of the various time-points and all of the different dependent variables. One 
would be safe in hypothesizing that having clinical normative data for individuals with 
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CLL or LGL on the specific outcome measures used in the study would not have made 
much of a difference to the overall results of the study.  
 
5.6.5 Nursing Staff 
Another impact on the results of this study was that the initial idea for this research was 
developed by one of the research nurses, who currently work in the Haematology Clinic, 
at the local hospital. One could hypothesize that because a member of nursing staff was 
able to develop such novel research into uncertainty in illness, psychological distress, and 
cancer, that they may be more attuned to the psychological needs of the patients they see 
at the hospital - in comparison to other hospitals.  If so, the nursing staff at the hospital 
may have a better understanding of the psychological impact that a diagnosis of cancer 
and being placed on watch and wait can have, and that understanding may have resulted 
in greater education and support. In theory, a greater level of exposure about one’s illness 
and the implications of watch and wait may have manifested in lower levels of 
uncertainty in illness, in comparison to other clinics where nursing staff may not have as 
much insight into the above psychological constructs or where they may not be as 
psychologically minded. Therefore, similar to the way in which a homogeneous sample 
makes it difficult for one to generalize results to a larger population, a nursing team who 
have greater insight into psychological well-being of their patients would make one wary 
about generalizing the results to patients with CLL or LGL to other hematology clinics, 
and, moving forward, it would be of benefit to collect data from different hospitals.  
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5.7 Strengths of Research  
5.7.1 Novelty of Current Research  
Based on the literature review in the introduction chapter, there have been no studies that 
have attempted to follow individuals over time with a diagnosis of CLL or LGL on watch 
and wait, while attempting to understand the psychological impact that these diagnoses 
can have on an individual. To be more specific, and again, from examining the literature, 
the construct of uncertainty in illness has not been investigated in individuals with a 
diagnosis of CLL or LGL, using any type of research design. Although uncertainty in 
illness has been investigated in a number of other forms of cancer, it was surprising that 
it has not been undertaken with CLL or LGL, especially as the prevalence of both of 
these forms of cancer are quite high and the idea of being put on watch and wait could be 
confusing and frightening to many individuals. 
 
5.7.2 Longitudinal Design  
Another important strength was the design of the study.  The longitudinal approach that 
was taken is unlike much of the research that has been undertaken investigating 
psychological well-being in cancer patients, which has mostly been cross-sectional. 
Although we did not have enough individuals at 12-months to analyze the data, because 
of time limitations, data will be collected for the rest of the participants, and a final 
analysis will be conducted once each participant has submitted the 12-month outcome 
measures. Having data over such a time period is not the norm for psychologically based 
research for patients with CLL or LGLs; as a result, it is a hope that researchers will be 
able to develop more robust conclusions about the relationships that exist between the 
psychological variables.  
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5.7.3 Multi-Disciplinary Approach  
A real strength of the current research has been the multi-disciplinary approach, as there 
have been a number of different discipline specialists who have been involved and have 
contributed to the research process (nursing, medicine, clinical psychology, and 
academia). Conducting research in a collaborative way with individuals from various 
disciplines can provide greater insight or different perspectives when attempting to 
answer a research question. Individually, and within a particular area of specialty, it is 
possible for one to develop a degree of “tunnel vision”, in that, it may be difficult to 
think of different methods or ideas when undertaking the research process (Lyons, 2004). 
The input that this current research received from individuals with varying forms of 
training and knowledge allowed researchers to think psychologically about a medical 
problem, which hopefully provided a broader understanding in this specific area of 
research. 
 
5.8 Clinical Implications  
Keeping in mind the size of sample and homogeneity of the sample, there are a number 
of clinical implications that can be drawn from the current research. Firstly, as a high 
proportion of individuals at time-1 had scores that would place them in the clinical range 
for anxiety, post-traumatic stress, and uncertainty, it is important to follow-up with these 
individuals to determine if they could possibly need any form of mental health support. 
Specifically, a high proportion of individuals (27 %) would be considered in the severe 
range for post-traumatic stress and it therefore may be prudent to administer trauma 
questionnaires to these newly diagnosed patients to determine level of severity; if it is 
high, consider psychological or trauma informed approaches to assist with their level of 
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distress. Generally, if following the initial screening the individual’s level of distress 
were still high, the individual could possibly be referred to services that may be able to 
provide support with regards to difficulties associated with mental health and adjustment 
following a diagnosis of CLL or LGL. It is important that the medical support the 
patients receive remains paramount and primary; psychological support could be offered 
in conjunction with medical treatment if it is determined by the qualified health 
professionals involved that the patient’s level of distress as it relates to their illness is 
having a negative impact on their overall mental health.   
 
Although the results from the current research study are preliminary, and should be 
interpreted with caution, it is still important to note the possible implications of the 
findings, specifically as they relate to uncertainty in relation to one’s illness. The results 
from both the repeated measures and reliable and clinically significant change analyses 
indicated that uncertainty in illness increased over time, although the increase that was 
detected was not deemed to be statistically significant. Once there is finalized data from 
all of the participants at 12-months it will be interesting to determine whether or not this 
upwards trend of uncertainty in illness continues. If it is determined that the trend 
continues, it could provide one with some insight that the individuals who have been 
assigned to watch and wait may still have difficulty understanding the impact of the 
diagnosis and the implications for treatment on their overall health. Therefore, it may be 
beneficial to provide these individuals with increased support or increased education in 
relation to CLL or LGL and watch and wait as a form of care throughout the disease 
process. Given the current situation in the NHS, and how cuts (see suggestion below) 
have had an impact on staffing levels which has led to an understaffing of nurses, as well 
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as nurses having to assume greater workloads (McIvar, 2003; Coombs, Arnolad, Loan-
Clarle & Wilkonson, 2007; Keogh, 2013; Mahony, 2014), it may be naive to expect those 
in health care to be more cognizant of psychological constructs such as uncertainty in 
illness and an individual’s mental health. However, there has been previous research 
completed that attempted to determine whether providing cancer patients with more 
information and support in relation to their diagnosis and subsequent treatment could 
have a positive effect on their psychological well-being. A number of studies examined 
patient education (PE), which would include more information regarding the illness or 
symptom(s), the management of said symptom(s), and in-depth discussions on the 
different treatment options. As health practitioners may not have the time or resources to 
provide this information in person, booklets, videos, and other educational materials are 
often used as a means to provide more information (Williams & Schreier, 2004; Weaver, 
Bell & Sansom-Daily, 2015). The overall goal of supplementary information is to 
increase understanding for the individual in a manner that is more informed or systematic 
in comparison to the individual searching for information themselves, which also could 
serve to increase one’s uncertainty in illness and anxiety (Spalding, 2003). A meta-
analysis was completed to determine the efficacy of cognitive behavioural therapy (CBT) 
and PE on those individuals with a diagnosis of various forms of cancer and cancer 
survivors on their QoL and psychological well-being. The research found that there were 
similar effects when individuals engaged in CBT or PE, but the effects of the CBT 
seemed to last longer (Osborne, Demoncada & Feuerstein, 2006).  Although there were a 
number of limitations with the analyses and that CLL or LGL were not cancers that were 
part of the analyses, it is still an important finding that an increase in patient education 
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can have a similar effect to a psychological intervention on the well-being of the 
individuals diagnosed with cancer.  
 
As there were a high percentage of individuals who would be considered as having 
psychological distress following diagnosis and the distress did not change over time, it 
may be beneficial to offer support throughout the process in the form of support-groups. 
Again, due to the current environment within the NHS (Stubbings & Scott, 2003; Duffin, 
2009; Snow, 2010; Patters, 2011; Mahony, 2014), with regards to cut-backs and nursing 
staff not having time to take on more responsibility, it may not be feasible to offer further 
support, education, or direct psychological input for those individuals whose mental 
health may have been negatively impacted by their cancer diagnosis. Research has been 
done that has investigated the impact of peer support groups for those individuals who 
have a diagnosis of cancer and also the differences between peer-led groups and 
professional-led groups. The research on peer support has drawn upon coping theory, 
social comparisons, and helper-therapy principle, in order to understand the positive 
impact that such groups can have (Campbell, Phaneuf & Dean, 2004; Hooey, Ieropoli, 
White & Jefford, 2008). Research that has compared peer-led and professional-led 
groups, found no difference in terms of the impact the group has on those who are 
involved. Findings that indicate no real difference suggest that it is not the professional 
background of the group leader, but instead, whether the group provides a “supportive 
environment, mutuality, a sense of belonging and whether it meets the perceived needs of 
those attending” (Ussher, Kirsten, Butwow, Sandoval, 2005). Other qualitative research 
has explored the powerful impact that such groups can have on the individuals who have 
been diagnosed with cancer. Specifically, qualitative research has highlighted that such 
  
153 
peer-led groups have empowered participants and led to an increase in “personal 
agency”, an increase in “confidence and self-control”, and an ability to better live with 
one’s cancer (Gray, Fitch, Davis & Philips, 1997; Cohen & Schulz, 2000; Ussher, 
Kirsten, Butwow, Sandoval, 2005). Due to the fact that there is seemingly good evidence 
for the use of peer support for those individuals with a diagnosis of cancer, and that peer-
led groups do not lead to different outcomes from professionally-led groups, it may be 
positive for those individuals with CLL or LGL on watch and wait to engage in such a 
group. As this study found that the diagnosis of CLL or LGL and being put on watch and 
wait could have an impact on anxiety, stress, and uncertainty in illness, a group that is 
facilitated by individuals who have been on the watch and wait pathway for a period of 
time and who have also developed an understanding of what that entails, could provide 
others with a sense of normalcy, a degree of knowledge, and support.  
 
Although greater education and peer-support have been researched and have shown to 
have a positive impact on an individual’s anxiety, mood, and stress following a diagnosis 
of cancer, there are also specific psychological interventions that may prove helpful for 
these patients with CLL or LGL who have been placed on the watch and wait pathway. 
Although psychological intervention may not be a priority for those individuals with a 
cancer diagnosis in comparison to their physical well-being, it is still important to 
highlight the efficacy that specific interventions have had on the mental-health of those 
with a diagnosis of cancer. There have been a number of studies that have shown the 
positive impact of psychosocial interventions (CBT, psychotherapy, mindfulness 
therapies, etc.) on individuals after their diagnosis of cancer (Devine & Westlake, 1995; 
Jacobson & Jim, 2008; Trager et al, 2012). Although research on psychological 
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interventions with cancer patients has been done with different forms of intervention, the 
research seems to gravitate towards mindfulness-based strategies or mindfulness-based 
therapy for supporting individuals with their mental health in oncology settings 
(Hoffman, Sawyer, Witt & Oh, 2010). The understanding is that for cancer patients, 
using mindfulness-based interventions to pay attention to the “present reality” may prove 
a respite from past ruminations related to the cancer and diagnosis, or future worries 
about further psychological or physical pain which may be associated with the cancer 
(Specca, Carlson, Mackenzie & Angen, 2006; Piet, Wurtzen & Zachariae, 2012). Yet, as 
with most research, there are those who promote caution in terms of the efficacy of the 
aforementioned approaches, or the underlying mechanisms that may result in positive 
change, as much of the outcome data in oncological settings, as it relates to the 
psychological interventions, are not clear on the methods used in the intervention or the 
allocation of interventions for the participants (Newell, Sanson-Fisher & Savolainen, 
2002). Whether it is further education, peer-support groups, or specific psychological 
interventions, one cannot deny that there can be a psychological impact that a cancer 
diagnosis can have on the mental health of certain individuals. The findings from the 
present study would indicate that individuals with a diagnosis of CLL or LGL should be 
given options in attempting to manage their psychological difficulties, as a supplement to 
their cancer treatment.  
 
It is also important to highlight that such specific interventions (CBT, mindfulness), peer 
support groups, providing greater education, and understanding following a diagnosis of 
cancer can not only have an impact on an individual’s mental health, but can also 
improve an individual’s physical well-being. Although mental health and psychological 
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constructs have been the focus of this research, mental health and physical health should 
not be considered as being two disparate entities, as they are very much intertwined. To 
date, there has been research that has been completed with those individuals with a 
diagnosis of cancer and the impact that specific psychological or psychosocial 
interventions can have on both the individual’s mental health and their physical health. 
Specifically, much of the research has focused on psychological interventions and 
support groups in order to measure the impact that such methods can have on an 
individual’s immune response. The body’s immune system is the “chief defence” against 
disease and is the main function of the immune system is to attempt to eradicate foreign 
substances (pathogens) that come into contact with the individual’s body. Within the 
literature, studies examined specific immunological or biological markers such as 
cortisol levels, inflammation cytokine markers (ie. Interlukin-6 or C-reactive protein, 
immune cell counts, heart-rate, blood-pressure, and other forms of biological 
measurements) (Miller & Cohen, 2001; Carlson, Speca, Faris & Patel, 2006). The 2001 
meta-analyses by Cohen & Miller attempted to examine studies that assessed whether 
psychological interventions can have a positive impact on immune response; their 
analysis concluded that psychological interventions can have modest impact on “altering 
immune parameters” (Miller & Cohen, 2001). However, more recently, further studies 
and reviews have been completed which have found data to suggest that psychological 
interventions and support groups can have a more profound impact on both an 
individual’s mental and physical health following a diagnosis of cancer (Richardson et 
al., 1997; Kiecolt – Glaser, Cruess et al., 2000; McGuire & Robles, 2002; Carlson, 
Speca, Faris & Patel, 2006; McGregor & Antoni, 2009; Janusek, Tell & Matthews, 2015; 
Zhao, Cu, Wang, Su, Li & Uw, 2016). Yet, it is important to remain cognizant that the 
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research in this field have used varying biological markers, different psychological 
approaches, with different interventions, many of which that have not highlighted the 
specific program or what specific protocol was used with the cancer patients. More 
important than the above limitations, is that the findings from these studies were 
undertaken with different forms of cancer (prostate, breast, lung and others), with 
different levels of severity, and not with those patients with CLL or LGL. Therefore, one 
can understand that such findings are not only varied, but preliminary, and must be 
interpreted with caution. Yet, if one could generalize the above findings, it is that such 
interventions or approaches may not only be beneficial for an individual’s mental health, 
but may also help those physically following their cancer diagnosis and, therefore, may 
also be beneficial for those individuals who have a diagnosis of CLL or LGL 
 
5.9 Future Directions  
The original goal of the current study was to recruit individuals who have been placed on 
watch and wait and those who are engaged in active treatment for CLL or LGL; however, 
given the time constraints and the physical health concerns for those on active treatment, 
researchers were unable to undertake a study to compare these two groups. Although the 
findings have shown a preliminary relationship between uncertainty and variables 
associated with psychological distress following an initial diagnosis, it is important to 
compare individuals on watch and wait to those engaged in treatment, especially over 
time. Comparing these two groups would provide more of an understanding as to 
whether uncertainty in illness is in fact related to being put on watch and wait as opposed 
to a more direct intervention following a diagnosis of cancer. Again, there seems to be a 
gap in the literature in comparing individuals on watch and wait and those engaged in a 
  
157 
direct intervention, and the impact these different approaches can have on psychological 
well-being and uncertainty in illness. 
 
Another method that would provide greater depth and insight in this area would be to 
conduct qualitative research with individuals who have been diagnosed with CLL or 
LGL and to query the uncertainty that they are possibly experiencing in relation to the 
cancer diagnosis. In theory, it would be of benefit to engage in purposive sampling, 
inviting participants who have participated in the current research, particularly those who 
not only scored higher on uncertainty in illness at time-1, but also those participants who 
had high scores over the different time-points. Such purposive sampling would allow one 
to conduct qualitative interviews into whether that level of uncertainty in relation to their 
illness is related to being placed on watch and wait, confusion, or lack of understanding 
about their diagnosis. Conducting qualitative interviews from a sample drawn from the 
current population would provide greater depth and specificity about whether they are 
uncertain about other aspects of the cancer diagnosis, or more specifically about the 
intervention of watch and wait. Using qualitative methodology as a follow-up from this 
current research would be the ideal way to move forward, as this current research has led 
to more questions that qualitative research would hopefully be able to answer.   
 
In regards to more specific methods and analysis, it would be helpful to undertake a 
study with a much larger sample of individuals who have a diagnosis of CLL or LGL and 
to follow these individuals over time. In the current study, if researchers had a larger 
sample, it would have been deemed relevant to explore other time-1 variables 
(demographic data: gender, age, relationship) and determine if such variables are 
predictive of distress over time. As recruitment was always going to be a challenge for 
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the current study, it was deemed important to initially examine the psychological 
variables, as if one were to include demographic variables, the results would have been 
extremely underpowered. Aside from examining other variables in the regression 
analyses, it could also be helpful to follow-up the participants longer than the initially 
planned 12-month period. For the purposes of the doctoral thesis, having the 12-month 
follow-up was ambitious, and researchers were unable to recruit enough participants 
before the submission date that would have made the 12-month data informative. 
However, for research where the time limitations are not as stringent, it would be 
insightful to follow these individuals with CLL or LGL for years. As CLL and LGL are 
chronic illnesses, individuals can live with the disease for many years without 
experiencing symptoms, and would be beneficial to gain further understanding about 
mental health and general well-being for those patients.   
 
5.10 Research Summary  
The research demonstrated that some of the participants in this study who had a diagnosis 
of CLL or LGL and were on the standard watch and wait pathway were possibly 
impacted psychologically by their diagnosis and the form of intervention.  
 
At time-1, immediately following their diagnosis, there were a high proportion of 
participants who were above the clinical cut-off for anxiety, uncertainty in illness, and 
post-traumatic stress, which was found to be higher when compared to previous research 
in different cancer and normative populations. Over a quarter of these participants would 
also be considered to be in the severe range for post-traumatic stress, which could 
possibly be indicative of the overwhelming impact that such a diagnosis can have on an 
individual. Also, relationships were found to exist between a number of the 
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psychological variables at time-1 and one of the strongest relationships that was found 
was between an individual’s uncertainty as it relates to one’s illness and intrusion. The 
other relationship at time-1 that had the strongest association was between the 
participants’ anxiety and overall post-traumatic stress. Such relationships were in 
keeping with the previous research in this area, although the individuals had other forms 
of cancer with varying degrees of physical severity.  
The participants’ level of post-traumatic stress at time-1 was found to be the strongest 
predictor of psychological distress at 6-months, but other variables such as uncertainty in 
illness and anxiety were also predictive of psychological distress at 6-months. The above 
finding was not in keeping with the initial hypothesis, that uncertainty in illness would be 
the strongest predictor and again such a finding could be attributed to the traumatic 
experience of a diagnosis of cancer.  
 
From time-1 to 6-months following the initial diagnosis, the analyses of change over time 
were not indicative of much change, as it related to the psychological variables. 
Specifically, in regards to the group change and individual change data, there was not a 
decrease in psychological distress, as was initially hypothesized. However, it was found 
that post-traumatic stress as measured by the IES-R did decrease from time-1 to 6-
months; a change that was determined to be statistically significant. In addition, when 
one looks at the individual change data, it seems that the strongest effect sizes that were 
found were a decrease between 3-months to 6-months and one must query whether the 
psychological distress will continue to decrease once all the data is collected and 
analyzed at 12-months follow-up.  
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A diagnosis of cancer can be devastating for the individual, not only in terms of their 
physical health, but also their psychological well-being. More research needs to be done 
with these individuals who have a diagnosis of CLL and LGL to determine the impact 
that their diagnosis has on them psychologically and also to determine if certain methods 
or support can be helpful in alleviating some of that distress. Cancer has an impact on 
everyone, and although research will continue to develop new medical treatments to 
better care for and manage the illness, research that attempts to understand the impact 
that such illnesses have and the subsequent treatments can have on the individual’s 
mental health must continue.  
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Appendices 
 
A: Outcome Measures 
Hospital Anxiety and Depression Scale (HADS) 
Patients are asked to choose one response from the four given for each interview.   They 
should give an immediate response and be dissuaded from thinking too long about their 
answers.  The questions relating to anxiety are marked "A", and to depression "D".  The 
score for each answer is given in the right column.  Instruct the patient to answer how it 
currently describes their feelings. 
 I feel tense or 'wound up':   
  Most of the time 3 
  A lot of the time 2 
  From time to time, occasionally 1 
  Not at all 0 
  
 
I still enjoy the things I used to 
enjoy: 
  
  Definitely as much 0 
  Not quite so much 1 
  Only a little 2 
  Hardly at all 3 
 
 
I get a sort of frightened feeling 
as if something awful is about to 
happen: 
  
  Very definitely and quite badly 3 
  Yes, but not too badly 2 
  A little, but it doesn't worry me 1 
  Not at all 0 
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I can laugh and see the funny 
side of things: 
  
  As much as I always could 0 
  Not quite so much now 1 
  Definitely not so much now 2 
  Not at all 3 
 
 
Worrying thoughts go through 
my mind: 
  
  A great deal of the time 3 
  A lot of the time 2 
  
From time to time, but not too 
often 
1 
  Only occasionally 0 
  
 I feel cheerful:   
  Not at all 3 
  Not often 2 
  Sometimes 1 
  Most of the time 0 
  
 
I can sit at ease and feel 
relaxed: 
  
  Definitely 0 
  Usually 1 
  Not Often 2 
  Not at all 3 
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 I feel as if I am slowed down:   
  Nearly all the time 3 
  Very often 2 
  Sometimes 1 
  Not at all 0 
 
 
I get a sort of frightened feeling 
like 'butterflies' in the stomach: 
  
  Not at all 0 
  Occasionally 1 
  Quite Often 2 
  Very Often 3 
 
 
I have lost interest in my 
appearance: 
  
  Definitely 3 
  
I don't take as much care as I 
should 
2 
  I may not take quite as much care 1 
  I take just as much care as ever 0 
  
 
I feel restless as I have to be on 
the move: 
  
  Very much indeed 3 
  Quite a lot 2 
  Not very much 1 
  Not at all 0 
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I look forward with enjoyment 
to things: 
  
  As much as I ever did 0 
  Rather less than I used to 1 
  Definitely less than I used to 2 
  Hardly at all 3 
  
 I get sudden feelings of panic:   
  Very often indeed 3 
  Quite often 2 
  Not very often 1 
  Not at all 0 
 
 
I can enjoy a good book or 
radio or TV program: 
  
  Often 0 
  Sometimes 1 
  Not often 2 
  Very seldom 3 
Reference: 
Zigmond and Snaith (1983) 
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IMPACT OF EVENT SCALE-REVISED 
 
     Instructions: The following is a list of difficulties people sometimes have after stressful life 
events. Please read each item, and then indicate how distressing each difficulty has been for you 
during the past 7 days with respect to the disaster. How much were you distressed or bothered by 
these difficulties? 
   
Not 
at 
all 
 
A 
little 
bit 
 
Mod
erate
-ly 
 
Quite 
a bit 
 
Ex-
treme
-ly 
1 Any reminder brought back feelings about it. 
 
0 1 2 3 4 
2 I had trouble staying asleep. 
 
0 1 2 3 4 
3 Other things kept making me think about it. 
 
0 1 2 3 4 
4 I felt irritable and angry. 
 
0 1 2 3 4 
5 I avoided letting myself get upset when I thought about it 
or was reminded of it. 
 
0 1 2 3 4 
6 I thought about it when I didn’t mean to. 
 
0 1 2 3 4 
7 I felt as if it hadn’t happened or wasn’t real. 
 
0 1 2 3 4 
8 I stayed away from reminders about it. 
 
0 1 2 3 4 
9 Pictures about it popped into my mind. 
 
0 1 2 3 4 
1
0 
I was jumpy and easily startled. 
 
0 1 2 3 4 
1
1 
I tried not to think about it. 
 
0 1 2 3 4 
1
2 
I was aware that I still had a lot of feelings about it, but I 
didn’t deal with them. 
 
0 1 2 3 4 
1
3 
My feelings about it were kind of numb. 
 
0 1 2 3 4 
1
4 
I found myself acting or feeling like I was back at that 
time. 
 
0 1 2 3 4 
1
5 
I had trouble falling asleep. 
 
0 1 2 3 4 
1
6 
I had waves of strong feelings about it. 
 
0 1 2 3 4 
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1
7 
I tried to remove it from my memory. 
 
0 1 2 3 4 
 
 
1
8 
I had trouble concentrating. 
 
0 1 2 3 4 
 
1
9 
Reminders of it caused me to have physical reactions, such 
as sweating, trouble breathing, nausea, or a pounding heart 
0 1 2 3 4 
 
       
2
0 
I had dreams about it. 
 
0 1 2 3 4 
 
2
1 
I felt watchful and on guard. 
 
0 1 2 3 4 
2
2 
I tried not to talk about it. 0 1 2 3 4 
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MISHEL UNCERTAINTY IN ILLNESS SCALE (Adult) 
 
INSTRUCTIONS: 
 
Please read each statement. Take your time and think about what each 
statement says in terms of your illness. 
 
Then place an “X” under the column that most closely 
measures how you are feeling TODAY. If you agree with a statement, then 
you would mark under either “Strongly Agree” or “Agree.” If you disagree 
with a statement, then mark under either “Strongly Disagree” or “Disagree.” 
 
If you are undecided about how you feel, then mark under “Undecided” for 
that statement. 
Please respond to every statement. 
 
1. I have a lot of questions without answers. 
 
Strongly Agree  Agree  Undecided      Disagree  Strongly Disagree 
  (5)     (4)         (3)      (2)      (1) 
____   ____      ____     ____   ____ 
 
2. I understand everything explained to me. 
 
Strongly Agree  Agree  Undecided   Disagree  Strongly Disagree 
(5)     (4)        (3)        (2)   (1) 
____   ____       ____       ____           ____ 
 
3. The doctors say things to me that could have many meanings. 
 
Strongly Agree  Agree  Undecided   Disagree  Strongly Disagree 
 (5)     (4)         (3)       (2)     (1) 
____    ____       ____       ____    ____ 
 
4.  There are so many different types of staff, it’s unclear who is responsible 
           for what. 
 
Strongly Agree  Agree  Undecided   Disagree  Strongly Disagree 
(5)     (4)        (3)        (2)   (1) 
____   ____      ____       ____   ____ 
 
5. The purpose of each treatment is clear to me. 
 
Strongly Agree  Agree  Undecided   Disagree  Strongly Disagree 
(5)     (4)          (3)        (2)   (1) 
____   ____        ____     ____   ____ 
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B: Patient Information Sheets  
 
Participant Consent Form 
 
“Watch and Wait” examining potential uncertainly in illness, depression and anxiety in 
patients with Chronic Lymphocytic Leukaemia or Low Grade Lymphoma. 
 
Principle Investigators:    Ms Tina Hickey, Clinical Trial Sister. Colchester 
General Hospital 
   Dr Michael Hamblin, Consultant Haematologist. Colchester 
General Hospital 
   Mr Seamus O’Byrne (D Clin psych) student, Essex University. 
  
Study Identification number _____________________________ 
Initial in each box 
1. I have read and understood the information sheet for the above study and have  
had the opportunity to ask questions. 
 
2. I agree to take part in this study and to complete questionnaires. 
 
3. I understand my participation is voluntary and that I am free to withdraw at any  
time, without giving a reason, and without my medical or legal rights being 
affected.  
 
4. I agree that sections of my medical notes may be viewed by responsible members  
of the research team at Colchester General Hospital or by regulatory authorities 
where  
it is relevant to my taking part in research. I give permission for these individuals 
to have access to my records.  
 
5. I agree that my details will be kept on an anonymised database.  
 
6. I agree that my anonymised responses may be shared in scientific publications  
and at scientific meeting.  
 
7. I agree that the data collected may be used in an anonymised form for research 
and educational purposes in the future. 
 
 
8. I agree for my GP to be informed about my participation in the study 
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Participant: 
 
Print Name____________________________________________________ 
 
Signature_____________________________________________________ 
 
Date_________________________________________________________ 
 
 
Researcher: 
 
Print Name______________________________________________________ 
 
Signature______________________________________________________ 
 
Date_________________________________________________________ 
 
 
Original copy of this form must be stored in site file, a copy offered to participant 
and a copy filed in the clinical notes 
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GP Information Sheet  
 
Haematology Clinical Trials 
Colchester General Hospital 
Turner Road 
Colchester 
Essex 
CO4 5JL 
Tel 01206 746421 
 
[Recipient Name] 
[Recipient Address] 
 
 
[Date] 
 
Dear Dr [Recipient] 
 
Re:  [Participant Name]     [Participant Address or DOB] 
 
I am writing to inform you that the above patient has consented to participate in a 
research study investigating the potential impact of uncertainty on depression, anxiety 
and trauma in patients with untreated Chronic Lymphocytic Leukaemia or Low Grade 
Lymphoma on “Watch and Wait”. The study involves completing questionnaires at 
regular intervals, and does not affect medical management in any way. The study is being 
run by Mrs Tina Hickey Clinical trials sister, Dr Mike Hamblin Haematology Consultant 
and Mr Seamus O’ Bryne who is studying for a Doctorate in Clinical Psychology at the 
University of Essex. The study has received approval from the East of England- Essex 
Research Ethics Committee  (REC reference number: 16/EE/0414). 
 
Please find enclosed a copy of the study information leaflet and signed consent form for 
your reference and inclusion in the patient's records. Should you have any questions or 
concerns about your patient participating in this study, please do not hesitate to contact 
the team on 01206 746421.  
 
 
Yours sincerely, 
 
 
 
Tina Hickey 
Clinical Trials Sister 
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Patient Information sheet 
 
Investigators     Ms Tina Hickey, Clinical Trial Sister. Colchester General 
Hospital 
   Dr Michael Hamblin, Consultant Haematologist. Colchester 
General Hospital 
   Mr Seamus O’Byrne, (D Clin Psych) trainee, Essex University. 
 
Introduction 
 
You are invited to take part in a research study.  It is entirely up to you to decide whether 
or not you would like to join the study.  Before you decide we would like you to 
understand why the research is being done and what it involves for you.  Your 
participation is completely voluntary, it’s up to you. 
 
Please take time to read the following information about the research study carefully.  
Talk to others about the research study if you wish and please ask your doctor or research 
nurse if you have any questions or would like more information. 
 
 Mr Seamus O’Byrne will be analysing the data provided by the questionnaires as part of 
his Doctorate in Clinical Psychology (D Clin Psych) from Essex University.  
 
Purpose of the research study 
 
There is very little research to describe the quality of life patients experience following a 
diagnosis of Chronic Lymphocytic Leukaemia or Low Grade Lymphoma during the 
period when your disease is being monitored on “Watch and Wait” and you do not 
require treatment.  Up until now, nearly all studies of quality of life in patients like you 
have been confined to clinical trials studying the effects of different chemotherapy 
regimens on your quality of life.  Therefore, the lack of knowledge about what quality of 
life issues patients face limits the ability of the health care team to deliver effective 
treatments to address your needs.  
 
Firstly, this study aims to collect information about the impact your diagnosis has had on 
your quality of life, in particular potential levels of uncertainty in illness, anxiety, 
depression or trauma.  Secondly, we would like to understand if levels of anxiety, 
depression or trauma change over the first year following your diagnosis.  Thirdly, does 
“uncertainty” about how your illness may change or develop have any influence on 
potential levels of anxiety, depression or trauma as time goes on and you are living with 
your condition.  
 
People can live with Chronic Lymphocytic Leukaemia or Low Grade Lymphoma for 
decades without any need for treatment and therefore, the goal of therapy for these 
patients is to maintain the highest quality of life.  Chronic Lymphocytic Leukaemia or 
Low Grade Lymphoma can be associated with a number of potential issues that could 
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affect you socially, physically or emotionally and subsequently have an impact on your 
quality of life. 
 
Why have I been invited to take part? 
 
You have been invited to consider taking part in this study because you have recently 
been diagnosed with Chronic Lymphocytic Leukaemia or Low Grade Lymphoma and 
your Hospital Specialist has assessed that at present your disease does not require any 
intervention or active treatment, but you will be monitored closely to see if and when 
treatment should start.  This approach is commonly called “Watch and Wait” and is 
based on evidence that suggests immediate or early treatment of patients with “low or 
intermediate level” of disease does not prolong the life of the patient.  
 
Do I have to take part? 
 
It is up to you whether or not you want to take part as participation is entirely voluntary.  
Your treatment and monitoring will be the same whether you take part or not.  Whether 
or not you decide to take part you will be given this information sheet to keep, and only 
asked to sign a consent form if you do decide to take part.  You are free to withdraw from 
the study at any time and without giving a reason.   A decision to withdraw from study 
will not affect the standards of your care. 
 
What will happen to me if I do take part? 
 
We are asking people with a recent diagnosis of Chronic Lymphocytic Leukaemia or 
Low Grade Lymphoma to complete 3 different questionnaires designed to measure levels 
of anxiety, depression or trauma.  We ask that you complete the questionnaires honestly 
and answer all questions if you can, though you do not have to give answers if you prefer 
not to. 
 
1. Hospital Anxiety and Depression Scale (HADS) 
2. Mishel’s Uncertainty in illness questionnaire (MUIS) 
3. Impact of Events Scale-revised (IES-R) 
We will approach you when you attend your routine clinic to complete these 
questionnaires. The first time will be within the first 3 months of diagnosis.  These 
questionnaires will be repeated 3 months later, 6 months later and finally at 12 months. 
 
We anticipate it will take approximately 20 minutes to complete all the questionnaires at 
each visit.  
 
What will happen if my disease changes and I need treatment? 
 
If your clinical situation changes after signing consent but before the final time point at 
12 months, then you will be re-assessed against the study’s inclusion and exclusion 
criteria.  If you no longer meet all inclusion/exclusion criteria at any time before 
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questionnaire completion, then you will be withdrawn from the study.  Examples would 
include disease changing from "watch and wait" pathway to requiring intervention 
treatment or in the unlikely event that you lose the ability to make your own choices and 
decisions after the consent process. 
 
Personal Information 
  
Participants who give written consent to participate will have baseline personal data and 
clinical data recorded.  This will include age, gender, ethnicity, religion, occupation, 
marital status, general well-being, disease stage, date of diagnosis, and any other 
illnesses.  This information may be collected from your medical notes or from you in 
person.  Information that identifies you such as your name and date of birth will be kept 
confidential. 
 
What are the possible disadvantages and risks of taking part? 
 
The risks of this research are minimal.  The proposed questionnaires for this study have 
not been reported to cause psychological or physical distress.  This study does not 
influence the treatment your Doctor has planned for you.  We will ask you to attend an 
additional visit to complete written consent.  You will not need to see your Doctor more 
often than you normally would but your visit will take longer whilst you complete 
questionnaires. 
 
What are the possible benefits of taking part? 
 
Participants may receive no direct benefit from this study, however, this study is intended 
to gain a better understanding of how your disease affects you whilst on “watch and 
wait” monitoring.  Taking part may provide insight and help healthcare professionals 
support those individuals seeking assistance with their anxiety and depression and design 
effective interventions to address the needs of future patients. 
 
Will I incur any expense will I be paid to take part? 
 
No. It will not cost you anything to take part in this study. Neither you nor this hospital 
will be paid for taking part in the study.  The questionnaires will be completed when you 
come to clinic for review with your Consultant Haematologist. You will not receive any 
financial reward for completing questionnaires even if we ask you to attend additional 
visit to complete questionnaire or provide written consent. 
 
Will my GP be told that I am part of this study? 
 
Yes. We will inform your GP that you are taking part in this study so that you can access 
support from them in the unlikely but possible circumstance that the questionnaires’ 
cause you any distress  
 
 
 
  
203 
What if there is a problem? 
 
Wish to complain formally, you can do this through your local hospitals Patient Advice 
and Liaison (PALS), or the NHS Complaints Procedure.  You can contact PALS by 
calling the hospital on 01206 747474 and asking to speak to the PALS team. 
If you have any questions about the research during this study you may contact: Tina 
Hickey on 01206 746421 or Clinical Trials Manager on 01206 744496. 
 
Will my taking part in the study be kept confidential? 
 
In you consent to take part in study you will be assigned a unique number which will be 
used to connect your questionnaire and personal data throughout the study. We will 
collect your name and initials on consent form with assigned unique number. .The 
Principal Investigator will ensure any information collected about you during the course 
of your participation will be kept strictly confidential and stored on a secure, restricted 
access computer or a locked filing cabinet in the research office at Colchester Hospital. 
Your anonymized study data will be available for future ethically-approved research and 
educational purposes, without your identity being made known.  Do discuss that with us 
if that would be a problem for you. 
 
Who has reviewed and approved this study? 
 
This study has been reviewed and approved by the Essex NRES Research Ethics 
Committee East of England, and by the Research and Development Department of 
Colchester Hospital.  
 
What will happen to the results of the study? 
 
The results of this research will be published in a medical journal after the study has been 
completed. Your research team should tell you the results and how you can access the 
published results. 
 
Patients will not be identified in any report or publication 
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C: Graphs and Tables: Assumptions Testing  
Normality Table – Shapiro Wilk’s Test Initial Data 
Psychological 
Measures 
Shapiro – Wilk 
 Statistic df Sig. 
Anxiety Time-1 .887 23 .014 
Anxiety 3-Months .883 23 .013 
Anxiety 6- Months .987 23 .151 
Depression Time-1 .812 23 .001 
Depression 3-
Months 
.835 23 .001 
Depression 6-
Months 
.801 23 .000 
HADS Total Time-1 .906 23 .033 
HADS Total 3-
Months 
.880 23 .010 
HADS Total 6-
Months 
.857 23 .004 
Intrusion Time-1 .907 23 .035 
Intrusion 3-Months .901 23 .027 
Intrusion 6-Months .858 23 .004 
Avoidance Time-1 .948 23 .263 
Avoidance 3-Months .925 23 .085 
Avoidance 6-Months .929 23 .102 
Hyperarousal Time-
1 
.844 23 .002 
Hyperarousal 3-
Months 
.868 23 .006 
Hyperarousal 6-
Months 
.793 23 .000 
IES-R Time-1 .950 23 .290 
IES-R 3-Months .932 23 .118 
IES-R 6-Months .905 23 .031 
MIUS-SF Time-1 .969 23 .657 
MIUS-SF 3-Months .949 23 .273 
MIUS-SF 6-Months .940 23 .176 
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Normality Table Log Transformed Data– Shapiro Wilk’s Test 
Psychological 
Measures 
Shapiro – Wilk 
 Statistic df Sig. 
Anxietylog Time-1 .920 23 .076 
Anxietylog 3-
Months 
.927 23 .105 
Anxietylog 6- 
Months 
.912 23 .052 
Depressionlog Time-
1 
.922 23 .083 
Depressionlog 3-
Months 
.959 23 .465 
Depressionlog 6-
Months 
.946 23 .263 
HADSlog Total 
Time-1 
.950 23 .313 
HADSlog Total 3-
Months 
.958 23 .441 
HADSlog Total 6-
Months 
.947 23 .227 
Intrusionlog Time-1 .944 23 .283 
Intrusionlog 3-
Months 
.923 23 .089 
Intrusionlog 6-
Months 
.953 23 .359 
Hyperarousallog 
Time-1 
.935 23 .002 
Hyperarousallog 3-
Months 
.890 23 .019 
Hyperarousallog 6-
Months 
.912 23 .046 
IES-Rlog Time-1 .877 23 .011 
IES-Rlog 3-Months .936 23 .041 
IES-Rlog 6-Months .906 23 .013 
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D: Variables: Time-1  
Anxiety Histogram, Box Plots and Q-Q Plots 
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Variables: Time-1  
Depression Histogram, Box Plots and Q-Q Plots 
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Variables: Time-1 
HADS Total Histogram, Box Plots and Q-Q Plots 
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Variables: Time-1 
Intrusion Histogram, Box Plots and Q-Q Plots 
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Variables: Time-1  
Avoidance Histogram, Box Plots and Q-Q Plots 
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Variables: Time-1 
Hyperarousal Histogram, Box Plots and Q-Q Plots 
 
 
 
 
 
  
212 
Variables: Time-1 
IES-R Total Histogram, Box Plots and Q-Q Plots 
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Variables: Time-1 
MIUS-SF Histogram, Box Plots and Q-Q Plots 
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E: Log Transformed Variables: Time-1  
Anxiety Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1 
Depression Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1 
HADS Total Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1 
HADS Total Histogram, Box Plots and Q-Q Plots 
 
 
 
 
 
  
218 
Log Transformed Variables: Time-1  
Intrusion Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1 
Avoidance Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1 
Hyperarousal Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1 
IES-R Total Histogram, Box Plots and Q-Q Plots 
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Log Transformed Variables: Time-1  
MIUS-SF Histogram, Box Plots and Q-Q Plots 
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F: Correlation Time-1  
 
Anxiety and Depression 
 
 
 
Anxiety and Intrusion  
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Anxiety and Avoidance  
 
 
 
 
 
 
Anxiety and IES-R Total  
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Anxiety and Uncertainty in Illness  
 
 
 
HADS Total and Intrusion  
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HADS Total and Avoidance   
 
 
 
HADS Total and IES-R Total  
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Intrusion and Avoidance  
 
 
 
Intrusion and Uncertainty in Illness  
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Avoidance and IES-R Total  
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G: Multiple Regression 
IESR Outcome Variable Transformed Data 
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Anxiety Outcome Variable Transformed Data 
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Depression Outcome Variable Normal Data 
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Depression Outcome Variable Transformed Data 
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H: Trauma Outcome: Histogram and Scatter Plot Residuals  
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Anxiety Outcome: Histogram and Scatter Plot Residuals  
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Depression Outcome: Histogram and Scatter Plot Residuals  
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I: Changes over Time Figures 
 
Group Change (Time-1 to 6-Months) 
 
 
Figure 1: Repeated Measures: Anxiety 
 
 
Figure 2: Repeated Measures: Depression 
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Figure 3: Repeated Measures: HADS Total Score 
 
Figure 4: Repeated Measures: Avoidance Subscale 
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Figure 5: Repeated Measures: Intrusion Subscale 
 
Figure 6: Repeated Measures: Uncertainty in Illness 
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Figure 7: Freidman’s ANOVA: Hyperarousal 
 
Figure 8: Freidman’s ANOVA: IES-R Total Score 
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J: Individual Change (Time-1 to 6-Months) 
 
 
 
Figure 9: Anxiety  
 
 
 
Figure 10: Depression 
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Figure 11: HADS Total  
 
 
 
Figure 12: Avoidance  
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Figure 13: Intrusion  
 
 
 
Figure 14: Hyperarousal 
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Figure 15: IES-R Total  
 
 
 
 
Figure 16: Uncertainty in Illness  
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